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VI. Thesis Abstract 
The aim of this Thesis was to further characterise and utilise an in vitro skeletal 
muscle (SkM) model, to investigate its potential use in further understanding the 
cellular and molecular adaptations to exercise in vivo. Candidate genes and 
proteins have been identified using in vivo, ex vivo and targeted in vitro 
experiments, however the complete picture of these molecular mechanisms are 
far from understood. Furthermore, the extent to which mechanical signals 
contribute to the intra-cellular mechanisms associated with exercise is also 
underinvesitgated. To this end, developing an in vitro model of SkM that can 
recapitulate in vivo SkM and respond to mechanical stimulation in a similar way 
to exercise will provide a means to begin to delineate the complex cellular and 
molecular regulation of SkM. 
The initial investigation (Chapter 3) characterised an optimal seeding density and 
culture period of C2C12 myoblasts within a 3 ml collagen gel. These data 
provided support for the use of collagen constructs seeded at 4 x 106 cells/ml, 
with no statistical differences observed in peak force, rate of force development 
and relative force compared to other seeding densities examined (table 3-2, all 
p > 0.05). However the use of 4 x 106 cells/ml supports previous data in a larger 
construct volume model, whilst the highest cell density possible in the system 
increases cell-cell contact required for fusion. Immunohistochemical and gene 
expression analyses provided evidence for the fusion of single seeded myoblasts 
into multinucleate myotubes, demonstrating an in vivo-like architecture.  
Chapter 4 presented data towards the characterisation and use of two distinct 
cyclical stretch regimens with respect to the acute biochemical and 
transcriptional responses. Data revealed increases in peak media lactate and 
reductions in peak media glucose, following cyclical stetch compared to control 
(p = 0.000 and p = 0.001 respectively, Fig. 4-2). Changes in mtDNA (Fig. 4-5) and 
associated mRNA transcriptional signals (Fig. 4-7) were mode dependent.  
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Chapter 4 presented a model of in vitro mechanical overload to investigate 
whether such a system could be used to investigate the mechanisms that 
regulate hypertrophy in SkM. Continuous static and ramp loading induced a 
transcriptional hypertrophic response (increases in IGF-I, MMP-9, p < 0.05, Fig. 5-
3 and reduction in IGFBP-5 mRNA’s, p = 0.027 and p = 0.059, Fig. 5-4) with 
disticint differences in the modes of overload employed, suggesting a mechano-
specific response of certain genes.  
Efforts towards optimising metods to investigate the intra-cellular signalling 
mechanisms that may underpin the responses to mechanical stretch were 
investigated and presented in appendix 1.  
The data presented in this Thesis demonstrates the development and novel use 
of an in vitro SkM model to investigate the acute response of SkM to increase 
loading. The characterisation detailed here will allow for future investigations to 
further advance our understanding of the complex interactions of mechano-
responsive genes and proteins in that regulate SkM plasticity.  
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1.1 General Introduction 
The experiments described in this Thesis represent work that has been 
undertaken to further develop, characterise and utilise an in vitro skeletal muscle 
(SkM) model to investigate the effect of mechanical loading upon the 
biochemical and molecular responses to SkM cells. This novel model 
characterisation presents a highly controllable and dynamic system, whereby the 
effects of mechanical signals on muscle cell biology can be investigated.   
When seeking to further understand in vivo SkM cell biology, it is necessary to 
appreciate existing knowledge concerning normal SkM development. When 
developing bio-mimetic tissue in vitro, the process of embryonic development is 
highly recapitulated. To this end, the mechanisms involved in this process will be 
highlighted to provide background to the processes underpinning the SkM tissue 
engineering. Furthermore, when seeking to develop a bio-mimetic model in vitro 
it is important to understand the structure and function of the native tissue. The 
review of literature will describe the structure and function of in vivo SkM, 
drawing on the important features to recreate in vitro.   
Investigating whether an in vitro model can recreate mechanisms which are key 
to in vivo SkM adaptation, it is crucial to highlight the key genes and proteins 
involved. As such, the review of literature will focus upon the key genes and 
proeteins that are postulated to regulated SkM adaptation, allowing for the 
targeted identification of manipulated mechanisms in the experimental model 
used.   
1.2 Embryonic Skeletal Muscle Development 
The embryonic development of SkM is a highly sophisticated process, but has 
been investigated extensively in the hope of understanding the mechanisms that 
contribute to musculoskeletal abnormalities from birth. Research has also sought 
to identify the stem cell populations that SkM is derived from in the embryo, to 
ascertain potential mechanisms that could provide therapy for musculoskeletal 
diseases.  
 3 | P a g e  
 
The formation of SkM in the embryo stems from the paraxial mesoderm which 
divides into somites on each side of the neural tube and the notochord 
(Buckingham, et al., 2003). Work in the 1970’s identified that the muscles of the 
limb and body develop from the dermomyotome edge of the somites (Christ, et 
al., 1974, Christ, et al., 1977). Further evidence suggests the epaxial region of the 
dermomyotome gives rise to the back musculature whilst the hypaxial region 
gives rise to the limb muscles (Buckingham, et al., 2003).  
Conversely, muscles of the head and neck develop from the preoptic axial and 
paraxial head mesoderm (Noden, 1983), contributing to a population of muscle 
precursor cells that are distinct from limb muscle in relation to molecular 
characterisation (McLoon, et al., 2007). The surface of the epaxial region of the 
dermomyotome de-epithelises and gives rise to a progeny of cells termed 
mesenchymal muscle precursor cells (MPC’s), which have the ability to migrate 
to the somatopleural mesoderm of the limb anlagen  (Christ and Brand-Saberi, 
2002). These cells then proliferate, differentiate and fuse to form the developing 
muscles. The patterning and migration of cells derived from the dermomytome 
rely on the presence of key proteins, including c-met and hepatocyte growth 
factor (HGF, Dietrich, et al., 1999). The presence of the transcription factor Pax3 
is essential for the expression of c-met, with Pax3 mutant mice displaying the 
absence of limb musculature (Tajbakhsh, et al., 1997).   
The mechanisms associated with the specification of myogenic cells rely heavily 
on a group of proteins belonging to the basic helix-loop-helix (bHLH) family of 
proteins, also termed the myogenic regulatory factors (MRF’s, Hawke and Garry, 
2001). Commitment of MPC’s to the myogenic lineage (cells now termed 
myoblasts) is characterised by the expression of MyoD and Myf5, with transgenic 
overexpression of these proteins inducing myogenic cell fate of cells from 
multiple lineages (Choi, et al., 1990).  
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The expression of these determination factors is present even before the 
formation of the myotome and they bind to the promotor regions of genes 
required for the execution of the myogenic programme (Buckingham, et al., 2003, 
Fig. 1-1). The expression of MRF’s myogenin and MRF-4 mark the differentiation 
and fusion of myoblasts to differentiated multinucleated myotubes (Buckingham, 
2003, Fig. 1-1). The number of these post-mitotic cells is set in utero and as a 
consequence do not have the ability to regenerate following damage and/or 
trauma. The regenerative process is therefore supported by population of 
resident stem cells.   
 
 
Figure 1-1. The embryonic development of SkM. (From Buckingham et al., 2003).  
 
 
 
 
 5 | P a g e  
 
1.3 Skeletal Muscle Structure and Function 
SkM facilitates the controlled voluntary movement of the body through 
attachments directly or indirectly via tendons, to the skeleton. The macroscopic 
orientations of SkM fibres are longitudinal in relation to the direction of 
movement, towards the proximal site of attachment (Smith, et al., 2010). The 
highly organised structure of SkM, both grossly and ultra-structurally permits the 
controlled generation of vector force for movement.  
1.3.1 Gross Structure and the Extra-Cellular Matrix 
SkM comprises of both cellular and extra-cellular components, working 
synergistically for the transmission of force. SkM consists of bundles of 
multinucleated cells (fibres), which align parallel to the axis of movement (Sciote 
and Morris, 2000, Fig. 1-2). The size of each muscle fibre can range in terms of 
diameter and length, with some fibres stretching the length of the whole muscle 
itself. The gross contractile protein filaments of the muscle fibre (termed 
myofibrils), occupy much of the intracellular space, and consequentially the 
nuclei, mitochondria and other organelles are located peripherally (Sciote and 
Morris, 2000). 
The extra cellular matrix (ECM) of SkM functions not only to support the muscle 
fibres, but also the supplying blood vessels and the motor nerves. There are 
three main layers of ECM within SkM, providing a supporting network of 
anchorage for the tissue. Each individual fibre is surrounded by the endomysium 
(basal lamina), incorporating a random network of collagen fibres in order to 
facilitate contraction (Smith, et al., 2010). In turn, fibres are grouped into 
bundles (fascicles) surrounded by the perimysium. This layer is more organised 
than the endomysium, with a multi-layered structure lying transverse to the axis 
of the muscle fibres (Gillies and Lieber, 2011). The complete tissue is surrounded 
by a double layered structure termed the epimysium.  
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Figure 1-2. The gross structure of SkM. (From, Gillies and Lieber, 2011).  
1.3.1.1 Collagen as a Major Structural Protein of Skeletal Muscle Extracellular 
Matrix 
There are four classes of extracellular matrix proteins within SkM; collagenous 
glycoproteins, non-collagenous glycoproteins, proteoglycans and elastin (Lewis, 
et al., 2001). Collagenous-glycoproteins and in particular collagens are 
abundantly found in SkM. Indeed, the connective tissue layers discussed form a 
reasonable component of SkM mass; up to 10 % of dry weight mass in the adult 
animal. Approximately 10 collagen protein types are expressed during embryonic 
SkM development, whereas Type I and III predominate in adult SkM (Kjaer, 2004, 
Gillies and Lieber, 2011).  
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The abundance of type I collagen is variable and has been cited to be from 30 % 
to 97 % of all collagen found in SkM (Bailey, et al., 1979, Bailey, 2001). The 
distribution of collagen types throughout the ECM hierarchical structure is 
debated in the literature due to methodological limitations of analysis, however 
it considered that type I collagen forms a major structural component of the 
perimysial layer (Gillies and Lieber, 2011).  
The organisation of collagen fibrils within the ECM plays a major role in the 
transmission of force throughout the tissue, with the fibril distribution and 
orientation a function of tissue activity (Gillies and Lieber, 2011). Despite the 
ECM having a distinct role in structure and force transmission it appears the 
influence of the ECM upon the development of passive tension is questionable. 
Experiments have provided evidence for the muscle fibre intrinsic nature of 
tension development (Magid and Law, 1985). This finding has steered much 
attention to the ‘molecular spring’, titin in providing answers as to the origin of 
passive tension (Magid and Law, 1985).  
1.3.1.2 Alternative ECM Function 
However, the ECM is not regarded as purely a structural component of SkM, 
rather it co-ordinates many cellular processes; including regeneration, neural 
transmission and myogenesis (Lewis, et al., 2001). The ECM and in particular 
ECM remodelling, play significant roles in satellite cell (SC) activation and 
myoblast migration required for regeneration (Lewis, et al., 2000). Moreover, the 
ECM plays a role in harbouring growth factors and binding proteins required for 
muscle cell differentiation and hypertrophy (Coppock, et al., 2004).  
1.3.1.3 Muscle Fibre Attachment to the ECM 
The cytoskeleton of SkM fibres is attached to the ECM via a complex network of 
proteins, including integrins and the dystrophin-dystroglycan complex (Hoffman, 
et al., 1987, Lewis, et al., 2001). Coupling the sarcolemma with the ECM, via 
numerous protein complexes, provides structural stability to SkM tissue.  
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Congenital defects in the dystrophin gene, leads to muscular dystrophy a disease 
characterised by pathophysiological regeneration (Hoffman, et al., 1987) .The 
interaction between the ECM and SkM cells is also vastly important for the 
transmission of mechanical signals into biochemical signals within the cell (often 
termed mechano-transduction, (Yamada, et al., 2012). Integrins play an 
important role in transmitting this signal following ligand binding (Lewis, et al., 
2001), with these mechanisms being highly induced following SkM contraction in 
vivo (Boppart, et al., 2011, Lueders, et al., 2011).  
1.3.2 The Ultra-Structure of Skeletal Muscle as a basis for contraction 
Myofibrils are long cylindrical structures that appear in parallel with repeating 
contractile subunits termed sarcomeres, aligned in series (Lieber, et al., 2002), 
which form the units of the complete SkM fibre. A sarcomere contains all the 
necessary proteins for contraction, organised into a highly complex interwoven 
network.  
The extent of muscle shortening directly relates to the sum of sarcomere 
shortening within the myofibril, whilst increases in the number of sarcomeres in 
series forms physiological hypertrophy and contributes to increased force (Lieber, 
et al., 2002, Jones, et al., 2004).  
The sarcomere itself comprises of two contractile filaments termed 
myofilaments, of which there is one thick and one thin filament related to the 
composition of the contractile protein within it; either myosin (thick) and actin 
(thin). The interdigitation of these filaments gives rise to the striated appearance 
(seen with light and dark banding) of SkM under light microscopes (Jones, et al., 
2004). Accordingly, the light refractive properties of the particular regions has 
allowed for their definition, namely the anisotropic band (A-band, containing 
only myosin filaments) and the isotropic band (I-band, containing only actin 
filaments).  
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The region of the A-band where there is no actin-myosin interaction is termed 
the H-zone, whilst the dark narrow banding through the middle of the I-band is 
named the Z-line (Z standing for zwitter, meaning ‘between’ in German, Jones, et 
al., 2004). The final definition of structure within the sarcomere is termed the M-
line, which is a dense zone in the centre of the A-band (McArdle, et al., 2004, Fig. 
1-3).  
1.3.3 Actin-Myosin Interaction: The Cross-Bridge Theory 
The molecular basis for contraction is based around the complex interaction 
between the two contractile proteins, actin and myosin. The complex and co-
ordinated interaction is mediated by the regulatory proteins, troponin and 
tropomyosin (McArdle, et al., 2004). In the non-contracted state, tropomyosin is 
positioned by the troponin complex in order to cover the myosin binding sites 
and hence preventing any interaction with actin.  
Following depolarisation of the cell surface membrane, the wave of 
depolarisation passes down the T tubules which are positioned within 
invaginations of the sarcolemma (plasma membrane, Gomes, et al., 2002, Jones, 
et al., 2004). Calcium (Ca2+) is released from the sarcoplasmic reticulum (SR) 
following interaction from the T tubules. Ca2+ then binds to Troponin C initiating 
the interaction of Troponin T and Troponin I. This in turn leads to the 
translocation of the Troponin-Tropomyosin complex from the actin filament, 
revealing a myosin binding site (Gomes, et al., 2002). This allows for the cyclic 
action (or contraction) of the actin-myosin interaction to occur.  
The process of the excitation of the membrane leading to active contraction 
myofilaments is termed Excitation-Contraction Coupling (ECC, Dulhunty, 2006). 
The sliding of the actin filament caused by myosin head movement was evident 
when under passive stretch conditions under an electron microscope, when the 
active contraction revealed only movement of the I-band (Huxley and 
Niedergerke, 1954).  
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This observation was also independently found in another laboratory at a similar 
time (Huxley and Hanson, 1954). These observations led to the development of 
the ‘sliding filament’ or ‘cross-bridge’ hypotheses, which aimed to describe the 
interaction and consequential actions of actin and myosin.  
Huxley (1957) postulated that there are two cross-bridge states; attached and 
detached, processes which are driven by the hydrolysis of ATP (Huxley, 1957). 
The release of phosphate from the actomyosin complex (bound actin and myosin) 
initiates the rotation of the S1 head of the myosin protein (Jones, et al., 2004). As 
the rotation phase comes to an end, ADP is released allowing for the binding of 
ATP to the actomyosin complex. Upon the binding of ATP to the actomyosin 
complex, the complex is dissociated with ATP bound to myosin where it is 
hydrolysed by ATPase, leaving the association of ADP and Pi with myosin. These 
products of ATP hydrolysis are thought to activate the S1 unit of the myosin head, 
in order to initiate the further binding of actin, where the cycle begins again.  
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Figure 1-3. The hierarchical structure of SkM: the molecular basis of contraction. 
(From, Hopkins, 2005).  
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1.4 Postnatal Skeletal Muscle Regeneration  
1.4.1 Satellite Cells (SC’s) 
SkM is a post mitotic tissue; therefore the existing differentiated cells do not 
have the intrinsic capacity to regenerate themselves. In this regard, the growth 
and regenerative capability of SkM from trauma (physiological or 
pathophysiological), comes from a resident population of stem cells termed SC’s 
(Sinanan, et al., 2006). These cells were identified and named as such due to 
their anatomical position between the sarcolemma and the basal lamina of 
isolated frog SkM tissue (Mauro, 1961). Since this discovery there has been a 
wide interest in SC biology concerning their activation, capacity for growth and 
regeneration and their ‘stem-like’ nature (Zammit, et al., 2006). As such, the SC 
has been deemed a potential target either intrinsically or extrinsically for the 
treatment of many SkM pathologies, including muscular dystrophies.  
1.4.1.1  Activation, proliferation and the identification of a muscle specific 
‘stem’‎cell 
One defining feature of a SC is that the basal lamina that surrounds the myofibre 
and SC is continuous (Hawke and Garry, 2001), positing the SC in an 
advantageous location for proliferation and chemotaxis to the site of 
regeneration. SC’s are mitotically quiescent in the adult and display limited gene 
expression in this state; characteristically CD34, Pax7 and Myf5 (Le Grand and 
Rudnicki, 2007). These markers are commonly used to identify SC’s in their niche 
(in vivo studies), along with the characterisation of such cells during ex vivo or in 
vitro preparations (Beauchamp, et al., 2000, Zammit, et al., 2006). The quiescent 
nature of a SC can be confirmed by the high nuclear-to-cytoplasmic ratio 
indicative of limited cellular activity, coupled with fewer organelles compared to 
the adjacent myonuclei (Hawke and Garry, 2001). Following trauma, they are 
activated from their quiescent state and express genes which are associated with 
commitment or determination to the myogenic lineage (discussed in section 
1.3.2, Sinanan et al., 2006).  
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The activation of these quiescent cells is complex in nature and the exact 
mechanisms in control are largely unknown. It is beyond the scope of this review 
to detail all of the proposed mechanisms; however the most well understood 
researched mechanisms will be detailed.  
1.4.1.1.1 Sphingosine-1-phosphate 
The intrinsic production of sphingosine-1-phosphate signals the entry of the SC 
into the cell cycle (i.e. activated from quiescent state in G0 into G1 phase of cell 
cycle, (Le Grand and Rudnicki, 2007). It has been shown that the inhibition of the 
synthesis of this protein severely reduces muscle regenerative capacity (Nagata, 
et al., 2006) and thus appears to play a key role in the activation and 
regenerative capacity of SC’s.   
1.4.1.1.2 Growth Factors 
Another protein that has been demonstrated to activate SC’s is the hepatocyte 
growth factor (HGF). Early experiments identified a protein contained within the 
extract of crushed muscle tissue, that what capable of stimulating the 
proliferation of quiescent SC’s (Bischoff, 1986), however the exact protein was 
not identified. Further studies demonstrated fibroblast growth factor-2 (FGF2), 
transferrin and platelet derived growth factor BB (PDGF-BB) effect SC 
proliferation from quiescence, without being able to account for all of the 
mitogenic activity evident within the extract (Chen, et al., 1994). The work of 
Tatsumi et al (1998) provided insight into the protein responsible for the 
activation of SC’s that has been described in the previous experiments. It was 
shown that HGF is localised to the ECM surrounding the muscle fibre and 
following damage, translocation of this protein to SC’s leads to the co-
localisation of HGF to its receptor c-met (Tatsumi, et al., 1998). Furthermore, 
injecting exogenous HGF to uninjured SkM activates SC’s from the quiescent 
state, whilst using an antibody against HGF abolishes SC activation following 
crush injury (Tatsumi, et al., 1998). These data together provide strong evidence 
for the positive effect of HGF on SC activation following trauma.  
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Another growth factor, IGF-I, has been shown to influence SC activation in single 
fibre analyses, where the cell is deemed to remain in a quiescent state (Bischoff, 
1986). Experiments utilising cell culture methodologies have suggested IGF-I may 
influence SC activation, despite the limited evidence of the cells remaining 
quiescent in this state (Tatsumi, et al., 2009). Indeed, IGF-I and the splice variant 
MGF, positively stimulate the proliferation of muscle derived cells (MDC’s) in 
culture (Ates, et al., 2007). PDGF-BB, epidermal growth factor (EGF) and 
transforming growth factor-β (TGFβ) have also been shown to increase SC 
proliferation, despite minimal evidence for their role in the activation of SC’s 
(Tatsumi, et al., 2009).  
These experiments were conducted using in vitro activation assays, based upon 
tissue digestion protocols therefore the activation of SC’s during the isolation 
process may confound results utilising this method. Alternative isolated single 
fibre-based methods for analysing the activation of SC’s, whereby the SC is 
mainted in its niche may provide a more physiological environment for 
experimentation (Nagata et al., 2006). The use of an in situ experimental design 
incorporating in situ hybridisation of genes of interest with the utilisation of 
specific activation reporters, would allow for the identification of SC activation 
related to particular influencing genes (Beauchamp et al., 2000).  
Fibroblast growth factors (FGF’s) were the first growth factors identified to have 
an effect on myogeninc cells (Sheehan and Allen, 1999). Early evidence 
suggested a mitogenic effect of FGF upon myoblasts, with a delayed 
differentiation capability (Gospodarowicz, et al., 1976). Much work from Ronald 
Allen’s lab has demonstrated the mitogenic effect of FGF’s upon SC’s and 
myoblasts, with data to suggest a synergistic role with IGF-I (Allen and Boxhorn, 
1989, Allen and Rankin, 1990), with little effect on differentiation.  
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1.4.1.1.3 Nitric Oxide 
Nitric oxide (NO) has also been shown to play a significant role in activating SC’s. 
In SkM neuronal nitric oxide synthase (nNOS) is localised to the sarcolemma by 
the association of its amino acid sequence to an element of the dystrophin 
cytoskeleton (Tatsumi, et al., 2009). The synthesis of NO is stimulated by exercise, 
along with trauma, mechanical stretch and shear force from L-arginine (Centeno-
Baez, et al., 2011).  
The most compelling evidence for the impact of NO on SC activation has been 
shown following the oral administration of guaifenesin dinitrate (GDN) to mice 
(Wang, et al., 2009), which is an NO donor directed to accumulate in SkM. 
Indices of myogenesis were increased 24 hrs post administration of GDN, 
including myf-5, myogenin and follistatin (Wang, et al., 2009). Transdermal 
treatment of GDN, also results in a significant (38 %) increase in DNA synthesis 
24 hrs post treatment (Wang, et al., 2009) and coupled with the myogenic data 
provides a strong evidence base for the role of the NO pathway in stimulating SC 
activation, proliferation and myogenesis in vivo.  
1.4.2 Satellite Cell Determination, Migration and Myogenesis 
Many of the gene and protein regulatory networks that control post-natal SkM 
regeneration and growth are the same as those that govern embryonic SkM 
development. Following the activation of the SC it asymmetrically divides, with 
one daughter cell returning to quiescence to replenish the stem cell pool 
(Morgan and Partridge, 2003). Following the correct cellular signals, the 
activated progeny commit to the myogenic lineage, regulated by the 
transcription factor MyoD (Buckingham, et al., 2003). The intermediate filament 
protein Desmin, is one of the earliest markers of commitment to the myogenic 
lineage and thus serves as key tool in identifying activated and committed SC’s.  
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Following commitment to the myogenic lineage, the migration of the myoblasts 
to the site of injury for regeneration is regulated by chemokines; these are 
proteins released by the damaged muscle cells to ensure the efficient migration 
of the regenerating cell (Griffin, et al., 2010). An extensive network of 
chemokines has been identified in the migration and fusion of myoblasts, with 
the stromal cell-derived factor-1α (SDF-1α) clearly displaying an important role 
following its inhibition (Griffin, et al., 2010).  
Other proteins including; matrix metallo-proteinase-9 (MMP-9, Lewis et al., 
2000), mitogen-activated protein kinase (MAPK), phosphatidylinositol 3-kinase 
(PI3 kinase, Al-Shanti, et al., 2011) and angiotensin II (Johnston, et al., 2010), all 
have a positive effect upon myoblast migration. Following the migration of the 
myoblasts to the site of injury these cells are capable of exiting the cell cycle, 
differentiating and fusing into the region requiring regeneration, concomitantly 
expressing myogenin and myogenic regulatory factor-4 (MRF-4, Hawke and Garry, 
2001). The process of myogenesis (myoblast fusion) can be recapitulated in vitro, 
with the fusion of myoblasts into newly formed myotubes. The gene and protein 
regulation involved in myogenesis have most commonly been identified with in 
vitro-based experiments. The expression of myogenin mRNA has been shown to 
reflect the commitment of single cells to fuse with other myogencially 
determined cells (Mudera, et al., 2010). In this respect, the identification of 
myogenin mRNA allows for the molecular identification of fusion potential of 
myogenic cells in vitro.   
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Figure 1-4. Satellite cell (muscle precursor cell) myogenic lineage determination 
and differentiation to a terminally differentiated myofibre or myotube (From 
Hawke and Garry, 2001).  
1.5 Skeletal Muscle Energy Metabolism: Products and Bi-Products?  
1.5.1 ATP Synthesis: The Currency for Skeletal Muscle Contraction 
As described previously (1.3.3), ATP is required for the cleavage of the myosin 
head from the actin filament during muscle contraction. The supply of ATP for 
this process is essential during continued muscle contraction and must be 
synthesised at a rapid and sustained rate to meet demands for voluntary 
movement.  
The synthesis of ATP occurs from two main sources; aerobic and anaerobic 
metabolism (De Feo, et al., 2003). The yield of ATP from aerobic metabolism of 
stored substrates (carbohydrate, fat and protein) is far greater than anaerobic 
metabolism; however the rate of synthesis is reduced (Wells, et al., 2008). The 
initial high rate of ATP synthesis from anaerobic sources and the prolonged high 
yield of ATP from aerobic sources, makes this system of ATP generation near 
ideal for SkM and sub-maximal voluntary exercise. The classified mechanisms of 
ATP production (phosphagen, glycolysis and mitochondrial respiration) work in 
synergy at the onset of contraction to generate ATP.  
 18 | P a g e  
 
It is only the relative contribution of ATP yield from each source that alters 
throughout contraction duration (Baker, et al., 2010). The phosphagen system is 
characterised by the production of ATP from two reactions catalysed by Creatine 
Kinase (CK) and Adenylate Kinase (AK) respectively (Equations 1 and 2). 
Equation 1 and 2. The Phosphagen System of ATP Synthesis (Adapted from 
Baker et al., 2010).  
 
The synthesis of ATP from the CK reaction is extremely fast due to the high 
abundance of Creatine Phosphate (CrP) found within SkM cells (Baker et al., 
2010). The production of AMP from the AK reaction is vastly important for the 
production of ATP in glycolysis through the allosteric activation of phosphorylase 
and phosphofructokinase (PFK, Bogdanis, et al., 1996).  
The ATP required for sustained muscle contraction is increasingly derived from 
breakdown of stored substrates. The breakdown of stored glycogen 
(glycogenolysis) forms a major process in the rapid generation of ATP (Greenhaff, 
et al., 1994, Pilegaard, et al., 1999), however the yield is still significantly lower 
compared to mitochondrial respiration. The complex reaction processes that 
form the glycolytic pathway results in the breakdown of glucose 6-phosphate to 
pyruvate, rapidly generating ATP (Greenhaff, et al., 1994). The high generating 
capacity of pyruvate from glycolysis and the inability of the mitochondria to take 
up pyruvate, results in conversion of pyruvate to lactate (through the pyruvate 
dehydrogenase reaction) in order to prevent the product inhibition of glycolysis 
(Baker, et al., 2010).  
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The production of lactate during intense SkM contraction was once thought to 
be a negative consequence of the inability of the mitochondria to sustain 
pyruvate transport, however it now considered that lactate plays a pivotal role in 
sustaining pyruvate production and regenerating cytosolic NAD+ (Robergs, et al., 
2004). The measurement of lactate that has been transported out of the SkM 
cells into the circulatory system has provided a key tool in understanding the 
metabolic responses to exercise (Beneke, et al., 2011). Moreover it has allowed 
for the characterisation of a subjects work rate and has been an important 
diagnostic tool of endurance performance in athletes and clinical populations 
(Faude, et al., 2009). 
Additionally the measurement of lactate kinetics in predicting oxidative capacity 
of SkM during exercise has also been demonstrated to be highly accurate 
(Roecker, et al., 1998). However to date, much of the experiments investigating 
lactate production and associated biochemical and functional outcomes, have 
been limited to in vivo situations. Thus, studying the production of lactate from 
SkM cells can provide evidence for the metabolic dynamics associated with SkM 
response to contraction. Furthermore, the specific investigation of lactate 
production following mechanical signals is yet to be fully investigated and could 
provide evidence for a mechano-metabolic effect of exercise. The investigation 
of lactate production in vitro would also allow for a more controlled approach to 
assessing the potential for lactate as a signalling molecule to stimulate SkM 
adaptation (Hashimoto, et al., 2007).  
Aerobic metabolism of stored substrates in the form of mitochondrial respiration 
(also termed electron transport chain and oxidative phospohorylation) produces 
the greatest yield of ATP (Holloszy and Kohrt, 1996, Baker, et al., 2010), but by 
definition requires the adequate supply of oxygen. The contribution of stored 
substrates to energy expenditure during muscular contraction is highly 
dependent on the intensity and duration of the exercise. An example of the 
differential substrate utilisation during exercise is depicted in Fig. 1-5.  
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Figure 1-5. The percentage contribution to energy expenditure relating to 
available substrates and the intensity and duration of muscular contraction. 
(Taken from Holloszy and Kohrt, 1996).  
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Following the production of pyruvate from the reactions of glycolysis, it is 
converted to Acetyl co-ezyme A (Acetyl CoA) for entry into Kreb’s cycle (also 
termed citric acid cycle and tricarboxylic cycle, Fig. 1-6) before the electron 
transfer process of the electron transport chain. One particular protein complex 
which is of great interest to SkM physiologists is the succinate dehydrogenase 
(SDH) complex (also known as complex II, Fig. 1-6). This complex has been shown 
to participate in both Kreb’s cycle and the electron transport chain (Oyedotun 
and Lemire, 2004). In this regard, the activity of this complex has been shown to 
increase with exercise and training (Ishihara, et al., 2002, Silva, et al., 2009) and 
be reduced in pathological conditions such as SkM dysfunction associated with 
heart failure (Wust, et al., 2012). The measurement of this protein complex has 
been shown to reflect Kreb’s cycle activity and maximal rate of oxygen 
consumption, when oxygen availability is not rate limiting (Bekedam, et al., 2003) 
and therefore can reflect SkM ability to produce ATP from aerobic metabolism.  
Much of the literature surrounding the biochemical and molecular aspects of 
aerobhic metabolism in SkM is limited to in vivo contexts. If proteins such as SDH 
are going to be potential targets for the treatment of SkM pathologies, in vitro 
experimentation will be required to screen potential pharmacological agents. 
Furthermore, in vitro experimentation would allow for the investigation of such 
proteins in an isolated system to determine the exent of extrinsic and intrinsic 
mechanisms in dystregualting aerobic metabolism.  
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Figure 1-6.‎The‎Kreb’s‎(Citric‎Acid)‎cycle- the complex nature of ATP generation. 
(From McArdle, et al., 2004).   
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1.6 Skeletal Muscle Mitochondrial Biogenesis  
1.6.1 Increasing the oxidative potential of SkM following SkM contractile 
activity: PGC-1α,‎the‎master‎regulator‎of‎mitochondrial‎biogenesis‎
(Adapted from Player and Lewis, 2012) 
Increased glucose uptake and an alteration in substrate utilisation towards a 
greater reliance on fat metabolism, represent some of the fundamental 
adaptations in SkM metabolism in response to endurance exercise (Holloszy, 
1967, Mole, et al., 1971, Oscai and Holloszy, 1971, Baldwin, et al., 1972). As such, 
endurance exercise has the ability to play a key role in the fight against epidemic 
metabolic disorders including; obesity, diabetes and hypertension. Further 
understanding the mechanisms that regulate this response will provide evidence 
for the development of exercise, but also pharmacological and potential genetic 
therapies for use in the clinic.  
Despite the potential for physical activity in targeting these diseases, the exact 
cellular and molecular mechanisms that govern the adaptations have only 
recently begun to be understood (Coffey, et al., 2006).  The pioneering work of 
John Holloszy demonstrated an increase in mitochondrial content and enzymes 
following exercise, providing the basic mechanism behind an increase in aerobic 
capacity with exercise training (Holloszy, 1967). The complex nature of the 
mechanisms along with many experimental limitations has hindered progress 
with regards to the co-ordinated nature of the genes and proteins involved in 
regulating this response. In the post genomic era it is now possible to investigate 
the role of every candidate gene with regards to its effect in SkM adaptation. In 
light of this, a surge in research investigating the molecular adaptations to 
exercise has provided us with a broad spectrum of potential mechanisms.  
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1.6.2 Signalling Mechanisms to activate PGC-1α protein: Primary and 
Secondary Messengers 
The peroxisome proliferator-activated receptor co-activator-1α (PGC-1α) has 
been identified as a tissue specific transcriptional co-activator capable of 
regulating the response of metabolic pathways to external stimuli (nutritional, 
physical and environmental, Puigserver, et al., 1998). The activity of this protein 
has therefore been proposed to play a primary role in the adaptive response to 
exercise. The mechanisms activating this co-activator are varied and complex and 
therefore it is beyond the scope of this review to detail every proposed 
mechanism. 
1.6.2.1 Ca2+, Calmodulin Kinases and p38 MAPK 
Despite the well characterised role for Ca2+ in excitation contraction coupling 
(ECC), a further role for this ion in regulating contraction induced-gene 
expression and muscle fibre phenotypes has been proposed (Berchtold, et al., 
2000). This hypothesis stemmed from the seminal work of Buller et al., (1960) 
who demonstrated the change in phenotype of SkMs upon the transplantation of 
an opposing motor neuron in the cat (i.e. fast to slow and vice versa, Buller, et al., 
1960). Force output and longevity is in part controlled and driven by motor nerve 
stimulation, which relates to the amplitude and duration of Ca2+ transients (Chin, 
2005). The particular expression and level of expression of genes directly relates 
to the Ca2+ transient, a term that has been described as excitation-transcription 
coupling (Chin, 2005, Gundersen, 2011). A large number of genes have been 
suggested to be activated upon increases in Ca2+ transients including; Myosin 
Heavy Chain (MHC) isoforms (Allen, et al., 2002), Glucose Transporter 4 (GLUT4, 
(Olson and Williams, 2000, Ojuka, et al., 2002a, Ojuka, et al., 2002b, Ojuka, et al., 
2003) and genes related to mitochondrial biogenesis (Ojuka, et al., 2002b).  
Investigations into the acute effects of Ca2+ transients upon the SkM related to 
exercise have specifically taken the form of in vitro based models, using Ca2+ 
stimulants including Caffeine and Ca2+ ionophores.  
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Raising intra-cellular Ca2+ in L6 rat SkM myotubes increases the expression of 
proteins involved in mitochondrial biogenesis, an effect that was blocked by 
dantrolene, which prevents the release of Ca2+ from the sarcoplasmic reticulum 
(SR, Ojuka, et al., 2003). Furthermore, ionophore A23187 increases the gene 
expression of Cytochrome c in L6 myotubes, suggesting a role for Ca2+ in 
regulating this gene transcript associated with oxidative phosphorylation 
(Freyssenet, et al., 1999).  
Ex vivo SkM preparations have further provided a mechanism of action for 
increases in genes and proteins associated with mitochondrial biogenesis. 
Increasing cytosolic Ca2+ using 3.5mM caffeine in rat epitrochlearis, does not 
elicit contraction, despite significant increases in the gene and protein expression 
of PGC-1α, COX-1 (cytochrome c oxidase I) and ALAS (δ-aminolevulinate synthase, 
(Wright, 2007). This increase is coupled with an increase in p38 MAPK, a 
response which is negated upon incubation with KN93, a Calmodulin Kinase 
(CaMK) inhibitor (Wright, 2007).  
The increase in the mitochondrial enzymes was completely diminished by the 
addition of a p38 MAPK inhibitor SB202190, suggesting a p38 MAPK-dependent 
mechanism of action (Wright, 2007). Recently, isoform specific data has revealed 
a significant role for p38γ MAPK in the adaptive response of mitochondrial 
biogenesis and vascular angiogenesis. Using a muscle specific gene deletion in 
mice, a dominant negative allele for p38γ MAPK but not p38α MAPK and p38β 
MAPK, blocked the phenotypic and underpinning transcriptional mechanisms 
(PGC-1α and vascular endothelial growth factor, VEGF) to motor nerve 
stimulated  contraction (Pogozelski, et al., 2009).  
Together, these in vitro,  ex vivo and in vivo data provide substantiation for the 
role of Ca2+ in activating a signalling cascade through CaMK and p38γ MAPK to 
induce mitochondrial biogenesis and metabolic adaptation.  
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1.6.2.2 AMPK: A critical energy sensing protein required to stimulate 
mitochondrial biogenesis 
Muscle contraction is sustained by the production of ATP, generated from 
oxidation of stored and non-stored fuels sources alike; principally plasma glucose, 
stored muscle glycogen, plasma lipids and intramuscular triglycerides.  
The 5’ AMP-activated protein kinase (AMPK) is activated in response to a 
reduction in high energy phosphates (increase in the ATP:ADP and ADP:AMP 
ratios, (Xiao, et al., 2011) and hence acute energy deprivation (Reznick and 
Shulman, 2006) and as such has received attention as a putative energy sensor. 
The main function for AMPK is to increase the potential for ATP synthesis, whilst 
inhibiting energy consuming anabolic processes, along with acting as a signalling 
protein for gene transcription during and following rapid energy depletion 
(Jorgensen, et al., 2006). 
Given this function of AMPK, it is not surprising that it has received widespread 
attention with respect to responses to exercise, a potent energy depleting 
stimulus. Various forms of experimental design have been used to investigate 
the role for AMPK as a signalling protein to activate PGC-1α.  
Pharmacological agents have provided a central understanding for the influence 
of activation of AMPK in regulating increases in mitochondrial enzymes, 
increasing the potential for oxidative phosphorylation production of ATP. 
Bergeron et al., (2001) used β-guanadinopropionic acid (β-GPA) to chronically 
activate AMPK in rats for eight weeks (wk). Data demonstrated the increased 
binding of nuclear respiratory factor-1 (NRF-1), along with an increase in 
cytochrome c protein expression and total mitochondrial content (Bergeron, et 
al., 2001). Moreover, a dominant negative form of AMPK in mice ablates the β-
GPA stimulated an increase in mitochondrial content as evidenced by electron 
microscopy in wild type (WT) littermates (Zong, et al., 2002) illustrating the 
necessity for AMPK in stimulating mitochondrial biogenesis.  
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These data provide key mechanistic evidence for the role of AMPK activation and 
subsequent signalling in inducing mitochondrial biogenesis through the 
activation of NRF-1 DNA binding activity (a downstream target of PGC-1α). The 
use of 5-aminoimidazole-4-carboxamide-1-β-D-ribonucleoside (AICAR) has also 
demonstrated a clear association between AMPK activation of PGC-1α and 
consequential increases in mitochondrial proteins (Leick, et al., 2010). Repeated 
injection of AICAR resulted in increases in cytochrome c oxidase I and 
cytochrome c protein expression (relative to a saline vehicle control) in white 
gastrocnemius of wild type animals, but not in whole body PGC-1α knock-out 
mice (Leick, et al., 2010). This data offers a clear pathway of AMPK-PGC-1α 
activation for increases in the mitochondrial proteins measured.  
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Figure 1-7. The necessity for AMPK in stimulating mitochondrial biogenesis. 
Electron micrograph demonstrating the requirement of AMPK in mitochondrial 
biogenesis. Dark staining represents the presence of mitochondria. (a) WT mouse 
(saline treated), (b) WT mouse (GPA treated to stimulate AMPK), (c) Dominant 
negative (DN)-AMPK transgenic mouse (saline treated), and (d) DN-AMPK 
transgenic mouse (GPA treated). Scale (bar = 1 m). Note the reduced amount of 
dark staining in the AMPK-DN micrographs (c and d) in basal and AMPK 
stimulated conditions, illustrating the importance of AMPK in stimulating and 
maintaining mitochondrial content in SkM. Taken from Zhong et al. (2002).  
 
Evidence for the exercise/contraction specific activation of AMPK-PGC-1α has 
been established using ex vivo and in vivo models. Atherton et al., (2005) used 
low frequency stimulation (LFS) of isolated rat extensor digitorum longus (EDL) to 
mimic endurance exercise and high frequency stimulation (HFS) to mimic 
resistance exercise. AMPK was activated at three hours (hr) post LFS, whilst HFS 
failed to increase AMPK activity (Atherton, et al., 2005).  
 29 | P a g e  
 
In vivo data has provided contrasting findings with regards to the role of 
endurance and resistance exercise activation of AMPK, with particular emphasis 
on training status.  
Some indication for the training specific nature of AMPK activation was shown by 
Coffey et al., (2006), who demonstrated an increase in AMPK activation following 
endurance exercise in non-endurance trained weight lifters, whilst no AMPK 
activation was evident in endurance trained athletes (Coffey, et al., 2006).  
Conversely, AMPK was activated in endurance trained athletes that undertook 
strength training, whilst no activation was observed in strength trained athletes 
(Coffey, et al., 2006). This data suggests the activation of AMPK is dependent on 
a novel stimulus to induce the metabolic milieu required. Contrary to this data, it 
has been shown that ten wk of training is not sufficient to suppress the 
activation of AMPK in either strength or endurance trained athletes, data that is 
coupled with increases in mitochondrial protein fractional synthetic rate 
(Wilkinson, et al., 2008). Together these data demonstrate the necessity for 
AMPK activation during and following exercise for the resulting increases in 
mitochondrial protein, leading to enhanced oxidative potential for future periods 
of metabolic challenge.  
The up-stream intra-cellular mechanisms that regulate the activation of these 
primary and secondary messengers for PGC-1α stimulation are yet to be 
elucidated. The degree to which such proteins are mechano-senistive has not 
been explored, with much focus on the metabolic determinants. As such, this 
provides a rationale for the use of a mechanically regulated controlled model to 
investigate whether mechanical signals have a part to play in this important 
cellular response. Furthermore, the ability to analyse intra-muscular metabolites 
alongside the activation and localisation of particular proteins, presents 
problems with regards to tissue abundance in human exercise studies. Moreover, 
the influence of single genes and proteins required for the activation of PGC-1α 
can only be achieved through the development of animal mutant models.  
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It is also difficult to isolate the intrinsic mechanisms that regulate PGC-1α 
activation in vivo due to the integrated nature of SkM. Thus, it is problematic to 
identify the key primary and secondary messengers intrinsic an extrinsic to SkM 
in realtion to PGC-1α and related transcriptnioal mechanisms. Targetted in vitro 
experiments delineating the primary and secondary activators of PGC-1α are 
warranted, in order to fully elucidate its role in response in mitxchondrial 
biogenesis.  
1.6.3 PGC-1α:‎Post activation Transcriptional Regulating Mechanisms  
Mitochondrial biogenesis occurs through the co-ordinated expression of both 
nuclear and mitochondrial genomes. Upon the activation of PGC-1α following 
exercise through the many mechanisms discussed here, it co-activates 
transcription factors required to induce mitochondrial biogenesis. PGC-1α 
activates many genes indirectly associated with increasing mitochondrial 
respiratory chain content, including NRF-1 and NRF-2 (Scarpulla, 2011). PGC-1α 
has been shown to activate the estrogen-related receptor-α (ERRα) and in 
conjunction with NRF-2α increases the expression of respiratory chain genes 
(Scarpulla, 2006, Zhang, et al., 2006).  
Cytochrome c has been used in a multitude of experiments as a marker of 
mitochondrial density. Therefore, understanding the transcriptional regulation of 
this gene is key to determining what regulates mitochondrial density.  
Evans and Scarpulla (1988) identified key elements on the promoter region of 
the cytochrome c gene, one of which binds NRF-1 protein, along with a cAMP 
response element (CRE) site (Evans and Scarpulla, 1989). If the NRF-1 or CRE sites 
are mutated, any effect in cytochrome c gene transcription to electrical 
stimulation of SkM is attenuated, suggesting an NRF-1 and CRE dependent 
mechanism for the increased transcription of cytochome c (Xia, et al., 1998). The 
co-ordinated expression of NRF-1 and NRF-2 also activates Tfam, which co-
ordinates the transcription of mitochondrial DNA (mtDNA, Scarpulla, 2008).  
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Tfam has also been shown to play a significant role in mtDNA replication, 
providing a RNA primer required for initial mtDNA synthesis (Hood, 2001).  
The myocyte enhancer factor-2 (MEF-2) is a transcription factor required for the 
expression of many muscle specific genes, including the regulation of the glucose 
transporter-4 (GLUT-4) promoter (Ojuka, et al., 2002a) and subunits of the 
respiratory chain COXVIaH and COXVIII (Lenka, et al., 1996). The transcriptional 
activity of MEF-2 is controlled as a balance between suppression by histone 
deacetylases (HDAC’s) and activation by PGC-1α and p38 MAPK (McGee and 
Hargreaves, 2004). Following cycling exercise HDAC-5 is exported from the 
nucleus, allowing for the association between PGC-1α and MEF-2 (McGee and 
Hargreaves, 2004). Moreover, at rest the majority of PGC-1α is found in cytosolic 
fractions, translocating to the nucleus 3 hr following an acute bout of high 
intensity exercise (Little, et al., 2010), an association that is related with 
increased levels of mitochondrial protein content 24 hr following exercise (Safdar, 
et al., 2011). These data together provide evidence for the role of PGC-1α in the 
activation of MEF-2 and nuclear encoding genes associated with increasing 
mitochondrial content and glucose transportation.  
Exercise is a potent stimulator of mitochondrial biogenesis, a compensatory 
mechanism to increase the oxidative potential of SkM. In doing so, SkM has the 
greater potential to oxidise fat and as such exercise forms a key preventative and 
treatment modality for metabolic diseases. To this end, the use of exercise and 
other therapies which have the potential to activate PGC-1α will be useful in the 
clinic for metabolic diseases. The molecular mechanisms that govern this 
response have begun to be elucidated; however the co-ordination of in vivo and 
targeted in vitro based experiments will provide further evidence into this 
complex cellular adaptation. Moreover, the specific use of tissue engineered SkM 
constructs will provide a highly controlled experimental design to delineate the 
molecular regulation of this vastly complex.  
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Particulaly, the use of models that are amenable to electrical and mechanical 
stimulation will be fundamental in identifying the basic mechanisms that are 
activated in response to these key stimuli for SkM contraction. Additionally, the 
ability to exogenously add proteins, pharmacological agents and potential 
neutraceuticals to an isolated system demonstrates the plausibility of tissue 
engineered SkM in understanding PGC-1α and mitochondrial mechanisms. 
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Figure 1-8. Intra-cellular signalling mechanisms regulating PGC-1α‎activation‎and‎post-activation transcriptional mechanisms. 
Abbreviations; SR (sarcoplasmic reticulum), Ca2+ (Calcium ion), CaMK’s (calmodulin kinases), p38γ MAPK (p38 gamma mitogen activated 
protein kinase), PGC-1α (peroxisome proliferator-activated receptor co-activator-1 alpha), NRF-1 and NRF-2 (nuclear respiratory factors 1 
and 2), AMP (adenosine mono-phosphate), ATP (adenosine tri-phosphate), pAMPK (phosphorylated 5’ AMP-activated protein kinase), 
Tfam (mitochondrial transcription factor A, mTFA), Cyto C (cytochrome c), COX (cytochrome c oxidase subunits), ROS (reactive oxygen 
species), RNS (reactive nitrogen species). 
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1.7 The Molecular Regulation of Skeletal Muscle Mass  
SkM mass contributes to overall health and wellbeing and it is clear that the loss 
of SkM mass with age (sarcopenia) or disease (cachexia) contributes to morbidity 
and mortality (Carmeli, et al., 2002, Rantanen, et al., 2003). SkM not only 
functions to provide movement and stability of the skeleton, but also contributes 
to the greatest metabolic pool within the human body (Bouzakri, et al., 2005). In 
this regard SkM mass loss contributes to increased risk of developing metabolic 
diseases such as type II diabetes (Srikanthan and Karlamangla, 2011). These 
health implications make the maintenance of SkM mass of significant clinical 
importance.  
SkM mass is maintained when a balance between protein synthesis and protein 
loss is achieved, with muscle mass loss presenting when there is a shift to net 
protein loss (Wust and Degens, 2007). Situations of tissue protein loss can be 
observed in the systemic system and has been characterised in urine, whereby 
nitrogen balance can be estimated (Wagenmakers, 1998). Muscle mass gain is 
achieved with a net increase in protein synthesis, which is a common 
consequence of resistance exercise (Dreyer, et al., 2006, Holm, et al., 2008) and 
nutritional stimulus (Phillips, 2012). The molecular regulation of muscle mass is 
vastly complex, with integration between systemic and intrinsic factors that 
stimulate transcriptional and post-translational mechanisms. The control of 
anabolic and catabolic signals will be explored in the following sections.  
1.7.1 Insulin-like Growth Factor-I (IGF-I) 
The unique characteristic of insulin-like growth factors is that the receptor (IGF-I 
receptor) is expressed in all tissues and cell types (Clemmons, 1998), indicating 
the high degree of importance this protein family plays in whole organism 
physiology. With regards to SkM physiology, IGF-I is of particular interest as it 
functions in embryonic SkM development (Liu, et al., 2012), myo-nuclear 
accretion (Vandenburgh, et al., 1991), protein synthesis (Adams and McCue, 
1998) and in vitro myogenesis (Hill, et al., 1985).  
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IGF-I acts at all levels of the endocrine system (endocrine, paracrine and 
autocrine), with 75 % of systemic IGF-I being produced by the liver (Schwander, 
et al., 1983). Remarkably, abolishment of IGF-I produced from hepatocytes in 
mice leads a 75 % reduction in systemic IGF-I without impairing growth (Sjogren, 
et al., 1999). This demonstrates the importance of IGF-I production from sources 
other than the liver in regulating growth and tissue maintenance. Increasing IGF-I 
through exogenous means, does not lead to increase protein synthesis in skeletal 
of humans (Yarasheski, et al., 1993, Musaro, et al., 2001), however genetic 
manipulation in mice using global or muscle specific overexpression leads to 
hypertrophy (Musaro, et al., 2001). Moreover, IGF-I mutant mice (IGF-I -/-) 
display underdevelopment of SkM (Powell-Braxton, et al., 1993). These data 
together provide evidence that IGF-I derived from muscle sources is of particular 
importance in stimulating myogenesis, hypertrophy and maintaining muscle 
mass.  
The action of IGF-I occurs through the IGF-I receptor, which is a heterotetramer 
that undergoes a conformational change following ligand binding with IGF-I 
(Clemmons, 2009, Fig. 1-7). This conformational change leads to the activation of 
the intrinsic tyrosine kinase which allows the docking of IRS-I (Clemmons, 2009). 
IRS-I then acts as docking protein for several signalling proteins including PI3-K, 
which forms part of the  mammalian target of rapamycin (mTOR) signalling 
cascade (Glass, 2003a, Glass, 2003b, Fig. 1-7), leading to an increase in the 
activity of the ribosomal machinery (Baar, 2006). The activation of this signalling 
cascade is highly induced by SkM overload, stretch as seen in a lapine model 
(McKoy, et al., 1999) and resistance exercise in humans (Adams and Haddad, 
1996, Allen, et al., 1997).  
However, evidence has been presented to suggest a functional IGF-I receptor is 
not needed for the activation of mTOR following SkM overload (Spangenburg, et 
al., 2008). This is supported by fact that IGF-I is expressed at far later time points 
than mTOR following overload in mice (Spangenburg, et al., 2008).  
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This seemingly unclear evidence for the role of IGF-I signalling in stimulating 
hypertrophy, may reside in the potential role of IGF-I in myogenesis. The 
myogenic role for IGF-I in embryonic and postnatal growth is undisputed (as 
discussed previously) and the acquisition of nuclei following resistance exercise is 
well documented in humans (Petrell, et al., 2006, Petrella, et al., 2008). The 
notion of a ‘ceiling size’ to which a muscle fibre can hypertrophy exists, due to 
the nuclei only being able to control a finite amount of cytoplasm (myonuclear 
domain, Harridge, 2007). The incorporation of activated SC’s into existing muscle 
fibres (myonuclear addition) following resistance exercise and overload may 
provide an explanation for the early or acute protein synthesis and delayed 
myogenic response (myonuclear addition) stimulated independently or 
dependently on IGF-I.  
1.7.2 IGF-I Binding Proteins (IGFBP’s) 
The complexity of IGF-I signalling is amplified through the control by IGFBP’s, 
proteins that act to carry IGF-I in either the blood or bind it to the ECM 
(Clemmons, 1998). IGFBP’s also regulates the interaction of IGF-I with its 
receptor (Hwa, et al., 1999a, Hwa, et al., 1999b) whilst increasing the half of the 
protein and therefore plays a major role in modulating its action.   
There have been six IGFBP’s cloned and sequenced, with their differential effects 
in different tissues studied extensively (Stewart and Rotwein, 1996). IGFBP’s in 
high concentrations inhibits growth (Wolf, et al., 2005) and a transgenic mouse 
overexpressing IGFBP-2 displays reduced myofibre size (Rehfeldt, et al., 2010). 
Furthermore, the ability of myoblasts to proliferate is also hindered in IGFBP-2 
(Rehfeldt, et al., 2010). There is evidence that IGFBP-2 and -5 have extensive 
effects on SkM studied in vivo and in vitro. This is exemplified when increased 
circulating serum concentrations of IGFBP-2, relates to disability and reduced 
muscle strength in elderly men (van den Beld, et al., 2003). Additionally an 
increase in IGFBP-2 mRNA has been shown to underpin the reduced myogenesis 
of parent C2 vs. daughter C2C12 myoblasts in vitro (Sharples, et al., 2011).  
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IGFBP-5 mRNA has been shown to decrease in a model of overload induced 
hypertrophy in rats (Awede, et al., 2002), whilst unloading of the overloaded 
hind limb resulted in atrophy coupled with an increase in IGFBP-5 mRNA (Awede, 
et al., 1999). The interplay between IGFBP-5 and the action of IGF-I is illustrated 
when a temporal effect of decreasing IGFBP-5 mRNA and increasing IGF-I mRNA 
was found (Awede, et al., 1999). Also, using a model of multiple population 
doublings of C2C12’s an increase in IGFBP-5 mRNA was shown to support 
reductions in myogenesis and myotube diameter (Sharples, et al., 2011). These 
data together provide evidence for the clear role of IGFBP’s in regulating the 
action of IGF-I, contributing to the modulation of muscle mass and myogenesis.  
The data surrounding the interaction of IGFBP’s with IGF-I is evident in both in 
vivo and in vitro, as described above. With evidience to suggest the mechanical 
regulation of IGF-I in vitro (Cheema, et al., 2005), experiments are yet to be 
conducted surrounding the influence of mechanical signals on IGFBP expression. 
Such experiments conducted in a more representative model of SkM in vitro (in 
terms of macroscopic and microscopic structure) would allow for an isolated 
approach to investigate these putuative key genes in regulating muscle mass. 
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Figure 1-9. The molecular regulation of SkM mass. Protein signalling and gene transcriptional mechanisms associated with protein 
synthesis and protein ubiquination. (From Sharples and Stewart, 2011). 
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1.7.3 Matrix‎Metalloproteinases‎(MMP’s) 
MMP’s are zinc dependent metallo-peptidases which serve to remodel the ECM 
(Lewis, et al., 2000) as a physiological process of adaptation, degeneration and 
regeneration following muscle cell trauma. This cycle of degeneration and 
regeneration can present itself in a pathophysiological manner, as evident in 
Duchenne muscular dystrophy (DMD) and in the mdx mouse (Bulfield, et al., 
1984), whereby the absence of the dystrophin protein prevents myofibre 
stability with the ECM. These enzymes are categorised into four classes based 
upon structure and substrate specificity, are synthesised in a latent form and 
require activation by peptidases to function (Lewis, et al., 2000).  
The MMP’s -2 and -9 (Gelatinases –A and –B respectively) have been shown to 
form a major part of the regeneration process, degrading components of the 
ECM required to facilitate activated SC migration and fusion into the site of 
trauma (Kherif, et al., 1999). This is supported by in vivo (Kherif, et al., 1999) and 
in vitro data (Lewis, et al., 2000), demonstrating the activity of MMP’s -2 and -9 
in the migratory and fusion phases of myoblasts. Moreover, this data provides 
clear evidence that the secretion of MMP’s from inflammatory activated cells 
(leukocytes) and SkM cells follows a temporal expression pattern. MMP-9 is 
expressed in the acute inflammation and activation of SC’s, whereas MMP-2 is 
expressed during myoblast fusion (Kherif, et al., 1999, Lewis, et al., 2000, Dahiya, 
et al., 2011). 
Data to support the role of MMP’s in regeneration and adaptation of SkM is 
further underpinned by extensive hypertrophy that is evident in mice 
overexpressing an active mutant muscle specific MMP-9 (Dahiya, et al., 2011). 
Increases in fibre cross sectional area, contractile apparatus protein and 
isometric force production were all consequences of this overexpression (Dahiya, 
et al., 2011), providing a clear indication of the extent to which MMP-9 can 
regulate hypertrophy. 
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However, the inhibition of MMP-9 using a specific antibody demonstrates the 
increased regeneration and reduced fibrosis following induced trauma 
(Zimowska, et al., 2008). These data together suggest there may be a 
physiological balance of MMP activity required to facilitate sufficient remodelling, 
whilst ensuring minimal fibrosis.   
Furthermore, MMP’s have been shown to increase the bio-availability and hence 
action of growth factors required for SC activation, fusion and hypertrophy. 
MMP’s activate IGF-I through the proteolysis of the IGFBP’s (Coppock, et al., 
2004), increasing its action and stimulating signalling through Akt and mTOR.  
The response of MMP’s has also been shown following both endurance (Carmeli, 
et al., 2002, Rullman, et al., 2007) and resistance-based (Madden, et al., 2011) 
exercise, despite high within and between subject variability. The response of 
MMP’s in this manner to different modes of exercise illustrates the generalised 
activation following different contraction types and exercise duration. Thus, the 
measurement of MMP’s in response to SkM contraction forms an indication of a 
physiological response to ensure satisfactory adaptation and regeneration.  
1.7.4 Myostatin and the Ubiquitin Proteasome Pathway 
SkM mass is also negatively regulated through pathways that serve to inhibit 
protein synthesis or increase proteolysis. The most studied pathways involved in 
these processes are the myostatin and ubiquitin proteasome pathways (UPP). It 
is acknowledged that there are multiple pathways that contribute to SkM 
proteolysis, including oxidative stress, nuclear factor κβ (NF-κβ) and tumour 
necrosis factor-α (TNF-α, Jackman and Kandarian, 2004), however it is beyond 
the scope of this thesis to review these areas.  The increase of these genes and 
proteins has been shown to be present in the aging population (Gumucio and 
Mendias, 2012) as well as in conditions of cachexia (McFarlane, et al., 2006). 
Conversely, a reduction in their expression has been shown as a response to 
resistance exercise to stimulate hypertrophy (Roth, et al., 2003, Louis, et al., 
2007).   
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Myostatin forms part of the transforming growth factor-β (TGFβ) superfamily of 
proteins and serves to negatively regulate SkM mass through various 
mechanisms. The discovery of myostatin was coupled with the identification of 
naturally occurring mutations, whereby excessive muscle growth leads to a 
hypertrophic phenotype (e.g. Belgian Blue Cattle, McPherron and Lee, 1997). 
This discovery has led to a wealth of research to investigate the mechanisms 
whereby myostatin has its influence.  
One potential mechanism for myostatin in preventing SkM hypertrophy or 
stimulating a reduction in muscle mass is through inhibition of SC activation and 
proliferation. A dose dependent reduction in myoblast proliferation is seen when 
incubating C2C12 myoblasts with myostatin, through the inhibition of Pax7 and 
MyoD co-localisation (Thomas, et al., 2000, Langley, et al., 2002). The inhibition 
of MyoD by myostatin further prevents the fusion of myoblasts (Langley, et al., 
2002). Data also demonstrates the effect of myostatin on the expression of 
‘atrogenes’ MuRF-1 (muscle RING finger-1) and muscle atrophy factor box 
(MAFBx) that form part of the UPP, a mechanism that is dependent on the 
expression of forkhead box O-1 (FoxO-1, McFarlane, et al., 2006). Myostatin also 
inhibits the Akt-mTOR pathway of protein synthesis (Amirouche, et al., 2009), a 
mechanism that is distinct from interactions with the atrogenes (Trendelenburg, 
et al., 2009, Goncalves, et al., 2010).  
The activation of MuRF-1 and MAFBx leading to a proteolysis, is partly controlled 
by the ubiquination and subsequent degradation of proteins at the lysosome 
that have been marked by these E3 ligases (Yang, et al., 2006, Baehr, et al., 2011). 
The deletion of MuRF-1 leads to the sparing of SkM tissue breakdown following 
denervation or glucocorticoid treatment (Baehr, et al., 2011), illustrating the 
effect of this gene in regulating muscle mass in response to these traumas.  
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These proteins and genes have been shown to be modulated by both endurance 
and resistance modes of exercise (Coffey, et al., 2006, Nedergaard et al, 2007), 
with MAFBx playing a significant part in regenerating muscle following damaging 
exercise (Okada, et al., 2008). A temporal effect has also been shown with MuRF-
1 and MAFBx mRNA expression, with an increase after an acute bout, with a 
reduction in proceeding bouts of exercise (Mascher, et al., 2008).  
The effect of myostatin, MuRF-1 and MAFBx on SkM mass is evident in the basal 
and exercised conditions, elucidating a potent effect upon proteolysis. 
Investigating the manner in which these genes are activated following exercise, 
specifically with particular modes and contraction types, will enable the 
development of targeted therapies for the alleviation of SkM wasting diseases. 
Furthermore, investigating the role of mechanical signals in the activation or 
suppression of these genes will provide mechansistic evidence as to the 
mechano-transcrioptional profile following exercise. Moreover, the instrinsic 
regulation of these genes following exercise or overload has not been 
investigated, providing rationale for the investigation in an isolated system 
indepdent of systemic factors and supporting tissues. In vivo models of SkM and 
exercise are limited in being able to investigate the mechanisms discussed above, 
with the limitation being explored further below.  
1.8 Limitations of in vivo testing to study cellular and molecular responses to 
exercise 
Notwithstanding the importance of human investigations for understanding of 
the adaptation of SkM following exercise, methodological limitations preclude 
many questions from being answered. The inherent variability in SkM response 
to exercise in humans often masks the identification of a particular protein or 
gene which may have a role in regulating adaptation. This has often lead to the 
use of animal genetic clones in exercise studies, which allows for a greater 
amount of experimental control, along with permitting the development of 
dominant/negative mutant animals to investigate the role of a particular gene. 
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The use of such animals in research does however prevent translation to human 
physiology due to the obvious anatomical distinctions between rodents and 
human beings. Of particular concern with both human and animal studies are the 
ethical constraints surrounding the experimental design, which often relate to 
the type of exercise or stimulation protocol and sampling of the tissue. In many 
cases human studies are limited in the number of biopsy procedures that can be 
performed on one individual, whilst animals are most commonly sacrificed 
following the experiment.  
Recently, evidence has been reported concerning the variability in the expression 
and phosphorylation of proteins highly implicated in protein synthesis; proteins 
that have received widespread attention in the field of exercise physiology in 
recent years. Caron et al., (2011) reported an 83 % increase in Akt and P70 S6K 
phosphorylation between biopsy samples taken from the vastus lateralis (VL) of 
the right leg in the morning (R1) and the left leg in the afternoon (AF). However, 
it was found that a second rested biopsy in the right leg (R2) did not affect the 
expression or phosphorylation of any of the proteins investigated, compared to 
(R1). These authors also found a significant effect of low intensity mobilisation 
on P70 S6K phosphorylation compared to R2 (p < 0.05, Caron, et al., 2011). Due 
to the nature of multiple biopsies with respect to sequential samples being taken 
from sites certain distances away from the previous biopsy, it is also conceivable 
that the fundamental anatomy and physiology of multiple samples may differ.  
The data presented here clearly demonstrates the necessity to standardise 
biopsy protocols, in the rested and exercising conditions, in order obtain valid 
results relating to the proteins of interest. The effect of multiple biopsy sampling 
has also been shown to affect the transcriptional response of particular genes 
(Friedmann-Bette, et al., 2012). In a crossover design experiment, 11 subjects 
undertook standardised squatting exercise or vibration exercise, with biopsies 
being obtained from the VL pre and at three time-points post exercise.  
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As a control group, 8 non-exercising control participants were subjected to four 
biopsies at equivalent time points. Similar changes (increased or decreased) in 
the gene expression of interleukin 6, interleukin 6-receptor and IGF-I amongst 
others, were found between the control group and the exercising group 
(Friedmann-Bette, et al., 2012). The authors concluded from this data that 
multiple biopsy sampling can influence the expression of the genes investigated, 
with no additive or supressive effect of exercise. As such, it is difficult to make a 
judgement upon the influence of the exercise condition upon the expression and 
regulation of these genes. It is important to consider however, that the exercise 
protocol used may not have been potent enough to induce the activation of the 
investigated genes. Moreover, other variables including the sample sizes, the 
training staus and heterogeneity of the population sample used and the tissue 
processing methodologies may all confound the observed response. The 
necessity for large sample sizes to generate required statistical power in human 
investigations is also a product of human heterogeneity, a limitation that does 
not translate to cell line-based in vitro experiments. The use of a cell line, 
whereby all the cells are genetically identical allow for the highly controlled 
investigation of putative regulatory genes or proteins.  
The inherent variation in human repsonses to exercise plays a significant role in 
observed effects and may often confound data. Recent evidence has provided 
support for such a notion, whereby individuals respond to a large extent in 
response aerobic (Timmons, et al., 2010) and resistance (Phillips et al., 2013) 
exercise. Such variability is governed by the expression of key genes, which are 
dysregulated in non-adaptive phenotypes (Timmons et al., 2010, Phillips et al., 
2013). This variation makes it difficult to ascertain the roles of particular genes in 
humans and poses the question as to why an exercise stimulus can or cannot 
activate certain genes and what the upstream mechanisms are.  
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These data also provide strong evidence for the use of a system that does not 
rely upon a traumatic biopsy procedure, which has been demonstrated to 
influence the expression of proteins and genes which may have vital roles in the 
adaptation of SkM to exercise. Furthermore, the use of an isolated in vitro 
system allows for the investigation of the individual stimuli (mechanical, 
metabolic, etc.) which contribute to the expression of key genes regulating 
phenotypic adaptation.  
When seeking to understand the adaptation of SkM to exercise, it is important to 
delineate between intrinsic and systemic regulation of proteins and genes. In 
vivo investigations permit the investigation of the integration between SkM and 
the systemic environment, however the influence of individual systemic factors 
and the intrinsic environment in isolation are not possible. Of particular interest 
is a recent investigation that demonstrated the requirement of intact 
adipocytokine signalling for the activation of PGC-1α following exercise (Li, et al., 
2011). Utilising the obese ob/ob mice (which display dysregulated adiponectin 
and leptin mediated AMPK signalling), responses to exercise training in terms of 
signals that mediate mitochondrial biogenesis were absent (Li, et al., 2011). In 
order that the authors could ascertain a causal relationship between the reduced 
adipocytokine signalling and the effect upon mitochondrial biogenesis, in vitro 
experiments were conducted treating the cells with adiponectin and leptin 
confirming the positive influence of these proteins (Li, et al., 2011).  
Such data can be considered proof of concept and requires further investigation 
to analyse the influence of intrinsic stimuli and proteins/genes that regulate PGC-
1α expression. Current monolayer in vitro approaches to do not allow for such 
investigation, providing evidence for the use of 3D tissue engineered SkM.  The 
multiple stimuli that effect SkM physiology and function, including neural 
activation and blood flow, means isolating the effect of mechanical signals alone 
extremely challenging.  
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Taking these limitations of in vivo exercise together, provides a strong rationale 
for the use of an in vitro, isolated system to further understand the role of 
mechanical signals on SkM physiology. The use of such systems to-date is 
extensively discussed below, however it is important to note there is currently no 
in vitro model of SkM that recapitulates in vivo tissue and that is also amenable 
to stimulation to model exercise or SkM loading.  
Taking into consideration the limitations of current in vivo investigations and the 
requirement for the development of an in vitro system, the following research 
questions are proposed; 
1. Can an in vitro model of SkM recapitulate the biochemical and molecular 
response seen with in vivo exercise? 
2. What contribution do mechanical signals play in the regulation of key 
adaptative genes? 
3. What is the intrinsically regulated response of genes required for 
adaptive phenotypes? 
To be able to address these research questions, the development and utilisation 
of current cell culture-based systems will be discussed and critiqued.  
1.9 Culture of Muscle Cells In Vitro 
SkM cells have been cultured in vitro for many years, with early studies 
identifying the spontaneous contraction of muscle cells derived from the patella 
region of a rat (Murray and Pogogeff, 1946, Pogozelski, et al., 2009). These 
pioneering experiments developed a field of cell biology which would contribute 
not only to the understanding of SkM development (myogenesis) and physiology, 
but also cell biology in general.   
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1.9.1 Primary Muscle Cell Cultures 
The use of primary tissue for the isolation of SkM cells has taken the form of two 
main isolation procedures. Firstly, explant cultures rely on the tissue maintaining 
the ability for SC activation, migration and commitment to the myogenic lineage; 
a technique which has been successfully used for many years (Pogogeff and 
Murray, 1945, Murray and Pogogeff, 1946). Secondly, enzymatic digestion of 
SkM tissue relies on the dissociation of the SC’s from the basal membrane, which 
has been achieved using various enzymes (collagenase, dispase, trypsin to name 
a few).  These methods display various amounts of success in isolating myogenic 
cells, with the inability to serially passage to obtain large cell numbers for 
experiments being one the main disadvantages of primary cells (Machida, et al., 
2004).  
However, isolating primary cells ensures a heterogeneous population of cells is 
obtained. This is an important factor when studying SkM in vitro considering the 
heterogeneous population of cells in vivo. Moreover, the influence of the non-
myogenic population of cells has been demonstrated to influence the myogenic 
potential and mechano-contractile phenotype of muscle derived cells (MDC’s) in 
vitro (Brady, et al., 2008). Conversely a myogenic only population of cells allows 
for the investigation of intrinsically regulated mechanisms of SkM cells.  
1.9.2 SkM Cell Lines 
The inherent variability and limitations of using primary sources for MDC’s 
contributed to the development of cell lines that display similar genotype and 
phenotype characteristics of primary cells, with increased control and 
homogeneity. The original myogenic cell lines were the L8, L84 and the C2 lines 
(Yaffe and Saxel, 1977). A further sub-clone of the original C2 cell line was 
characterised by Blau et al., (1985) termed the C2C12 sub-clone, which is the 
most well used myogenic cell line cited in the literature (Blau, et al., 1985).  
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These cell lines were based upon the differentiation characteristics of cells 
isolated from primary sources and have been used to study myogenesis and 
postnatal muscle physiology. The control and reproducibility associated with 
these cells lines, has contributed to a greater understanding of the intrinsic 
molecular mechanisms associated with particular physiological and 
pathophysiological conditions within SkM.  
1.9.3 Monolayer Cell Culture 
MDC’s and muscle cell lines have most commonly been cultured in a monolayer 
environment. Despite the relative simplicity of this technique, this environment 
does not recapitulate the 3D nature of SkM. Undeniably, the morphology of cells 
cultured in monolayer does not represent that of in vivo SkM (Smith, et al., 2012).  
The ability of the cells to receive physical cues from attachment to a matrix in 3D 
seems to be the key influencing factor in obtaining a morphological and 
physiological representation of in vivo SkM. Furthermore, as one of the main 
functions of SkM is to produce force for mechanical movement (Baar, 2005), a 
monolayer culture system does not allow for such measurement. This notion has 
led to the development of tissue engineered SkM constructs.   
1.10 SkM Tissue Engineering 
3D SkM culture systems have successfully been developed, using various 
methods to develop fused SkM cells displaying in vivo-like morphology and 
function. The use of these tissue engineered models in basic physiological 
research is emerging (Khodabukus, et al., 2007), however the goal of tissue 
engineering as a field is to ultimately provide a replacement for damged or 
diseased tissue ( Machingal, et al., 2011, Corona, et al., 2012,).  
For successful 3D in vitro culture, the composition of the extra cellular matrix 
(ECM) used needs to promote the alignment and fusion of seeded myoblasts 
(Klumpp, et al., 2010).  
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This has been achieved using both synthetic (Acarturk, et al., 1999, Saxena, et al., 
1999, Shah, et al., 2005) and naturally derived polymers ( Vandenburgh and 
Kaufman, 1979, Vandenburgh, 1988,  Vandenburgh, et al., 1989, Vandenburgh, 
et al., 1991, Powell, et al., 2002, Cheema, et al., 2003, Cheema, et al., 2005, 
Huang, et al., 2005, Brady, et al., 2008, Khodabukus and Baar, 2009, Mudera, et 
al., 2010, Khodabukus and Baar, 2012, Smith, et al., 2012).  
It has been suggested that the rigidity of synthetic polymers may affect the 
contractile properties and function of the developed myotubes and if the 
polymer is bio-degradable this may affect the alignment of cells achieved (Bian 
and Bursac, 2009, Bian and Bursac, 2008, Thorrez, et al., 2008). Moreover, the 
proteins required for cell-matrix interaction via integrin-mediated cell 
attachment are coated onto the scaffold to ensure cell attachment and viability 
(Bacakova, et al., 2003).  
The use of naturally derived polymers (including fibrin and collagen) has been 
shown to overcome these issues. The rapid polymerisation allows for an even 
distribution of the cells seeded, and the nano-structure allows for multiple 
attachment sites for the cells (Bian and Bursac, 2008). The alignment of cells 
within the 3D matrix has also been shown in the early stages of development 
(Cheema, et al., 2003). Another advantage of the use of naturally derived 
polymers is the ability to easily stimulate, both mechanically and electrically, due 
to the mechanical compliance of the polymerised tissue (Powell, et al., 2002, 
Cheema, et al., 2005).   
The use of collagen hydrogels for SkM tissue engineering is increasingly popular 
and the fact that collagen is a large component of the ECM in vivo (Lewis, et al., 
2001), provides a rationale for its use. The use of a 3D collagen based model to 
study SkM development is well characterised in the literature (Cheema, et al., 
2003, Cheema, et al., 2005, Brady, et al., 2008, Mudera, et al., 2010, Smith, et al., 
2012) and provides a good model to investigate SkM adaptation to mechanical 
stimuli.  
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The use of static mechanical signals, promotes the alignment and fusion of the 
seeded cells (Smith, et al., 2012), promoting morphology, gene expression and 
passive contractile phenotype that represents in vivo SkM (Mudera, et al., 2010, 
Brady, et al., 2008, Smith, et al., 2012). A summary table of current collagen-
based matrices for SkM tissue engineering is presented overleaf. 
Table 1-1. Tissue Egineered SkM models 
System References 
Chamber slide long term model Smith et al., (2010), Sharples et al., 
(2012) 
 
Culuture Force Monitor (CFM) acute 
(24 hr) model 
Cheema et al., (2003), Cheema et al 
(2005), Brady et al., (2008), Mudera et 
al., (2010) 
Engineered muscle bundles Rhim et al., (2007), Hinds et al., (2011) 
Pre-clinial drug screening in vitro 
muscle tissue 
Vandenburgh et al., (2008) 
Bioartificical Muscle Gawlitta et al. (2008), Boonen et al. 
(2010), Langelaan et al. (2011) 
Organoids Vandenburgh et al. (1996) 
Adapted from Smith et al., (2010) 
With the main goal for tissue engineering to develop artificial tissues for the 
regeneration and replacement of injured or diseased tissue, efforts were placed 
towards the improvement of in vitro constructs to be able to function within the 
in vivo environment upon implantation. In recent times, the use of such models 
to understand in vivo physiology and function has been explored (Khodabukus, 
et al., 2007).  
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To this end, the phrase ‘pre-clinical models’ has been given to tissue engineered 
musculoskeletal tissues, for the testing of pharmacological, genetic and exercise 
therapies (Gibbons, et al., 2012).  
1.11 Stimulating SkM In Vitro 
During voluntary movement, SkM is activated and responds to electrical and 
mechanical stimuli. When seeking to mimic these stimuli in vitro electrical and 
mechanical stimulation models have been employed, to further understand the 
molecular responses that govern adaptation. Stimulating cultured human 
myotubes in vitro (electrical pulse stimulation, EPS) has revealed an increase in 
metabolic parameters including glucose uptake, lactate production, ATP turnover 
and citrate synthase activity (Nikolic, et al., 2012). Additionally, an increase in key 
genes regulating adaptation to exercise were also modulated including PGC-1α, 
glucose transporter-4 (GLUT-4) and interleukin-6 (IL-6) expression (Nikolic, et al., 
2012).  
Another study utilising EPS showed an increase in AMPK and MAPK activity, 
whilst also confirming the expression and release of IL-6 into the culture media 
(Nedachi, et al., 2008). These data confirm the metabolic response of SkM cells 
following electrical-mediated stimulation, demonstrating activated mechanisms 
to increase ATP generating efficiency and substrate utilisation.  
Using a 3D fibrin self-assembling model of SkM Khodabukus et al., (2007) 
articulately showed that electrical stimulation produced a similar response in 
S6K1 phosphorylation to that seen in an in vivo exercise protocol (Khodabukus, 
et al., 2007). More recently it has been shown that 24 hrs of continuous electrical 
stimulation resulted in an increase in force, partly dependent on the activation of 
the anabolic signalling protein mTOR (Khodabukus and Baar, 2012). Data 
concerning the electrical stimulation of SkM cells, illustrates the activation of 
both metabolic and hypertrophic pathways, providing key mechanistic data as to 
the adaptation of SkM to increase contractile activity.  
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Clearly SkM experiences mechanical stresses in vivo during contraction and as a 
passive effect (gravity, opposing external forces etc.). Studying the effect of 
these stresses in vitro, provides a highly controlled environment whereby direct 
quantifiable external forces can be applied to the cell. Using ex vivo SkM fibre 
preparations has revealed the increased active tension in response to mechanical 
stretch (Mutungi, et al., 2003)(Ramsey, et al., 2010). Increases in Ca2+ and 
consequential active tension have also been shown in smooth muscle cells in 
response to stretch (Ito, et al., 2006, Yadid and Landesberg, 2010). This increase 
in activate force as a consequence of mechanical strain is thought to be 
dependent on the stretch activated channels (SAC’s). This hypothesis is 
confirmed when using streptomycin (an SAC inhibitor), whereby there is no 
evidence for active force in response to stretch of bioengineered cardio-myocyte 
cells compared to a large increase in control (Birla, et al., 2008).   
These data indicate the potential for cardio-myocyte active tension in response 
to mechanical stretch, a response that warrants further investigation in SkM cells 
particularly in a 3D environment. Nevertheless, stretching SkM in vitro induces a 
passive mechanical response with a possible active resultant component. 
Relating to the addressed research questions presented in this Thesis, these data 
provide rationale that passive mechanical signals may contribute to active 
tension observed in vivo. As such the use of a SkM model of passive mechanical 
stretch will provide evidence as to the role of mechanical signals in regulating a 
molecular, depdent or independent of active tension.  
Vandenburgh and Kaufman (1979) were the first authors to demonstrate the 
hypertrophic response to mechanical stretch of avian isolated SkM cells in vitro. 
Following continuous cyclic stretch, it was shown that the rate of amino acid 
uptake, protein synthesis and the total protein were all elevated compared to 
control (Vandenburgh and Kaufman, 1979). This was amongst earliest 
experiments to illustrate the mechanical sensitive nature of mechanisms that are 
associated with increasing SkM cell size and force generating capacity.  
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Data using a cell line, also demonstrates a reduction in protein synthesis 
immediately post stretch, despite increases in the molecular signals governing 
hypertrophy (Atherton, et al., 2009) data which supports in vivo findings of 
reduced protein synthesis immediately post exercise (Dreyer, et al., 2006). A 
potential autocrine mechanism for increases in anabolic signalling was 
demonstrated by the use of conditioned media from stretched myotubes onto 
control cells, illustrating an increase in anabolic signalling (Baar, et al., 2000). 
These in vitro data provided novel evidence for the role of direct mechanical 
signals in mediating an increase in anabolic protein signalling.  
The mechanical stimulation of cells in monolayer also results in an increased CK 
efflux in the first few hrs of stretch, suggesting an increase in cellular metabolism 
(Vandenburgh, et al., 1989). It is important however, to consider that the 
increased CK activity could be a result of cell membrane damage as a 
consequence of stretch. On the contrary, in vivo data demonstrates an increased 
CK activity in human plasma reflective of tissue enzyme activity (Thompson, 
Scordilis et al. 2006). The measurement of CK as a marker of tissue damage or 
increased metabolism is particularly amendable to investigation in vitro and 
relates to the proposed research questions. An increase in glucose metabolism 
was also seen with in vitro stretch signifying an effect of mechanical activation on 
glucose uptake (Hatfaludy, et al., 1989).  
Notwithstanding the novel data that has been generated from the extant in vitro 
SkM literature, the bio-mimicity of the in vitro systems discussed must be 
examined; these systems that are often monolayer in nature and random the 
alignment of the cells does not represent in vivo muscle tissue. There is evidence 
to suggest the differential regulation of signalling pathways that mediate 
myogenesis and hypertrophy in response to uniaxial and multi-axial stretch in 
vitro (Hornberger, et al., 2005). Indeed, when using stretch systems to study SkM 
adaptation it is important to consider both the morphology of the construct used, 
but also mechanical forces applied.  
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To overcome this issue the 3D in vitro culture systems amenable to mechanical 
stretch have been developed, which more greatly represent in vivo tissue 
morphology and function, compared to monolayer models. These systems are 
more advanced than current electrically stimulated monolayer systems, with 
regards to how the cells interact with the ECM. This interaction is vital for SkM 
integrity as the transmission of vector force and has been postulated to 
contribute to mechano-transduction (Klossner et al., 2009, Crossland et al. 2013). 
This provides evidence for the development and utilisation of an in vitro model 
which incorporates a representative ECM and has the ability to be stimulated, 
both mechanically and electrically, whilst investigating the response of genes 
that regulate SkM adaptation. Specifically relating to this Thesis, the role of the 
integrated ECM in the response to mechanical signals can only be invesgated in a 
3D model.  
The extant literature demonstrates the use of such models to investigate SkM 
physiology. Powell et al., (2002) demonstrated that the dynamic stretch of in 
vitro muscle tissue resulted in myofibre hypertrophy and an increase in passive 
force, a response similar to that seen in vivo (Holm, et al., 2008, Powell, et al., 
2002). The mechanical stimulation of a 3D collagen based constructs also 
produced an increase in mechano-growth factor (MGF, Cheema, et al., 2005), 
similar to the response seen following resistance exercise (Hill and Goldspink, 
2003). However it is important to consider that this study was modelling the 
development of SkM in culture, as the mechanical stimulation occurred 
immediately post the synthesis of the construct. The effect of mechanical 
overload on primary dystrophic and normal SkM cells MGF expression, 
demonstrated no apparent effect in a 3D tissue engineered model (Evans, et al., 
2010). This surprising finding may reflect the inability of the overload protocol 
used, to induce a continuous cyto-mechanical response due to cell stress 
shielding.  
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The role of MMP’s in the response to mechanical stretch has also been 
investigated in a 3D gelafoam model of SkM, establishing an increase in MMP-2 
at 6 hrs of stretching (Auluck, et al., 2005). Increases in MMP-2 are seen 
chronically with in vivo exercise (Rullman, et al., 2007), suggesting an accelerated 
nature of the in vitro system. The monolayer and 3D SkM models that have been 
used to investigate the effects of mechanical cues on SkM cell response and 
adaptation have provided a foundation for research in this area. Much focus has 
been placed on the hypertrophic protein signalling and transcriptional response, 
with minimal attention on the molecular pathways that regulate metabolic 
adaptation.  
The development of a SkM model which morphologically replicates in vivo tissue, 
with regards to gross architecture, cell morphology, myoblast fusion, ECM 
composition and stimulation modality will provide a key tool in further 
delineating the influence mechanical signals that mediate muscle cellular 
response and in particular metabolic and hypertrophic adaptation. Furthemore, 
the use of this model will allow for the specific identification of the stimuli 
required for the required adaptive phenotype (aerobic or hypertrophic) in a 
highly controlled environment. Such a model will prove useful in the 
identification of key genes and proteins regulating adaptation to exercise and 
will provide a pre-clinical test bed for the screening of exercise, pharmacological 
and genetic therapies for SkM disease. These data will allow for a more targeted 
approach to human investigations, minimising required resources and allowing 
for a more targeted scientifc approach.  
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1.12 Thesis Aims 
Taking the above rationale forward, the following Thesis aims were set to 
address specific research questions undertaken in each experimental chapter.  
1. Extensively characterise the development of a previously published 3D 
SkM model using the C2C12 cell line, with regards to the cell culture 
conditions required to develop a bio-mimetic tissue. 
2. Utilise this model to investigate the effect of mechanical stimulation on 
the molecular responses which are known to occur with in vivo exercise 
or increased SkM load.  
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2 Methods 
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2.1 Cell Culture Procedures 
All cell culture work was carried out using a Class II Heraeus Biological Safety 
cabinet in aseptic conditions. Cells were incubated at 37°C and 5% CO2 in a 
Heracell 240 (Thermo Fisher Scientific, Rosklide, Denmark) incubator for both 
sub-culture and experimentation.  
2.2 The C2C12 Cell Line 
C2C12 Mouse C3H muscle myoblasts were sourced from the Health Protection 
Agency Culture Collections (HPA Cultures, Salisbury, UK). C2C12 cells are a sub-
clone of the C2 parental cell line that was obtained from crush injuring the leg of 
the C3H mouse to induce SC activation and proliferation (Yaffe and Saxel, 1977). 
The C12 sub-clone was isolated for the apparent proliferative and fusion capacity 
(Blau, et al., 1985). In order to ensure the specific sub-clone that was purchased 
displayed the published characteristic fusion potential of C2C12’s, an experiment 
was conducted as detailed (Fig. 2-1). 
2.3 Resuscitation of Frozen Cells  
Cells were plated at a density of 1500/cm2 (see Cell Counting 2.4.1) in T75 tissue 
culture flasks (Nunc, Fisher Scientific, Loughborough, UK) in accordance with the 
data sheet recommendation. During the counting process, cells were counted for 
viability in order to ascertain the level of cell death following cryopreservation. 
Vials with greater than 25% cell death (trypan blue positive) were discarded. 
Furthermore, non-viable cells do not have the ability to attach the the tissue 
culture plastic substate and as such, can be removed following viable cell 
attachement. If a 50% confluence (as subjectively deemed by light microscopy) 
was not achieved in the following 24 hrs after seeding, the flask was discarded 
due to the extent of non-viable cel present. 
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Cells were cultured in 20ml Growth Media (GM) [Dulbecco’s Modified Eagle’s 
Medium (DMEM, Sigma-Aldrich, Gillingham, UK) supplemented with 20% foetal 
bovine serum (FBS; PAA Laboratories, Somerset, UK), penicillin (100 U/ml; 
Invitrogen, Paisley, UK) and streptomycin (100 μg/ml; Invitrogen)]. Cells were 
then sub-cultured in order to develop a cryopreserved stock of cells. 
2.4 The Passaging (Sub-culturing) of Adherent Cells 
A relative passage assignment was used upon obtaining the cells and as such the 
first passage was deemed passage 1 (P1). For all experimentation cells were 
cultured in T175 tissue culture flasks (Nunc), due to the large number of cells 
required. Cells were used between passages 3-8 for all experiments as previous 
research has indicated the reduced myogenic potential of C2C12’s upon multiple 
population doublings (synonymous with passages, Sharples, et al., 2011). This is 
despite the well documented immortalised view of the cell line. Passaging took 
place once cells had reached between 60-70% confluence, in order to prevent 
the fusion and differentiation of the myoblasts to myotubes, but increase the 
number of cells required for experimentation.  
Growth media (GM) was removed from the culture flasks and discarded. The 
monolayer of cells was then washed twice with the appropriate amount of 
calcium and magnesium-free Phosphate Buffered Saline (PBS; Fisher Scientific). 
This process removes the majority of the proteins found in the serum of the GM, 
which have an inhibitory effect on the activity of Trypsin. 1 ml/25 cm2 of 0.05 % 
Trypsin/EDTA (Sigma-Aldrich) was added to the culture flasks. Following the 
agitation of the flask to allow the solution to cover the entire cell monolayer, the 
flask was incubated for 2-5 min depending on cell detachment. Cells were 
viewed under an inverted light microscope (Ceti, Medline, Oxon, UK) at 10x 
magnification in order to identify whether the cells had detached. Once all the 
cells were detached, GM medium was added in double volumes to the 
Trypsin/EDTA, in order to terminate the digesting and sequestering effect.  
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The cell suspension was then mixed by inversion and transferred to a conical 
centrifuge tube for centrifugation at 2000 rpm for 5 min at 4°C. Following 
centrifugation, the supernatant was carefully discarded so not disturb the pellet 
of cells. The pellet was re-suspended in an appropriate amount of GM, in order 
to count the cells using a haemocytometer (see Cell Counting 2.4.1). Cells were 
plated into the appropriate number of flasks at a density of 1500 cells/cm2, or 
used for experimentation.  
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Figure 2-1. The fusion of C2C12 myoblasts. C2C12’s were plated at a density of 1500 cells/cm2 and maintained in GM until confluency. 
Media was subsequently changed to differentiation media (DM, DMEM supplemented with 2% Horse serum [PAA] and 1% 
penicillin/streptomycin [Invitrogen]). Note the extent of fusion and number of nuclei within the single highlighted myotube (highlighted 
by the dotted line with) Scale bar = 50 µm. 
 62 | P a g e  
 
2.4.1 Cell Counting 
Specific cell numbers were needed for experimentation so a method for cell 
counting was employed using a haemocytometer. 10 µl of a cell suspension was 
added to 10 µl of Trypan Blue solution (Gibco, Invitrogen, UK), in order to 
determine viable and non-viable cells. 10 μl of this solution was pipetted under 
each end of the haemocytometer’s coverslip to fill the chamber by capillary 
action. 
Using a light microscope at x10 magnification, the numbers of cells present were 
counted in each of the four divided corners of haemocytometer (Fig. 2-2). The 
following equation was used to determine the total viable cell number: 
Equation 2-1 Cell Counting 
Total cell number = (four chamber viable cell number/4) x 2 x 10,000 x volume of 
cell suspension 
Where; ‘2’ is the multiplication for the dilution factor and ‘10,000’ is the 
multiplication for the correction factor for the haemacytometer.  
To work out the required volume for a particular number of cells for sub-culture, 
cryopreservation or experimentation, the following equation was used; 
Equation 2-2 Required Cell Number 
Volume of cell suspension for required cell number (ml) = (required cell 
number/actual total cell number) x volume of actual total cell suspension  
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Figure 2-2.  Schematic diagram of the counting chambers of a haemacytometer. 
Cells were diluted 1:1 with Trypan Blue (Gibco) and loaded into a Neubeur 
haemamacytometer. Cells stained blue were deemed non-viable. (Obtained from; 
http://www.cf.ac.uk/biosi/staffinfo/kille/Methods/Cellculture/HAEMO.html, 
accessed 15.9.09).  
2.5 Cryopreservation of Cells 
Stocks of C2C12’s were cryopreserved at multiple passages between P3-P6 for 
future use in experimentation. Cells were Trypsinised as per the sub-culturing of 
adherent cells (2.4) and counted accordingly (2.4.1). Cells were then frozen at a 
concentration of 1 x106/ml in freezing media (FM) containing 90% FBS and 10% 
di-methylsulphoxide (DMSO, Fisher Scientific, UK).  
2.6 Cell Seeded 3D Collagen Constructs 
2.6.1 Material preparation 
The collagen constructs used throughout this project were based upon a 
previously published protocol (Smith, et al., 2012). The 3D culture model involves 
seeding cells in a collagen based solution and allowing it to polymerise within a 
mould between two fixed points.  
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The fixed points were custom made structures termed floatation bars and A-
frames (Fig. 2-3). Depending on the experiment, the type of A-frame constructed 
was different; the CFM and t-CFM frames provide attachment to a strain gauge 
and fixed point, whereas the frames for the glass chamber system were 
constructed to fit around the short axis ends of the chamber. Constructs were 
cast in glass chambers for maturation experiments (detailed in experimental 
chapters). The floatation bars were constructed using polyethylene plastic mesh 
(Darice Inc, Strongsville, Ohio, US) and stainless steel wire of 0.3 mm diameter 
(Scientific Wire Company, Great Dunmow, UK, Fig. 2-3). Three 5 x 3 mm sections 
of mesh were bound by two lengths of 0.3 mm wire. The A-frames for both the 
CFM and t-CFM systems, along with the glass chamber system, were constructed 
using 0.7 mm wire (Scientific Wire Company). All floatation bars and A-frames, 
along with the glass chambers and CFM moulds were sterilised before 
experimentation using 70% ETOH and a UV function on the biological safety 
cabinet.  
2.6.2 Collagen Gel Preparation 
0.3 ml of 10 x MEM (Gibco) was added to 2.6 ml of type 1 rat-tail collagen (First 
Link, Birmingham, U.K.; in 0.1 M acetic acid, protein concentration n =2.035 mg/ 
ml). Sodium hydroxide (NaOH, Fisher Scientific) was used in 5 M and 1 M 
concentrations to neutralise the solution in a drop-wise fashion until a colour 
change (yellow to cirrus pink) was observed. Following neutralisation, a cell 
suspension of the correct number of C2C12 cells for experimentation, were 
added in a volume of 0.1 ml GM.   
The resulting solution was set in either a Chamber Slide (Lab-Tek, Fisher Scientific, 
UK) or a Derilin mould (G.W. Cowler Ltd, Mead Lane, Hertford, UK), between two 
polyethylene mesh flotation bars (‘A-frames’), placed in a 37°C humidified 
incubator with 5% CO2 and allowed to gel for 30 min. Once set, the compliant 
construct was physically detached from the base of the mould and floated in 
standard growth medium.  
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The ‘A-frames’ provided two attachment points which lead to the development 
of lines of longitudinal isometric strain. The result was a 3D tissue possessing uni-
axially aligned myoblasts capable of differentiating and performing directed 
contraction, analogous to in vivo SkM (Fig. 3-5).  
 
Figure 2-3. Floatation bar and A-frame set-up for collagen constructs. A) 
Custom made floatation bars with A-frames. B) Positioning of floatation bars and 
A- frames within a chamber slide. Note how the A-frames fit over the short axis 
perimeter to provide axial tension. Dimensions of the chamber and flotation bars 
are annotated with a dashed line. The blocked arrow lines annotate the grades of 
wire used for the A-frames. Adapted from (Smith, et al., 2012). 
2.7 The Culture Force monitor (CFM) 
The Culture Force Monitor (CFM) is an apparatus whereby real-time force 
contraction of 3D cellular collagen constructs can be accurately measured. The 
original CFM is now well documented in the literature (Eastwood, et al., 1996) 
however this system used 5ml larger gels requiring greater numbers of cells.  
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A new CFM system was set up using smaller gels in order to reduce the number 
of cells required and increase the cost effectiveness of the system.   
2.7.1 Rig construction 
A rig which could support all the required components of the CFM was 
constructed using a PTFE base and glass fibre poles (G.W. Cowler), cut to 
specification. The rig allowed for the positioning of the force transducer and 
opposing fixed point in a single plane, to accurately measure the force generated 
as a consequence of contraction of the gel. During experiments, the alignment of 
the force transducer and the opposing fixed point was achieved through the 
measurement of distances along the rig using digital calipers (Silverline, UK). This 
accurate measurement allowed for the controlled set up of the system between 
experiments, to minimise variation in the alignment and forces transduced.  
2.7.2 The Force Transducer 
The central measuring beam (Fig. 2-4) of the CFM was manufactured from a 0.15 
mm thick Copper-Beryllium sheet (Goodfellow Metals Ltd, Cambridge, UK) cut 
into strips of 100 x 10 mm. Transducer class strain gauges (Wellyn Strain 
Measurement, Basingstoke, Hants, UK) were attached to the Copper-Beryllium 
beam in a full bridge electrical network at 20 mm from one end, to give a 
maximum lever arm for maximum sensitivity. A hook was soft soldered onto the 
opposite end of the measuring beam to facilitate connection to the culture 
through the custom made stainless steel wire A-frame. The force transducer was 
attached through a wired mechanism to the Model P3 Strain Indicator and 
Recorder (Vishay, Basingstoke, UK) connected to a computer via USB. This unit 
acted as a bridge amplifier, static strain indicator, and digital data logger. Micro-
strain (µƐ) and time data was collected at a rate of 1 Hz (one reading per second) 
for all measurements.  
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2.7.2.1 Calibration of the Force Transducers 
Before each experiment the force transducers need to be calibrated, in order to 
check the integrity of the force transducer and also to provide an equation to 
convert the micro-strain (µƐ) reading to micro-Newton’s (µN). Prior to calibration 
the force transducers were left in the incubator for a period of 24 hrs to 
thermally adjust to the normal operational temperature, humidity and CO2 
content.  
The force transducers were calibrated against known masses which ranged 
between 0.5 g and 0.03 g (Table 2-1). Using the output software the correct 
channel was ‘zeroed’. Each mass was attached to the force transducer via the 
attachment hook and then data was recorded for a period of 10 mins. The 
collected data was averaged and this value was recorded as the output for the 
particular mass. This process was repeated for each of the masses on the force 
transducers. Each of the average readings in micro-strain were plotted against 
theoretical value of force that each of the known masses would produce, in 
accordance with acceleration due to gravity (Table 2-1).  
Table 2-1. CFM Force Calibration 
g kg 
Expected 
Force (N) 
Expected 
Force (μN) μƐ 
0.5 0.0005 0.004905 4905 244.2433 
0.3 0.0003 0.002943 2943 139.222 
0.2 0.0002 0.001962 1962 92.79642 
0.05 0.00005 0.000491 491 25.96563 
0.03 0.00003 0.000294 294 24.09446 
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Figure 2-4. Typical CFM Calibration Curve. This curve allows for the conversion 
of recorded micro-strain (µƐ) to µN. It also allows for the assessment of the 
integrity of the strain gauge electrical bridge network on the transducer.  
The r2 value represents the extent to which the two variables are correlated. If a 
value any less than 0.95 is observed, the force transducer should be returned to 
the manufacturer for testing, as the accuracy and/or sensitivity of the force 
transducer is no longer effective. If the r2 value in ≥ 0.95, the equation obtained 
from the trend line can be used for experimentation when converting the raw 
data in micro-strain to micro-Newton’s.  
Equation 2-3 Conversion of data from micro-strain‎(µƐ)‎to‎micro-Newton’s‎(µN) 
Force (µN) = 20.355 x µƐ 
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Figure 2-5.  The Culture Force Monitor (CFM). A) Schematic of the CFM 
illustrating the constructed rig to hold the force transducer (left) and fixed point 
(right). The dashed arrowed line between the force transducer and fixed point 
illustrates the requirement for alignment B) Image of the actual CFM set-up with 
a collagen construct tethered ready for experimentation. The alignment of the A-
frames in all planes is of paramount importance to allow for the transfer of 
longitudinal force to be accurately detected by the force transducer.  
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2.7.3 Tethering the Construct to the CFM 
Stainless steel wire ‘A-frames’ attached to the flotation bars facilitated a 
connection between the construct and the CFM. The force measurement system 
for the CFM is extremely sensitive, therefore when tethering the construct to 
both the fixed point and the measuring beam, it is important that the mechanics 
are correct. If not, the force output may not represent the contraction from the 
construct. The two A-frames must be aligned in both a superior view along with a 
lateral view when looking into the incubator.  
2.7.4 CFM Data Analysis 
The raw data collected at 1 Hz was processed in Microsoft Excel in order to 
obtain a mean reading for each minute of experimentation. This data was then 
converted to micro-Newton’s and plotted on a graph to represent the force-time 
contraction profile of the constructs (Fig. 3-1). Data was also analysed for initial 
rate of force development for each minute up to 60 min of contraction (µN/min). 
Data was also analysed for peak force and relative peak force according to cell 
seeding density. For compairsons in generated force between seeding densities 
or other conditions detailed in expiermental chapters, inferential statistical 
analysis was performed. Data was analysed for normal distrubtion and 
compliance to test assunmptions prior to presentation of data.  
2.8 The Tensioning Culture Force Monitor (t-CFM) 
2.8.1 Background and Set-Up 
Essentially the t-CFM is an addition to the CFM, in that the setup is the same 
apart from the collagen gel PTFE mould sits upon a stage attached to a 
programmable motor. The stepper motor (Parker-Hannifin, Poole, UK) is 
connected to a Four Axis Motor Control Cabinet (Micromech Systems Ltd, 
Braintree, UK) which in turn is connected to a computer via an RS232 cable. 
Parker EASI-V software (Parker-Hannifin) was used to program the regimes.  
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2.8.2 Stretching Regimes  
Regimes of mechanical stretch were devised using available commands on the 
Parker EASI-V software (Parker-Hannifin) within the command terminal (Fig. 2-6). 
The basic commands and an example of program development are detailed 
below.  
DECLARE = Declare a new program 
D = Distance (to program strain, defined below) 
A = Acceleration 
V = Velocity 
T = Time Delay 
LOOP = Loop selected program 
K = Stop program or command 
SV = Save program 
When mechanically stimulating in vitro tissue the term ‘strain’ is often used to 
quantify the amount of displacement the construct is subjected to. Strain is 
defined as;  
Strain (ε) = Δl/l 
Where l is length and Δl is the change in length (final length-original length). 
Equation 2.4 Definition of Strain 
Cultures subjected to mechanical stretch were cast and matured in the glass 
chamber or chamber slide systems (longitudinal length = 45 mm). Therefore, to 
initiate a strain the distance of motor movement was programmed accordingly. 
The EASI-V software commands distance in motor steps, where 10,000 motor 
steps = 1 mm.   
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Hence to induce a 10% strain; 
10% Ɛ = Δl/45 mm 
Δl = 45 mm x 10% Ɛ 
Δl = 4.5 mm 
∴ Distance in motor steps = 45,000 
Equation 2.5. To calculate 10% strain 
 
Figure 2-6. Axis terminal of EASI-V software. This software terminal was used to 
programme the mechanical stimulation regimes.  
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2.9 Analytical Procedures 
2.9.1 Conditioned Media Lactate and Glucose Analysis 
2.9.1.1 Principle  
The analysis of plasma Lactate and Glucose have been used extensively in 
Exercise Physiology to characterise bouts of exercise with regards to the energy 
systems utilised. Various methods of measuring these substrates have been used; 
however the most commonly available methods take advantage of a basic 
chemical reaction. Using the Analox (P-GL5; London, UK) system Lactate and 
Glucose concentrations are determined by amperometric measurement of an 
oxido-reductase enzyme reaction (van Someren, et al., 2005). This device is a 
quick and cost effetctive way to obtain metabolite data and has been shown to 
produce data with a high degree agreement to standard spectrophotometric 
measures detailed below (van Someren, et al., 2005). 
In the presence of oxygen, Lactate is oxidised by the enzyme Lactate oxidase to 
pyruvate and hydrogen peroxide;  
  
Equation 2.6. Oxidation of Lactate 
In the presence of oxygen, Glucose is oxidised by the enzyme glucose oxidase to 
gluconic acid and hydrogen peroxide; 
 
Equation 2.7. Oxidation of Glucose 
Therefore, under these reaction conditions, Oxygen consumption is directly 
proportional to Lactate and glucose concentration respectively. 
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2.9.1.2 Procedure  
The Analox Analyser P-GL5 (Analox, London, UK) was utilised for the assessment 
of Lactate and Glucose concentrations within conditioned media samples. The 
manufacturers have validated the use of this method against standard 
spectrophotometric methods. It has been demonstrated that similar analysers 
from the same manufacturer (Analox GM-7, Analox, UK) utilising the 
amperometric principle, that the covariance of lactate measurements is very low 
(0.8-1.1 %, van Someren, et al., 2005).  
The analyser was appropriately setup and calibrated using 8 mmol.L standards 
for both lactate and glucose. 10 µL samples were loaded and all reactions were 
performed in triplicate for each experimental sample, with final presented values 
representing a mean of the three triplicate reactions. Samples were always 
analysed within 24 hrs of sampling in order to preserve the concentrations of the 
substrates in question.  
2.9.2 Immunohistochemistry (IHC) 
2.9.2.1 Principle 
The reagent used for fixation of the specimen is of importance, in order to retain 
the cytoskeletal structure and cellular architecture, whist identifying a suitable 
permeablisation buffer will allow for a great specificity for the antibody (Leong et 
al., 2010). The immunolocalisation of antigens within cells or a tissue is a 
common technique used in cell and molecular biology (Wheatley and Wang, 
1998) and relies on the development of epitope specific antibodies, raised either 
in vivo, or more recently developed, in vitro. The use of a primary antibody raised 
in a particular species dictates the use of a secondary antibody, which must 
target the appropriate immunoglobulin of the primary species (Wheatley and 
Wang, 1998), Figure 2-7). Secondary antibodies conjugated to fluorophores allow 
for the detection of the antibody using fluorescence microscopy, by absorbing 
light at specific wavelengths and emitting light at a greater wavelength.  
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Many fluorophores are now available, thus allowing for the detection of multiple 
proteins simultaneously.    
 
 
Figure 2-7.  Principle of IHC for analysing Desmin protein expression on SkM 
cells.  
2.9.2.2 Procedure 
2.9.2.2.1 Gel Fixation 
The following protocol was based upon that described in (Smith, et al., 2012). 
GM was removed from the glass chamber and the constructs were rinsed twice 
with 3 ml of PBS to remove and media and serum. 2 ml of PBS was left in the 
chamber and a 2 ml solution of Methanol/Acetone diluted 1:1 (100 Methanol, 
Company; 100% Acetone, Fisher-Scientific) was added and left at room 
temperature (RT) for 15-20 min. The solution was then removed and further 2 ml 
of the Methanol/Acetone fixative was used for 15-20 min. The constructs were 
removed from their chamber and A-frames and mounted upon polylysine 
coasted microscope slides (Fisher-Scientific), before being ringed with a PAP pen 
(Sigma-Aldrich) in order to prevent any staining reagents from dispersing from 
the tissue on the slide.  
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2.9.2.2.2 Immunostaining  
The constructs were blocked for 1 hr using TBS (+ 5 % Goat serum [Sigma-Aldrich] 
and 0.2 % Triton X-100 [Fisher-Scientific]). Two further 5 min washes with TBS 
preceded treatment with the primary antibody (Rabbit Polyclonal to Mouse 
Desmin, Abcam, Cambridge UK) diluted 1:200 in TBS (+ 2 % goat serum and 0. 
2 % Triton X-100). The sections were then incubated overnight at RT. 
The constructs were again washed twice with TBS before being treated with the 
secondary antibody (Goat anti-Rabbit FITC, Stratech, Newmarket, UK) diluted 
1:200 in TBS (+ 2 % serum, 0.2 % Triton X-100). The samples were incubated for 1 
hr at RT in a darkened humidified chamber before being washed 3 times with 
TBS. SYTOX Green Nuclear stain (Invitrogen) was diluted 1:300 in water and 
applied to the samples for 30 mins. A cover glass was used to mount the slide 
using a drop of MOWIOL mounting medium (Sigma-Aldrich).        
2.9.3 Confocal Microscopy 
The mounted slides were visualized using a Zeiss LSM-510 fluorescence confocal 
microscope with associated software. Cell-associated fluorescence was visualized 
by epifluorescence, using the following filters; FITC (excitation at 485 nm and 
emission at 520 nm) and SYTOX® Green (excitation at 504nm and emission at 
523nm). Images were exported to ImageJ (National Institutes of Health, US).  
2.9.4 Gene expression using Quantitative Reverse transcription Polymerase 
Chain Reaction (qRT-PCR) 
QRT-PCR was used in order to investigate the expression of genes involved in the 
myogenic programme along with those acutely regulated following SkM 
contraction and overload.  
2.9.4.1 Principle 
The blueprint for all proteins takes the form of messenger ribonucleic acid 
(mRNA), which is transcribed from a DNA sequence.  
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In order that the expression and identity of any gene transcript can be explored, 
a reverse transcription (RT) procedure must be completed. An RT enzyme often 
takes the form of an RNA virus enzyme, with a role in vivo to transcribe the viral 
RNA genome into a template for host transcription systems (Bartlett, 2002). The 
reverse transcribed mRNA (termed copy DNA, cDNA) can then be amplified in a 
PCR reaction.  
The principle of the PCR reaction is based upon the rapid multiplication of a 
specific cDNA segment, performed by a polymerase enzyme originally isolated 
from the species Thermus Aquaticus. The unique characteristic of this enzyme is 
the ability to withstand high temperatures required for the denaturation step of 
PCR, without denaturing (Spurway and Wackerhage, 2006).  There are three 
main stages to a PCR cycle; 1) annealing, 2) extension and 3) denaturation. The 
thermal cycling protocol (2.9.4.4) allows for these processes to occur. 
Quantitative PCR is a method for analysing the amplification of the product 
during the PCR reaction using fluorescent dye technology.  
The most common forms of such technologies include probe based dyes and 
SYBR Green I. SYBR Green I was used throughout this thesis and the chemistry of 
how the dye works is illustrated in Figure. 2-8 below. SYBR Green only fluoresces 
when bound to double stranded DNA (dsDNA, Kubista, et al., 2006). An inbuilt 
flourometer within the real time PCR machine will quantify the fluorescence at 
the end of the extension step. Upon the sufficient amplification of the target 
sequence, fluorescence will develop above the threshold line, termed the cycle 
threshold (CT). 
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Figure 2-8.  Principle of qPCR using SYBR Green (Amended from Qiagen, UK). 
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2.9.4.2 RNA extraction 
The following protocol is based upon the recommendations from the 
manufacturer of TRIzol® (Sigma-Aldrich), with modifications in order to obtain the 
highest RNA yield. In order to prevent the degradation of the RNA, all materials 
used were cleaned using RNase Zap®(Sigma-Aldrich).  
GM was removed from the mould and the construct was rinsed twice with 3ml of 
PBS to remove and media and serum. Gels were removed from the ‘A-Frames’ 
using a scalpel blade and transferred into a 50ml centrifuge tube. 500 μl TRIzol® 
was added to the tube and vortexed for 20 sec. A homogeniser (IKA T10, Fisher-
Scientific) was cleaned using 70% ETOH, dried and then used to break up the 
collagen gel. Once most of the gel has broken down, triturating with a pipette 
was sufficient to break down the last fragments. The solution was then 
transferred into a 1.5 ml RNAse free tube (Fisher-Scientific).  
Samples were first treated with 100 μl chloroform (Sigma-Aldrich) and were 
shaken vigorously for 15 sec and allowed to incubate at room temperature for 2-
3 min. Samples were spun for 15 min at 4oC at a speed of 12000 g. Following 
centrifugation, the solution appears in phases; the upper aqueous phase 
containing the RNA. This phase was carefully transferred to a fresh 1.5 ml RNAse 
free tube; the other phases contain DNA and protein which will contaminate the 
sample if disturbed.  
250 μl isopropyl alcohol (Fisher-Scientific) was then added to the aqueous 
solution containing RNA. The samples were incubated at room temperature for 
10 min before being spun for 10 min at 4oC at a speed of 12000 g. The 
supernatant was removed, being careful not to dislodge the RNA pellet. The tube 
was blotted onto tissue paper in order to remove as much of the isopropyl 
alcohol as possible. 100 μl of 75% ETOH (diluted in nuclease-free water) was then 
added to the sample and incubated at room temperature for 5 min. 
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Samples were spun for 5 min at 4oC at a speed of 7500 g; the supernatant was 
removed and any further ethanol was left to evaporate for 15 min. The isolated 
purified RNA was then re-suspended in 50 μl nuclease-free water. RNA quantity 
and quality was determined using a Fisherbrand Nanodrop 3000 (Thermo Fisher) 
spectrophotometer at 260 and 280 nm absorbance.   
2.9.4.3 Primer Design 
When designing oligonucleotide primers for PCR, there are some important 
considerations to account for to achieve accurate and reliable gene expression 
data. The common considerations discussed in the literature are displayed in the 
following table.  
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Table 2-2. Considerations for the design of qRT-PCR Primers 
Consideration Solution Description 
Primer Length 18-24 bp Primer length generally 
controls specificity of the 
target sequence 
Amplicon Length 50-150 bp Allows for a more 
efficient amplification 
during each thermal cycle 
Genomic DNA 
Amplification  
Design primers 
crossing Exon-Exon 
boundaries 
Primer sets homologous 
within an Exon can 
increase genomic DNA 
amplification 
GC Nucleotide Content Approximately 50% GC nucleotide content 
relates to annealing 
temperature. 50% GC 
content with allow for a 
sufficient thermal window 
for the annealing phase of 
the PCR reaction 
Annealing Temperature 50-62˚C 
 
Optimal thermal 
temperature for the 
amplification of  
Primer-Dimer Ensure no 
complementary 
nucleotides in 
opposing primers, 
particularly at the 3’ 
end 
Primer-dimer will inhibit 
the efficient of the 
amplification of the target 
sequence 
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Primer design considerations based upon recommendations from (Dieffenbach, 
et al., 1993). All designed primer sets were assessed against all possible cross-
matches using a Basic Local Alignment Search Tool (BLAST) available online 
(http://blast.ncbi.nlm.nih.gov/). All primers used within experiments presented 
in this thesis are displayed in Table 2-3. During each PCR experiment a melt curve 
analysis was used to determine the melting temperature of the final synthesised 
product. Primers were deemed to have synthesised a single specific target if a 
single peak was evident on the melt curve analysis (Fig.2-9).  
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Table 2-3. qPCR Primer Sequences  
Target Gene Forward‎Sequence‎(5’‎to‎3’) Ref. Seq. 
Number 
RPII-B F:GGTCAGAAGGGAACTTGTGGTAT 
R:GCATCATTAAATGGAGTAGCGTC 
NM_153798.2 
Myogenin 
 
MMP-9 
F: CCAACTGAGATTGTCTGTC 
R: GGTGTTAGCCTTATGTGAAT 
F: CTGGCAGAGGCATACTTG 
R: GCCGTAGAGACTGCTTCT 
NM_031189.2 
 
NM_013599.2 
PGC-1α 
 
Tfam 
 
Cytochrome C 
 
NRF-1 
 
NRF-2 
 
COX-II 
 
F: GAAGGGAATGGGAAAGGTAGA 
R: AACAGGACATGGAAAGCAGAT 
F: CACGCTTTACCCTTCGTTCT 
R: CTCATTTCCCTGCCATTCTCTA 
F: GCCGACTAAATCAAGCAACA 
R: CAATGGGCATAAAGCTATCG 
F: CCTCAGCCTCCATCTTCT 
R: CTTAACACTTCTGTCACCTTCA 
F: TCCCGCTACACCGACTAC 
R: TCTGACCATTGTTTCCTGTTCTG 
F: GAAGCGATTCTAGGGAGCAG 
R: GGAGCAGCGATTCTGAGTAGA 
NM_008904.2 
 
NM_009360.4 
 
NM_007808.4 
 
NM_010938.4 
 
NM_008065.2 
 
NM_ 010339.1 
 
 84 | P a g e  
 
β-Globin 
 
F: GAAGCGATTCTAGGGAGCAG 
R: GGAGCAGCGATTCTGAGTAGA 
NM_008220.4 
IGF-I F: GCTTGCTCACCTTTACCAGC 
R: TTGGGCATGTCAGTGTGG 
NM_010512  
 
MMP-9 F: CTGGCAGAGGCATACTTG 
R: GCCGTAGAGACTGCTTCT 
NM_013599.2 
IGFBP-2 F: AGTGCCATCTCTTCTACAA NM_008342.3 
 
IGFBP-5 
R: GCTCAGTGTTGGTCTCTT 
F: GAAGAGGTGGTGACAGAG 
 
NM_010518.2 
 
MuRF-1 
 
MAFBx 
R: TGACAACAAGATCGGGAA 
F: CCAAGGAGAATAGCCACCAG 
R: CGCTCTTCTTCTCGTCCAG 
F: GTCGCAGCCAAGAAGAGAA 
R: CGAGAAGTCCAGTCTGTTGAA 
 
NM_001039048.2 
 
NM_026346.3 
Myostatin F: TACTCCAGAATAGAAGCCATAA 
R: GTAGCGTGATAATCGTCATC 
NM_010834.2 
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Figure 2-9.  Example of a melt curve from the Qiagen Rotogene. The 
appearance of a single peak, relates to the amplification of a specific product. 
This provides evidence for the specificity of primer annealing.  
2.9.4.4 Quantitative Reverse Transcription Polymerase Chain Reaction (qRT-
PCR) 
A single step reaction chemistry was used for the qRT-PCR for all experiments. 
This allows for the reverse transcription (RT) and the PCR to occur one after the 
other in the same sample tube and as such saving time and reducing potential 
contamination from handling samples. Due to the nature of the chemistry and 
thermo-cycling protocol, the reverse transcriptase enzyme in the RT Mix (Qiagen, 
West Sussesx, UK) is inactivated following the initial thermal protocol.  
Following the manufacturers guidelines for the reverse transcription chemistry, 
70ng reactions were used for each sample. A dilution was made from the stock 
RNA concentration, in order to have 70ng in 9.5μl, for however many reactions 
were being conducted. The Qiagen Qiagility Robot was used to perform all 
‘master mix’ and sample preparations, using programmable software.  
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The 20 μl reaction volume consisted of the following; 9.5 μl RNA, 0.15 μl forward 
primer, 0.15 μl reverse primer, 10 μl Quantifast SYBR Green Mix (Qiagen) and 0.2 
μl of the RT-Mix (Qiagen). Once the sample preparation was complete the 
samples were loaded into a Rotogene 3000Q (Qiagen) for the one step reaction. 
The PCR thermo-cycling was as follows; RT Step (Hold at 50°C for 10 mins, Hold 
95°C for 5 mins) and PCR Step (Cycling 95°C for 10 sec, 60°C for 30 sec). 
Fluorescence at the end of each extension step was measured using the Green 
Channel at excitation 470 nm emission 510 nm. An example amplification plot is 
represented in Figure 2-10.  
2.9.4.4.1 Data analysis 
The mean CT values for duplicates for each sample were used to calculate relative 
mRNA expression of the genes of interest (GOI) compared to an experimental 
control and endogenous control gene (RPII-B). A threshold was added to the PCR 
amplification curve within the lower third of the exponential phase, in order to 
obtain a CT value for each sample.  
The relative gene expression levels were calculated using the comparative CT 
(ΔΔCT) equation otherwise known as the Livak method (Schmittgen and Livak, 
2008) for determining normalised expression ratios, where the relative 
expression is calculated as 2-ΔΔCT , where CT represents the threshold cycle. An 
example equation for calculating a normalised gene expression is displayed 
below.  
Table‎2.‎Calculation‎of‎normalised‎gene‎expression‎using‎the‎comparative‎ΔΔCT 
method. Where; GOI = gene of interest, CT = cycle threshold, HKG = house-
keeping gene. The ΔCT is the CT of the GOI minus the CT of the HKG. The ΔΔCT 
represents the ΔCT of the sample minus the ΔCT of the control sample (in this 
example Sample 1).  
Name GOI CT HKG CT CT CT 2^- CT 
Sample 1 Myogenin 20.2 RP2B  18.67 1.655 0 1 
Sample 2 Myogenin 21.34 RP2B 18.77 2.55 0.9 0.538 
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Figure 2-10.  qRT-PCR Amplification plot using the Rotogene 3000.  Note the exponential increase in fluorescence, followed by linear and 
plateau phases. 
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2.9.5 DNA Trizol reagent 
2.9.5.1 Procedure 
2.9.5.1.1 DNA Isolation, Purification and Quantification 
DNA was isolated from the phenol-chloroform phase separated during the initial 
step of RNA extraction. Removal of any of the aqueous phase was carefully 
conducted prior to the addition of 150 µL of 100% ETOH. Samples were then 
mixed by inversion and incubated at RT for 2-3 min, before centrifugation at 
2,000 g for 5 min to pellet the DNA. The phenol-ETOH supernatant was removed 
and transferred to another tube for protein isolation. The DNA pellet was then 
washed in 500 µL of wash solution containing 0.1 M sodium citrate (Fisher-
Scientific) in 10% ethanol, pH 8.5. Samples were incubated for 30 min at RT and 
mixed periodically be inversion. The sample was centrifuged at 2,000 g for 5 min 
before a further 2 washes for 30 mins. 750 µL of 100% ETOH (Fisher-Scientific) 
was added to each sample and incubated for 20 min at RT, with periodic mixing 
to ensure the precipitation of the entire DNA sample. A 5 min centrifugation 
preceded the air drying of the DNA pellet for approximately 30 min, following the 
removal of all the ETOH.  
The DNA pellet was then re-suspended in 8 mM sodium hydroxide (NaOH, 
Fisher-Scientific), with insoluble material being pelleted at 12,000 g for 10 min. 
DNA was immediately quantified using a Fisherbrand Nanodrop 3000 (Thermo 
Fisher) spectrophotometer at 230 nm and 260 nm absorbance. DNA was stored 
at -80˚C overnight prior to use in mtDNA experiments. The isolated DNA is not 
stable in 8 mM NaOH and therefore cannot be stored for prolonged periods of 
time. Hence all mtDNA analyses were performed within 48 hrof DNA isolation.  
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2.9.5.1.2 RNA:DNA Ratios 
Upon isolation, purification and quantification of protein and DNA, ratios were 
calculated. RNA:DNA ratios have previously been used to quantify the level of 
transcription occurring within the tissue. Ratios were calculated as; µg.µL/µg.µL.  
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3 Experimental Chapter 1: The extensive characterisation of a 3D in vitro 
Skeletal Muslce model using the C2C12 cell line 
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3.1 Introduction 
In order to understand the physiology of SkM further, the necessity  for 
experimental control has driven the  development of in vitro SkM culture 
systems (Baar, 2005). Experiments in monolayer including the use of primary 
sourced SkM cells and SkM cell lines, have been utilised to examine the cellular 
and molecular physiology of in vivo muscle tissue. Muscle cells in vivo develop 
and grow in a three dimensional (3D) environment, receiving many important 
physiological cues from the surrounding extra-cellular matrix (ECM, (Smith, et al., 
2010) and as such, monolayer investigations may not reflect true in vivo 
physiology. Moreover, recent evidence has suggested the enhanced fusion of 
cells seeded in a 3D matrix and displaying similar gene expression of a marker of 
differentiation compared to monolayer cultures (Smith, et al., 2012).   
A collagen based model, which has been shown to initiate the required 
mechanical signals for uni-axial tension, is now extensively published within the 
literature (Brady, et al., 2008, Mudera, et al., 2010, Smith, et al., 2012). Data 
demonstrates the development of lines of principle strain, as evidenced using 
finite element analysis (Eastwood, et al., 1998) along the longitudinal axis with 
this collagen-based culture system. This facilitates the alignment of seeded cells 
in a single plane and has been shown to be sufficient in promoting the alignment 
(Cheema, et al., 2003) and fusion myoblasts or muscle derived cells (MDC’s, 
Brady, et al., 2008, Mudera, et al., 2010, Smith, et al., 2012).  
The early work in this system carried out by Cheema et al (2003) examined the 
seeding density and force characteristic response of C2C12’s compared to other 
primary sourced cells including human dermal fibroblasts and rabbit smooth 
muscle cells. This data illustrated the stark differences in cell-matrix interaction 
and contraction between each cell type (Cheema, et al., 2003), with a delayed 8 
hr lag phase evident for C2C12’s.  
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There was also confirmation of early myoblast fusion within the C2C12 
constructs, however the open nature of the CFM system contributes to 
contamination and prevents long term culture for enhanced maturation. 
Additionally, these constructs were 5 ml collagen preparations with 20 x 106 cells, 
requiring long monolayer sub-culturing. This limiting factors, prevent the use of 
the model proposed by (Cheema, et al., 2003) in longer term physiological 
experiments.  
Recently, Smith et al., (2012) published additional characterisation and 
optimisation of this model using 3 ml constructs, to enable the longer term 
culture of primary rat MDC’s. The longer term culture of this model allows for 
the enhanced maturation of the seeded MPC’s to attain architecture greatly 
similar to that of in vivo tissue (Smith, et al., 2012). Moreover, the histological 
analysis provides further evidence for the increased bio-mimicity of 3D culture 
systems over conventional monolayer culture.  
Characterising the culture conditions required for the long term culture of a cell 
line within this system, would combat experimental and ethical issues 
surrounding of the previous 5 ml CFM model and the use of primary cells as 
presented in (Smith, et al., 2012). Furthermore, data has previously shown the 
high seeding density required to achieve fusion within this model (Smith, et al., 
2012, Cheema, et al., 2003). Achieving this high cell number with primary cells is 
methodologically challenging, due to the limited myogenic potential of MDC’s 
with multiple divisions; even as low three passages (Machida, et al., 2004). 
Therefore, developing the Smith, et al., (2012) model further for use with a cell 
line that enables long term culture will increase experimental productivity due to 
reduced cell isolation and characterisation from primary sources. Further, an 
increase in control will be achieved due to the homogeneity and sustained 
myogenic potential with cell lines.  
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In addition, developing precise control procedures within specific cell lines, will 
allow for the detailed and controlled investigation of key genes and proteins 
involved in SkM adaptation, regeneration and degeneration. In the context of the 
aims of this Thesis, the further development and characterisation of this model 
will provide a foundation from which the effects of mechanical signals on cell 
response can be investigated.   
3.1.1 Aims  
1. To characterise the use of C2C12 cells in 3 ml collagen constructs with 
respect to seeding density, culture period, macroscopic and histological 
parameters in the development of a bio-mimetic SkM construct.  
2. To set up the mechanical stimulation system and to provide preliminary 
evidence for the acute regulation of genes implicated in SkM adaptation 
utilising characterised in vitro SkM constructs.    
3.1.2 Hypotheses  
It was hypothesised that with increased seeding density, the ability for the cells 
to attach and contract the matrix will be enhanced. Furthemore, the expression 
pattern of the key myogeninc gene myogenin would display a pattern similar to 
that witnessed in previous experiments in collagen constructs (Smith, et al., 
2012). It is also hypothesised that following evidence of this gene expression 
pattern, the histological confirmation of myotubes would be achieved. Following 
this characterisation, it was hypothesised that an acute regimen of mechanical 
stretch would increase the expression of genes similar to that seen with in vivo 
exercise.  
3.2 Methods 
3.2.1 Cell Culture 
The C2C12 SkM cell line was cultured according to methods detailed (Methods 
2.4).  
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3.2.2 Cell seeded 3D Compliant Collagen Constructs 
Collagen constructs were prepared as previously described (Methods2.6). 
Constructs were made identically for CFM and Chamber Slide experiments. 
However it is important to note the A-frame structures were prepared differently 
for CFM and Chamber Slide experiments (see section 2.6.1).  
3.2.3 CFM Experiments 
Recent data has revealed the necessity for 14 day culture for the fusion of MDC’s 
within collagen constructs (Smith, et al., 2012); however it is clear that the 
immediate 24 hrs post seeding is vital for cell attachment and survival of seeded 
cells. The force characteristics of myoblasts and MDC’s within these constructs 
has previously been used to provide data regarding cell-matrix and cell-cell 
interaction (Mudera, et al., 2010, Brady, et al., 2008, Cheema, et al., 2003), key 
determinants of cell survival and potential fusion. Therefore, investigating the 
CFM force profiles of seeded cells is an important factor in defining the myogenic 
potential.  
The endogenous force characteristics associated with the seeded cells 
remodelling the collagen matrix over a 24 hr period is now comprehensively 
illustrated in the literature (Mudera, et al., 2010, Brady, et al., 2008, Cheema, et 
al., 2003, Eastwood, et al., 1998). Data has provided evidence for the use of 4 x 
106 C2C12 cells/ml for a 5 ml construct to achieve a high cell density for 
attachment and fusion of the seeded myoblasts (Cheema, et al., 2003).  
The current investigation aimed to characterise whether this seeding density 
would remain optimal for use in 3 ml constructs. Reducing construct volume will 
reduce sub-culture time to obtain required cell numbers and reduce financial 
expense, associated with engineering the constructs. Prior to any 
experimentation the CFM was set-up and calibrated accordingly (see section 2.7). 
n = 3 collagen constructs were prepared for each seeding density as follows; 1 x 
106, 2 x 106, 3 x 106 and 4 x 106 cells/ml.  
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A preliminary seeding density of 5 x 106 cells/ml was used, however the force 
generation was sufficient to pull the construct away from the floatation bar and 
therefore this seeding density was discarded.  
Following the polymerisation, the constructs were floated in GM and were 
immediately tethered to the CFM. There was no more than 30 min between the 
seeding of the myoblasts and the beginning of force measurement.  
Micro-strain (µƐ) and time data was collected at a rate of 1 Hz for all 
measurements (sees section 2.7). Raw data from the CFM was converted into μN 
and analysed as follows. Peak force was taken as the greatest value of force 
obtained over the 24 hr period. In order to assess the whether peak force was 
dependent upon cell density and to further ascertain cell-cell and cell-matrix 
interactions, peak force was also calculated relative to total seeded cell number. 
Rate of force development (RFD) was calculated as a mean increase in μN/min 
for the first 60 min of experimentation. Representative force traces for n = 3 
constructs is graphically represented (Fig. 3.1).  
Previous data had provided evidence for a 5 day culture period necessary to 
induce C2C12 myoblast fusion within the 5 ml constructs, therefore no histology 
was performed on the 24 hr CFM experiments 
3.2.4 Chamber Slide Experiments 
Following the definition of the optimal seeding density for use in experiments, 
the investigation of the macroscopic contraction of cell seeded collagen 
constructs was performed over 14 days. n = 4 constructs per time-point were 
seeded at 4 x 106 cell/ml for 5, 7 and 14 days in chamber slides. Scaled images of 
the constructs were measured throughout the time-course of culture using 
Image J software (NIH Image, US). Analysis of myogenin and PGC-1 mRNA was 
also conducted over the 14 day culture period, in order to evaluate the 
expression of these genes essential for the myogenic programme.  
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The expression pattern of these genes would provide essential information as to 
the required culture period for the differentiation of the seeded myoblasts into 
multinucleated myotubes, as previous data using human MDC’s has shown the 
induction of myogenin mRNA expression only in multinucleated myotubes 
(Mudera, et al., 2010).  
At each time-point constructs were removed from their chamber and A-frames 
for RNA extraction. Previous published data has suggested 14 days is adequate 
for the formation of primary rat MDC’s (Smith, et al., 2012), however it was 
important to define a time-course of gene expression for the C2C12 cell line.  
To examine whether the 14 day culture period was sufficient for the 
development of multinucleated myotubes, n = 3 collagen constructs were 
seeded at 4 x 106 cell/ml for 14 days. Following 14 days experimentation, the 
constructs were removed from the chamber slides and fixed using methanol and 
acetone (see methods section 2.9.2). Constructs were mounted onto polylysine-
coated microscope slides for immunostaining. The constructs were stained to 
investigate the presence of intermediate filament protein Desmin, an early 
marker of commitment to the myogenic lineage (see 2.9.2). This protein has 
commonly been used to identify myoblasts and multinucleated myotubes in this 
model (Brady, et al., 2008, Smith, et al., 2012). Images were taken using a Zeiss 
LSM 510 confocal microscope with associated software. Cell-associated 
fluorescence was visualized by epifluorescence, using; FITC to detect Desmin 
(excitation at 485 nm and emission at 520 nm) and SYTOX® Green to detect 
nuclei (excitation at 504 nm and emission at 523 nm).  
3.2.5 Tensioning Culture Force Monitor (T-CFM) Experiments 
Following the definition of the seeding density and culture time required for the 
development of constructs with multinucleated myotubes, the effect of 
mechanical stimulation on genes which have been implicated in the adaptation 
of SkM to increase load were investigated.  
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This preliminary investigation aimed to ensure the new mechanical stimulation 
system was operated correctly, whilst also investigating the response of genes 
that would be examined in future experiments. n = 3 control constructs (CON) 
and n = 3 stretch constructs (STR) were seeded and matured for 14 days in 
culture before being transferred to the t-CFM for experimentation.  
A previous investigation has used a 7.5 % substratum strain to investigate the 
response of seeded MDC’s to cyclical mechanical strain (Auluck, et al., 2005). This 
loading pattern is also similar to continuous loading that would be evident with 
in vivo SkM contraction. Hence, a 7.5 % cyclic continuous strain was applied to 
the constructs for 60 mins. CON constructs were tethered to the t-CFM for 60 
mins without stretch. At the 60 min time-point, constructs were immediately 
removed from the t-CFM, detached from the A-frames and submerged in 500 L 
TRIzol for RNA extraction. 
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Figure 3-1. Schematic representation of collagen construct preparation and experimentation
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3.2.6 Construct Macroscopic Contraction, Isolated RNA and Gene Expression 
Analysis Experiments 
In order to analyse the effect of construct macroscopic contraction upon RNA 
isolation and gene expression n = 9 constructs were seeded in chamber slides 
with 4 x 106 cells/ml for 14 days maturation. At 14 days, image analysis of the 
extent of contraction was performed and the constructs were sampled for RNA 
extraction. The expression of genes associated with SkM development, 
differentiation and adaptation were investigated using RT-qPCR.  
3.2.7 RNA Isolation and Purification 
At each experimental sample time-point, constructs were removed from their 
chamber and RNA was extracted using the TRIzol method according to the 
manufacturer’s protocol (Invitrogen Life Technologies, Carlsbad, CA, USA, see 
section 2.9.4.2). RNA quantity and quality were assessed by UV spectroscopy at 
O.Ds of 260 and 280 nm using a Nanodrop 3000 (Fisher Brand, Thermo Fisher 
Scientific, Rosklide, Denmark) spectrophotometer. 70 ng of RNA was used per 
RT-qPCR reaction.  
3.2.8 RT-qPCR Primers 
Primers (see section 2.9.4.3) were designed and synthesised by Sigma-Aldrich, 
without the requirement of further purification. Primers were designed to meet 
standard quality criteria; yield products spanning exon–intron boundaries to 
prevent any amplification of genomic DNA and minimal secondary structure or 
inter-molecular/intra-molecular interactions (hairpins, self-dimer and cross-
dimer).  
3.2.9 RT-qPCR and Data Analysis  
Once the sample preparation was complete (2.9.4), the samples were loaded 
into a Rotogene 3000Q (Qiagen) for the one step reaction using the Quantifast 
SYBR Green Mix (Qiagen). Fluorescence at the end of each extension step was 
measured using excitation at 470 nm and emission at 510 nm.  
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The mean CT values for duplicates were used to calculate relative mRNA 
expression of the genes of interest (GOI) compared to an internal normaliser and 
an endogenous housekeeping gene (HKG, RPII). The relative gene expression 
levels were calculated using the comparative CT (ΔΔCT) equation otherwise 
known as the Livak method (Schmittgen and Livak, 2008) for determining 
normalised expression ratios, where the relative expression is calculated as 2-
ΔΔCT , where CT represents the threshold cycle.  
3.2.10 Statistical Analyses 
All statistical analysis was performed using SPSS software version 17 (SPSS INC, 
Chicago, IL, USA) and Graphpad Prism 6 (California, USA). All data analysis and 
out is detailed in Appendix 2 (8.2.1), where normal distribution and tests 
assumption statistics are presented. Significant differences between variables 
were analysed using independent t-tests and one way analysis of variance 
(ANOVA). For ANOVA, data was tested for homogeneity of variance (Levene’s 
test) to comply with the assumptions of this form of analysis, where all test 
assumptions were met. A pair-wise comparison post-hoc test was performed 
with a Bonferroni adjustment for any data with significant F values. Analysis of 
relationships between variables was conducted using linear regression (Pearson’s 
correlation). The two tailed alpha value of significance was set at p ≤ 0.05 for all 
analyses. All data is presented as mean ± standard error of the mean (SEM).  
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3.3 Results 
3.3.1 Constructs seeded with 4 x 106 cells/ml represent the greatest potential 
for the formation of a bio-mimetic SkM model 
Increases in peak force were observed in the 3 x 106 and 4 x 106 seeding densities 
compared to 1 x 106 and 2 x 106 constructs despite no statistical main effect (p = 
0.405, Fig. 3.2 A). The 4 x 106 cells/ml constructs displayed the greatest mean 
RFD compared to all other seeding densities, despite no main effect being 
observed for this variable reaching statistical significance (p = 0.063, Fig. 3.2 B).   
In order to ascertain the cell behaviour associated with seeding density and peak 
force, data was calculated for relative peak force. A significant main effect for 
relative peak force was observed (p = 0.009). A reduction in relative peak force 
for 2 x 106 cells/ml (p = 0.029) and 4 x 106 cells/ml (p = 0.014) compared to 1 x 
106 cells/ml constructs was observed for this variable, with the reduced relative 
peak force in the 3 x 106 cells/ml constructs approaching significance (Fig. 3.2 B). 
This data demonstrates a differential effect on peak force, when accounting for 
seeding density. 
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Table 3-2. 24 hr Force characteristics of collagen constructs seeded with 1, 2, 3 
and 4 x 106 cells/ml.  
Seeding Density Peak‎Force‎(μN) Rate of Force 
Development 
(μN/min,‎Initial‎
60 min) 
Relative Peak 
Force 
(μN/Total‎
seeded 
cell 
number 
1 x 106/ml 619 ± 92 5 ± 2 206 ± 30 
2 x 106/ml 570 ± 182 1 ± 1 95 ± 30 
3 x 106/ml 1008 ± 222 2 ± 4 112± 24 
4 x 106/ml 917 ± 362 9 ± 2 76 ± 30 
Main Effect for 
Seeding Density 
(p value) 
P = 0.405 P = 0.063 P = 0.009 
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Figure 3-2. Representative mean force trace profiles from CFM experiments conducted over a 24 hr culture period. n = 3 experiments 
for all seeding densities were conducted with data collected and processed at 1 Hz. Constructs were seeded at 1 x 106/ml, 2 x 106/ml, 3 x 
106/ml and 4 x 106/ml. Data presented is representative of data collected due to the large volume of data geneeated for each experiment.  
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Figure 3-3. CFM data analysis following 24 hr experimentation. Data was collected at 1 Hz and analysed for the following parameters to 
identify differences between seeding densities. n = 3 experiments were conducted for each seeding density. A) Peak force; data was 
analysed based upon the highest force recorded over the 24 hr experiment. (p = 0.405). B) Rate of Force Development (RFD); data was 
analysed as a mean increase in force produced per minute for the initial 60 mins of each experiment. (p = 0.063). C) Relative peak force 
displayed per million seeded cells (both *p < 0.05 compared to 1 x 106 cells/ml). Data is presented as mean ± SEM. 
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3.3.2 Construct diameter reduces over time in culture 
A significant main effect for construct diameter (p = 0.000) was further revealed 
sharp decline in gel diameter over the first week in culture, with a significant 
reduction by 3 days compared to 24 hrs (p = 0.016, Fig. 3-4). The second week in 
culture resulted in a mean, but non-significant further reduction in gel width 
compared to 5 and 7 days, reaching a final width of 9.10 ± 0.43 mm (p = 1, Fig. 3-
4). 
 
Figure 3-4. Time-course of macroscopic contraction of collagen constructs 
seeded with 4 x 106 cells/ml for 14 days. A significant reduction in gel with at 3 
days in culture (p = 0.016) compared to the 24 hr time-point. No significant 
further reduction in gel width was observed beyond 5 days. *all p < 0.05 
compared to 24 hrs. N = 3+ constructs were analysed. Data is presented as mean 
± SEM. Scale bar = 10 mm.   
24 hrs  14 Days  
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3.3.3 A culture time of 14 days is required for the expression of the myogenic 
programme 
Following evidence for the remodelling of the collagen matrix of a 14 day culture 
period, it was important to investigate whether the single seeded cells has fused 
within the constructs. Studying the pattern of myogenin mRNA provides 
evidence for the time course of the myogenic programme within the constructs 
and has previously been used within this model as an indicator for differentiation 
(Mudera, et al., 2010, Smith, et al., 2012). However it was important to 
demonstrate a similar expression pattern as a transcriptional indicator of fusion 
of C2C12’s in this model.  
Data presented here illustrates a higher to lower expression pattern of myogenin 
mRNA across the 14 day culture period in the chamber slide system. Mean 
reductions from 0.98 ± 0.35 at 5 days to 0.74 ± 0.43 at 7 days, falling to 0.57 ± 
0.38 at 14 days (no significant main effect p =0.072, Fig. 3-5 A), demonstrate a 
reduction in the transcript required for differentiation. This provides evidence 
from a transcriptional perspective that the induction and potential fusion of 
seeded myoblasts to multinucleated myotubes has occurred within this time 
course of experimentation.  
The process of myoblast fusion requires vast amount of ATP to supply the energy 
required during this developmental process. Indeed PGC-1α has been shown to 
play a pivotal role in co-ordinating mitochondrial biogenesis, to stimulate a 
greater oxidative potential for ATP production during the regeneration of SkM 
(Duguez, et al., 2002). The expression pattern of PGC-1α mRNA demonstrates 
variable expression, with mean reductions at 7 and 14 days compared to 5 days 
(main effect p = 0.132, Fig. 3-5 B).  
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Figure 3-5. Time-course of gene expression of genes required for the myogenic 
programme. Collagen constructs were seeded with 4 x 106 cell/ml. n = 3 
constructs per time-point were used. A) Reductions in myogenin mRNA at 7 and 
14 days compared to 5 days culture (p = 0.072). B) Reductions in PGC-1α mRNA 
expression at 7 and 14 days compared to 5 days in culture (p = 0.132). Data is 
presented as mean ± SEM.  
With transcriptional evidence for the development of myotubes within the 
collagen constructs by 14 days at 4 x106 cells/ml, it was important to determine 
histologically whether myotubes had formed. Collagen constructs were 
immunostained for cytoskeletal intermediate filament protein Desmin, a specific 
marker of cells of the myogenic lineage.  
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Images did indeed reveal the alignment and fusion of myoblasts to 
multinucleated myotubes in a single plane (Fig. 3-5). Images also revealed the 
development of myotubes in multiple axes, as demonstrated by myotubes 
present in different focal planes. This data further supports previous immuno-
histological analyses of SkM cells in this system (Smith, et al., 2012) and 
demonstrates the conserved nature of myotube development and orientation in 
an alternative cell type. 
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Figure 3-6. Collagen constructs seeded with 4 x 106 cells/ml for 14 days. Fixed constructs were immunostained with Desmin (Red) and 
SYTOX Green (Nuclei). Scale bar = 20 μm. Note the high level of orientation of the cells and the myotubes present with multiple nuclei as 
indicated by arrows.  
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3.3.4 Cyclic mechanical stretch of characterised constructs identifies large 
variation in gene expression response 
Following the characterisation of the required seeding density and the duration 
of culture to develop a construct with multinucleated myotubes, the use of these 
constructs for mechanical stetch experiments was sought. In order to test the 
mechanical stimulation system developed within the laboratory a preliminary 
cyclic mechanical stretch experiment was conducted. This experiment sought to 
examine the effect of 60 mins continuous cyclic stretch at 7.5 % strain, upon the 
regulation of genes that would be investigated in greater detail in future 
experiments. This strain and stimulation mode has been shown to be effective in 
inducing a mechano responsive of MDC’s (Auluck, et al., 2005).  
Surprisingly, gene expression analysis showed a high degree of variation in the 
response of the stretched constructs (STR) compared to static controls (CON, Fig 
3-7). A significant difference in reduction in Tfam mRNA expression was observed 
between STR and CON (p < 0.001). This finding is unanticipated considering the 
role Tfam plays in response to mechanical and metabolic signals to stimulate 
mitochondrial biogenesis in vivo. Evidently, there were no other significant 
changes in gene expression, with no apparent pattern indicative of a 
physiological response. This variation appeared to reside in variation in the 
expression of the genes of interest (GOI), as there was stability in the expression 
of the HKG (CT’s, 18.56 ± 0.49, CON vs. 18.86 ± 0.78, STR). As such the significant 
effect for Tfam may represent an error in variability, which may change with 
increased statistical power.  
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Figure 3-7. Acute mRNA regulation in response to cyclic mechanical stretch 
relative to static controls. n = 3 collagen constructs were seeded at 4 x 106 
cells/ml for 14 days for both conditions. PGC1-α = Peroxisome proliferator-
activated receptor gamma coactivator 1-alpha; MMP-9 = matrix 
metalloproteinase-9; Tfam = mitochondrial transcription factor A; CytoC = 
Cytochrome C; COXII = cytochrome C oxidase subunit II. Data is presented as a 
relative increase above control (CON, dotted line). Data is presented as mean ± 
SEM.  
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Table 1. Significance values for differences between STR and CON constructs 
subjected to 7.5% continuous cyclic strain.  
Gene P Value (Significance, STR vs CON) 
PGC-1α 0.683 
MMP-9 0.548 
Tfam 0.000 
CytoC 0.341 
COXII 0.433 
3.3.5 Construct bowing correlates to isolated RNA concentration and gene 
expression; a <10 mm construct width experimental control required 
for future experimentation 
The inherent variation within the constructs was evident from the CFM data and 
the gene expression data from both the time-course and mechanical stimulation 
experiments. This demonstrates a variation in cell behaviour between construct 
samples, despite the same culture conditions. It was also witnessed that the 
macroscopic contraction (construct diameter) was variable between cultures. It 
was hypothesised that these variations would contribute to a difference in basal 
gene expression of the constructs and in this light would manifest a high level of 
variation during post stretch gene expression analysis. In order to develop a 
method to control for such variations, the expression of genes known to regulate 
differentiation, maturation and metabolism were investigated in relation to the 
extent of contraction of the constructs over a 14 day culture period.  
The extent of construct contraction significantly predicted the amount of total 
RNA isolated from the constructs (R² = 0.7788, p < 0.01, Fig 3-8 A), demonstrating 
a potential increased level of transcription with a greater amount of bowing.  
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The expression of an endogenous proposed housekeeping gene (HKG, RPII), was 
also found to be highly dependent on the extent of the construct bowing (R² = 
0.945, p < 0.0001, Fig. 3-7 B). The amount of isolated RNA also significantly 
negatively predicts the CT of RPII (R
2 = 0.87, p= 0.0002, Fig. 3-8 C), despite the 
amount of template RNA for the RT-PCR reaction remaining the same. This level 
of variability proposes significant problems when using the comparative delta 
delta CT method (Schmittgen and Livak, 2008) for gene expression analysis. This 
method is dependent on the stability of the endogenous control gene, to reliably 
and validly investigate gene expression.  
A moderate positive relationship was found between the extent of construct 
bowing and myogenin mRNA CT (R² = 0.459, p > 0.05, Fig 3-8 D), suggesting a 
modulation of the potential for differentiation. Furthermore, the extent of 
contraction positively correlated to the CT of IGF-I, a gene highly implicated in 
SkM differentiation and hypertrophy (R² = 0.459, p = 0.0449, Fig 3-8 E). A 
significant positive correlation was also found between construct diameter and 
the CT of PGC-1α (R² = 0.695, p = 0.0053, Fig 3.7 F). This suggests that the extent 
of the bowing of the constructs affects the potential to stimulate mitochondrial 
biogenesis, a necessity to increase mitochondrial content for ATP synthesis 
required for fusion and cell survival. As such this will contribute to increased cell 
survival, attachment to the matrix and potential for fusion, increasing the bio-
mimicity of the model. 
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Figure 3-8. Linear regression analyses between construct contraction (gel width), isolated RNA and consequential gene expression. n = 
9 collagen constructs seeded at 4 x 106 cells/ml were cultured for 14 days prior to images analysis and RNA extraction. A) There is a 
significant negative relationship between construct width and isolated RNA. B) Construct width significantly positively correlates to RPII 
CT. C) Isolated RNA concentration significantly negatively correlates to the observed CT of RPII. D) There is a moderate positive linear 
relationship between construct width and myogenin CT. E) Construct width significantly predicts the CT of IGF-I. F) There is a significant 
relationship between construct width and PGC-1α CT.
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3.4 Discussion 
The aim of the current investigation was to further characterise the use of an 
established 3D model of SkM in vitro. The requirement to characterise the use of 
a cell line in this system for long term culture, will allow for the investigation of a 
homogenous population of seeded cells without the requirement of primary 
tissue sources. Moreover, the use of a homogenous cell populated tissue will 
combat experimental issues surrounding the inherent variability between 
primary and particularly human cells. This increased control will provide a model 
to analyse the molecular mechanisms that govern in vivo SkM and particularly 
myogenic cell physiology.  
3.4.1 CFM Data 
Previous investigations have used the CFM to investigate the cytomechanical 
properties of cells within this model of SkM. Data reported here provides 
evidence for the use of 4 x 106 cells/ml 3 ml C2C12 collagen constructs a 
reduction in volume from previous published data (Brady, et al., 2008, Mudera, 
et al., 2010, Smith, et al., 2012). This data demonstrates differential 
cytomechanical characteristics for each seeding density investigated (Fig. 3-2), 
further suggesting that the initial RFD may not relate to the peak force achieved 
(Fig. 3-3, Mudera, et al., 2010). This may reflect the complex nature of the cell-
matrix and cell-cell interactions that are modulated dependent on seeding 
density, as demonstrated by calculating relative peak force (Fig. 3-3 C).  
Furthermore, seeding 5 ml collagen constructs at 1 x 106 cells/ml results in an 8 
hr lag phase of force development, compared to constructs seeded at 4 x 106 
cells/ml that show a similar profile to that presented here (Cheema, et al., 2003).  
The force profiles for each seeding density used in the current investigation, 
demonstrate the development of traction, contraction and force plateau, 
characteristic of cells within collagen matrices (Fig. 3-2, Eastwood, et al., 1998). 
This therefore illustrates that reducing the gel volume and consequential cell 
number does not affect the cytomechanical characteristics of cells within this 
system.  
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Previous data has demonstrated the importance of the aspect ratio of the long 
and short axes in determining cell behaviour within collagen matrices (Eastwood, 
et al., 1998). The aspect ratio of constructs seeded in 5 ml and the 3 ml 
constructs presented here is the same. This further supports the notion of aspect 
ratio as an important determinant in cell behaviour, rather than construct 
volume.  
3.4.2 Construct Width 
Once a seeding density of 4 x 106 cells/ml was defined for the use in further 
experiments, the extent of the characteristic bowing within this model was 
investigated. Previous data has established a significant reduction in the 
construct surface area throughout a time course of culture (Smith, et al., 2012). 
Data presented here, further demonstrates a significant reduction (p < 0.01, Fig. 
3-4) in the construct width over 14 days in culture. This demonstrates in this 
myoblast only model, that the cells are capable of remodelling the matrix, a 
phenomenon that was thought to be mainly driven by the non-myogenic 
component of primary cell seeded constructs (Smith, et al., 2012). However it is 
important to note the magnitude of the bowing in this current investigation is 
not as great as reported in Smith et al., (2012), suggestive that the non-myogenic 
component of primary cell cultures have the ability to remodel the matrix to a 
greater extent. Furthermore, previous work has suggested a synergistic role for 
the non-myogenic cells in the development of these constructs (Brady, et al., 
2008).  
Notwithstanding a role for the non-myogenic cells, it is demonstrated here that 
C2C12 myoblast only constructs remodel the collagen matrix promoting an 
increased cellular density to enhance the potential for myoblast fusion. The 
increased cell density will also promote an increased cell to matrix ratio, 
developing a tissue that more greatly represents in vivo SkM. Following the 
identification of matrix remodelling, it was necessary to ensure that single 
seeded myoblasts fused into post-mitotic multinucleated myotubes.  
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3.4.3 Fusion of seeded myoblasts 
The expression of both myogenin and PGC-1α mRNA were found to follow a high 
to low pattern (Fig. 3-4), suggestive that the transcriptional signals required for 
differentiation were switched on at 5 days then down-regulated throughout the 
rest of the culture period. The expression of myogenin marks the entry of 
myoblasts into the differentiation process (Hawke and Garry, 2001); whilst 
myogenin and PGC-1α have been demonstrated to play a pivotal role in the 
regenerative process of SkM in vivo (Duguez, et al., 2002). These data provide 
support that the model developed here recapitulates the developmental and 
regenerative processes that occur with SkM in vivo, in terms of myogenin and 
PGC-1α expression patterns.  
The data presented here also follows a similar pattern to that seen in this model 
using primary rat MDC’s, whereby myogenin follows a high to low expression 
over a 14 day culture period (Smith, et al., 2012) sufficient to induce myoblast 
fusion. Experiments presented later in this thesis aimed to investigate the role of 
PGC-1α in response to mechanical stretch and therefore it was important to 
ensure its expression was completely down-regulated before experiments could 
begin. Coupled with the myogenin data, a 14 day maturation period prior to 
mechanical stretch experiments would be necessary to meet this requirement.   
Analysis of the cellular architecture within this model was also necessary to 
confirm the presence of differentiated cells in this system at 14 days in culture.  
Previous data has showed the alignment of cell from multiple cell types, which is 
highly dependent on the predictable lines of strain throughout the matrix 
( Eastwood, et al., 1996, Cheema, et al., 2003, Smith, et al., 2012). This 
mechanical cue has been shown to be sufficient to encourage the alignment and 
fusion of seeded myoblasts (Sharples, et al., 2011, Smith, et al., 2012). This 
current investigation confirmed the presence of highly orientated myotubes, 
morphologically similar to in vivo SkM (Fig. 3-5).  
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Additionally, the 3D environment and mechanical tension generates cellular 
architecture which is improved above standard monolayer cultures, whereby the 
presence of branched myotubes is often found in this cell line (Sharples, et al., 
2011). Despite evidence for myoblast fusion, it was not possible to quantify the 
extent of the process, due in part to the 3D nature of the constructs. In particular, 
the presence of myotubes and nuclei in multiple focal planes prevents the 
objective measurement of fusion, due to the limitation of microscopy to a single 
plane of focus at any one time. Future work using confocal microscopy and 
automated image analysis software may overcome this problem.  
3.4.4 Mechanical stretch  
Following the confirmation of the presence of myotubes with the culture 
conditions discussed, a preliminary investigation was conducted using 
mechanical stretch. It was found that the expression of genes that have 
previously been shown to be implicated in the acute response of SkM to 
increased load (Hood, 2001, Rullman, et al., 2007) was highly variable in this 
system (Fig. 3-6). This variability resulted in no statistical and physiological 
pattern of expression from being attained, giving rise to questions over 
reproducibility of culture in this model. It was evident from construct 
observations used in the mechanical stretch experiment, that there were 
inherent differences in the extent to which the constructs macroscopically 
contracted.  
3.4.5 Gel width as a control measure 
To this end, the extent to which the constructs bow over 14 days in culture was 
investigated in relation to expression of genes associated with myogenesis, 
hypertrophy and metabolic plasticity. Of particular interest was the positive 
association between construct contraction and the amount of total RNA isolated 
from the constructs (Fig. 3-7 A). Myogenesis is highly dependent on the 
expression of a magnitude of genes to co-ordinate the determination and fusion 
of myoblasts.  
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Early work demonstrated the increased half-life of synthesised RNA species at 
the fusion process (Buckingham, et al., 1974) and that hypertrophy is 
characterised by an increase in total RNA (Goldberg, 1967). These data suggest 
the muscle adaptation and regeneration is co-ordinated to a great extent by a 
transcriptional mechanism required for myoblast fusion and hypertrophy. It 
could therefore be hypothesised that the increase in total isolated RNA 
associated with the constructs that have contracted the greatest, have the 
greatest potential for fusion and hypertrophy.  
The stable expression of an endogenous control gene is required for use in qPCR 
analysis using the comparative CT method (Schmittgen and Livak, 2008). Data 
presented here demonstrates the variability in the house keeping gene used 
(RPII CT expression) which is highly dependent on the extent of construct bowing 
(Fig 3-7 B). Thus, using these data in experiments to infer the regulation of 
particular genes will not provide insightful and meaning data.  
The expression of the myogenic regulatory factors (MRF’s) is indispensable for 
myogenesis, both embryonically and post-natally (Hawke and Garry, 2001). 
Myogenin augments the differentiation programme leading to myotube 
formation (Berkes and Tapscott, 2005). Evidence presented here suggests that 
the extent of bowing the constructs moderately relates to the expression of 
myogenin mRNA (CT, Fig. 3-7 D). The pattern of expression may reflect the 
increased density of cells within the matrix, as cells in closer proximity to each 
other will co-ordinate the expression of myogenin to induce fusion.  
Additionally increases in myogenin have been associated with increased fusion 
within this cell line (Sharples, et al., 2010). The positive association between 
construct width and the expression of IGF-I CT also provides evidence for an 
altered potential for differentiation and hypertrophy (Fig 3.7 E). IGF-I has been 
reported to play a significant role in mediating myoblast differentiation (Allen 
and Boxhorn, 1989), regulated in part through the PI3K pathway (Coolican, et al., 
1997).  
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Indeed, IGF-I has also been suggested underpin the morphological and 
biochemical differentiation observed within the C2C12 cell line (Sharples, et al., 
2010). A muscle specific knock out of the IGF-I receptor (IGF-IR, MKR), 
demonstrates an essential role for IGF-I in myoblast differentiation (Heron-
Milhavet, et al., 2010) whereby isolated MKR muscle precursor cells showed 
impaired differentiation compared to wild type controls following muscle 
damage (Heron-Milhavet, et al., 2010). This data therefore suggests that 
increased IGF-I mRNA expression associated with construct bowing may result in 
increased fusion, developing a tissue that is more characteristic of in vivo SkM.  
PGC-1α has been suggested to be the master regulator of mitochondrial 
biogenesis, stimulating the co-ordinated expression of mitochondrial and nuclear 
encoding genes to increase mitochondrial DNA and protein content (Hood, 2001). 
Investigating the metabolic control within the constructs revealed a significant 
linear relationship between construct bowing and PGC-1α mRNA expression (CT, 
Fig. 3-7 F, R2 = 0.69, p = 0.0053). This data suggests the increased potential for 
mitochondrial biogenesis in constructs that have remodelled the matrix to a 
greater extent. Evidence has also suggested the increased expression of PGC-1α 
mRNA and mitochondrial transcription factor protein expression during the 
onset of satellite cell differentiation (Duguez, et al., 2002) increasing the ATP 
generating potential to support the myogenic process.  
Additionally, using a specific inhibitor against mitochondrial protein synthesis 
reduced the differentiation of C2C12’s as evident by a reduction in muscle 
creatine kinase (Hamai, et al., 1997). These data suggest that the increased 
expression of PGC-1α seen in the constructs that have bowed to a greater extent, 
may promote increased fusion compared to constructs with reduced PGC-1α 
mRNA expression.  
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Drawing upon this data, it is proposed that a control over the extent of bowing of 
the constructs should be in place for future expeirments. As such, constructs that 
do not contract the matrix beyond a 10 mm width should be excluded from 
further experimentation. This control will allow for the reduced variability in 
basal gene expression, in order that any regulation of particular genes by an 
experimental condition may be analysed in reliable and valid conditions. This 
would contribute to approximately a 75 % seed-experiment conversion rate, 
increasing the level of control for mechanical stimulation experiments.  
3.5 Conclusions  
Data presented here demonstrates the proposed use of a seeding density of 4 x 
106 C2C12 cells/ml in a 3 ml collagen-based model of SkM. Further a culture 
period of 14 days is required for the development of multinucleated myotubes, 
with displaying morphology representative of in vivo SkM. Variation in gene 
expression following mechanical stimulation resulted in the investigation of 
construct macroscopic contraction as a control measure.    
Altered regulation of genes implicated in the development and maturation of 
SkM have been shown to be dependent on the cytomechanical properties of the 
seeded cells, as evident by the differential amount of construct bowing. 
Controlling for this variability using a construct contraction cut-off point, will 
allow for the controlled investigation of SkM physiology and pathophysiology in a 
bio-mimetic in vitro model. Moreover the characterisation of this model using a 
cell line in an isolated system permits the investigation of intrinsic mechanisms 
that regulate SkM plasticity.    
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4 Modelling Contrasting Regimes of Skeetal Muscle Loading Using Bio-
Engineered Skeletal Muscle: Metabolic and Transcriptional Responses 
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4.1 Introduction 
Following the extensive characterisation of the SkM constructs in the previous 
chapter, the utilisation of this model to investigate responses to cyclical stretch 
were investigated. SkM is often described as diapplying a high degree of 
plasiticity, as it adapts readily to the physiological demands placed upon it, 
whether mechanical or metabolic, or both (Pilegaard, et al., 2000). Endurance 
based exercise has the ability to increase the oxidative capacity and metabolic 
efficiency of SkM (Holloszy, 1967) and as such, endurance exercise and training 
represents a key mode of physical activity in the fight against many pathologies 
including ageing, cancer and metabolic disorders such as, obesity, hypertension 
and diabetes (Rockl, et al., 2007).  
Despite the widely accepted benefits of endurance exercise, the molecular 
mechanisms underpinning the responses are still poorly understood (Coffey, et 
al., 2006). It has been suggested that phenotypic adaptations are regulated by 
transient and temporal changes in key genes which are activated following a 
bout of exercise (Hood, 2001).  Such changes can occur within hrs of an exercise 
stimulus, driven mainly by post-translational modifications of key signalling 
proteins. As a consequence, these changes have been thought to govern the 
adaptations observed in oxidative capacity and substrate utilisation via increases 
in mitochondrial number and content (Olesen, et al., 2010). Much focus has been 
placed upon understanding the mechanisms and consequences of the activation 
of the master regulator of mitochondrial biogenesis, PGC-1. This gene and 
protein forms a major part of the network that controls mitochondrial plasticity.  
In spite of an increase in research into some of the molecular signals that govern 
this process, methodological limitations associated with in vivo testing including 
muscle biopsy sampling method, complex temporal gene expression, ethical 
considerations and inter-individual differences, have hindered a greater 
understanding of the complex molecular pathways (Caron, et al., 2011, 
Friedmann-Bette, et al., 2012).  
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The use of in vitro systems allows for the controlled investigation of endogenous 
metabolic and molecular responses, controlling for the influence of systemic 
factors that would be present in the circulatory system in vivo. The notion of the 
use of ‘pre-clinical models of exercise intervention’ provides a more high-
throughput analytical tool for the investigation of potential exercise and 
pharmacological therapies for disease.  
To date the use of controlled in vitro SkM systems, have commonly taken the 
form of electrically stimulated models in an attempt to replicate contractile 
activity which stimulates mitochondrial adaptation (Nedachi, et al., 2008, Nikolic, 
et al., 2012). Conversely, the use of mechanically stimulated models to 
investigate mitochondrial dynamics has received little attention, despite a recent 
review suggesting the in vivo-like metabolic adaptations that can be observed 
using in vitro stretch systems (Passey, et al., 2011). Moreover, in vivo skeletal 
movement and muscle contraction results in a significant mechanical stimulus 
upon SkM cells. This stimulus has not been fully investigated with respect 
stimulating a mitochondrial and metabolic response and therefore provides an 
interesting area of research.   
Previously published data utilising a monolayer and multi-axial SkM cell stretch 
model system has demonstrated stretch-induced glucose uptake, providing 
evidence for a mechanical signal in regulating this fundamental homeostatic 
process (Iwata, et al., 2007). This data provides a clear foundation for further 
work to be conducted surrounding the influence of mechanical stretch on 
metabolic parameters in SkM. However in vitro stretch systems such as that used 
by Iwata et al. (2008) lack structural and mechanical comparison to in vivo tissue, 
with many of these limitations discussed previously (see section 1.11). 
Importantly, many stretch paradigms currently used lack in vivo-like comparisons 
in terms of the variables manipulated including; duration, load and velocity of 
stimulation.  
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Therefore, the current investigation sought to address many of these issues to 
investigate the influence of mechanical stretch upon muscle cell metabolism and 
mitochondrial DNA replication. Following the characterisation of the SkM model 
in the previous chapter, these variables could be investigated in a highly 
controlled environment which recapitulates much of the in vivo SkM niche.  
4.1.1 Aims and Hypotheses 
1. Characterise the acute biochemical responses to two distinct modes of 
mechanical stretch, which represent in vivo modes of SkM loading.  
2. Analyse the acute transcriptional response regulating mitochondrial 
biogenesis and mtDNA synthesis.       
It was hypothesised that the distinct mechanical stetch regimes would contribute 
to a differential metabolic response, due to the differences cell-matrix response 
to the workload. Furthemore, it was hypothesised that these biochemical 
metabolic differences wouls translate to a distinction in the transcriptional 
response of the genes of interest. 
4.2 Methods 
4.2.1 Cell Culture 
For all experimentation cells were used below passage 8. Monolayer cell culture 
was performed to increase cell numbers required for expeirments (see section 
2.4).  
4.2.1.1 Cell seeded 3D compliant collagen constructs 
N = 9 collagen constructs were prepared as previously described in the Methods 
section (2.6). Following 4 days of culture in GM the medium was changed to 
differentiation medium (DM), to stimulate maximal levels of fusion, according to 
a previously published protocol (Smith et al., 2012). DM was changed every 48 
hrs. A subsequent 10 days of culture allowed for the differentiation of singled 
seeded myoblasts into multinucleated myotubes aligned in a single plane, as 
characterised in the previous chapter.  
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4.2.2 Mechanical stimulation experiments 
Following this 14 day developmental period, constructs were removed from the 
chamber slides and transferred to polyethylene moulds. A-frames for attachment 
to the t-CFM were fixed into the floatation bars and 6 ml DM was added to the 
mould. Constructs were then mounted upon the t-CFM for mechanical strain 
experimentation. N = 3 static controls (no mechanical stretch) were used as 
controls. An in vivo equivalent of such a control would take the form of a non-
exercised group of participants or animals. The following stimulation protocols 
were conceived to investigate whether contrasting regimes of external 
mechanical load could induce a differential intrinsic cellular response, similar to 
that seen with in vivo exercise (Gibala, et al., 2006, Burgomaster, et al., 2008, 
Bartlett, et al., 2012).  
4.2.2.1 Continuous Cyclic Mechanical Stimulation Protocol  
In order to model a lower intensity strain of mechanical load, a stimulation 
protocol was developed to replicate the mechanical nature of such a regime in 
vivo; continuous moderate intensity exercise. To this end, a continuous cyclic 
load of 7.5 % (0.4 Hz; Fig. 4-1 A) was applied to the constructs for 60 mins.  
4.2.2.2 Intermittent Cyclic Mechanical Stimulation Protocol 
Similarly, a stimulation protocol was developed to model the mechanical nature 
of a bout of higher intensity and increased load. As such, the following protocol 
was used; 10 % intermittent cyclic load for 10 repetitions (0.3 Hz; Fig. 4-1 A) was 
followed by a 90 sec rest period (1 repetition). 3 further repetitions proceeded, 
with a 3 min rest period following the final repetition. The set of four repetitions 
was classed as an interval. Four intervals were completed in total. Previous 
literature has indicated that these strain and stimulation modalities can induce 
acute responses to SkM cells in vitro, further providing justification for their use 
(Powell, et al., 2002, Auluck, et al., 2005, Sasai, et al., 2010).  
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Figure 4-1. Continuous and Intermittent Cyclic mechanical stretch regimes. A) 
Graphical representation of the pattern of stretch used over the 60 minute 
expeirmentation. The clear constant workload in the Continuous condition is 
denoted by the insense black block up to 7.5 % strain. It is also clear to see the 
individual repetitions and intervals in the Intemrittent condition.  B) Insert of the 
cyclical nature of the mechanical strain employed for 3 cycles for each condition.  
4.2.3 Substrate Analysis 
In order to analyse the metabolism of lactate and the uptake of glucose during 
the mechanical stretch protocols, conditioned media sampled from the media 
contained within the polyethylene moulds, was sampled post experimentation. 
An Analox Analyser P-GL5 (Analox) was appropriately calibrated and used to 
analyse both [lactate] and [glucose] within the conditioned media. To test 
whether the collagen gel was acting as a sponge with respect to absorbing and 
releasing lactate at any stage of the stimulation protocol, an a-cellular construct 
was tested for media lactate concentration during mechanical stretch.  
 128 | P a g e  
 
No differences in media lactate were observed for either stretch regime (data 
not shown).  
4.2.4 Construct Sampling and Extraction Protocol 
Immediately following the end of the stretch protocol, the construct was 
removed from the t-CFM and the ‘A-frames’ and immersed in TRIzol (Invitrogen). 
RNA and DNA were extracted using the TRIzol method (see 2.9.4.2). RNA:DNA 
ratios were calculated as μg/μL:μg/μL.  
4.2.5 Quantitative Reverse Transcriptase Real-Time PCR (qRT-PCR) 
A one step reaction chemistry was used for the qRT-PCR for all experiments 
(Quantifast, Qiagen).  Samples were prepared as described previously (see 
methods, 2.9.4). The mean CT values for duplicates were used to calculate 
relative mRNA expression of the genes of interest (GOI) compared to an 
experimental control and endogenous control gene (RPII-B). The relative gene 
expression levels were calculated using the comparative CT (ΔΔCT) equation 
(Schmittgen and Livak, 2008). All individual samples were normalised to sample 
CT= 1 for analysis of all gene expression.   
Table 2. qPCR Primer Sequences  
Target Gene Forward‎Sequence‎(5’‎to‎3’) Ref. Seq. Number 
RPII-B F:GGTCAGAAGGGAACTTGTGGTAT 
R:GCATCATTAAATGGAGTAGCGTC 
NM_153798.2 
MMP-9 F: CTGGCAGAGGCATACTTG 
R: GCCGTAGAGACTGCTTCT 
NM_013599.2 
PGC-1α 
 
F: GAAGGGAATGGGAAAGGTAGA 
R: AACAGGACATGGAAAGCAGAT 
NM_008904.2 
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Tfam 
 
Cytochrome C 
 
NRF-1 
 
NRF-2 
 
COX-II 
 
β-Globin 
F: CACGCTTTACCCTTCGTTCT 
R: CTCATTTCCCTGCCATTCTCTA 
F: GCCGACTAAATCAAGCAACA 
R: CAATGGGCATAAAGCTATCG 
F: CCTCAGCCTCCATCTTCT 
R: CTTAACACTTCTGTCACCTTCA 
F: TCCCGCTACACCGACTAC 
R: TCTGACCATTGTTTCCTGTTCTG 
F: GAAGCGATTCTAGGGAGCAG 
R: GGAGCAGCGATTCTGAGTAGA 
F: GAAGCGATTCTAGGGAGCAG 
R: GGAGCAGCGATTCTGAGTAGA 
NM_009360.4 
 
NM_007808.4 
 
NM_010938.4 
 
NM_008065.2 
 
NM_ 010339.1 
 
NM_008220.4 
4.2.6 mtDNA Analysis 
mtDNA copy number was assessed based upon a previously published protocol 
( Philp, et al., 2011, Safdar, et al., 2011). Briefly, mtDNA copy number, relative to 
the nuclear diploid chromosomal DNA content, was quantitatively analysed using 
qPCR.  
Primers were designed within the COX-II region of the mitochondrial genome 
along with a nuclear encoding gene β-Globin (Table 4.1). qPCR was performed 
using isolated DNA using a Quantifast SYBR Green (Qiagen) qPCR kit on the 
Rotogene 3000 (Qiagen). Serial dilutions of DNA to create standards of known 
quantities of DNA were used in conjunction with the Rotogene associated 
software to generate standard curves and representative DNA copies. Data is 
represented as mtDNA copy number per nuclear diploid genome.  
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4.2.7 Statistical analyses 
All statistical analysis was performed using SPSS software version 17 (SPSS INC, 
Chicago, IL, USA) and Graphpad Prism 6 (California, USA). Significant differences 
between variables were analysed using one way repeated measures ANOVA’s. 
Normal distribution and homogeneity of variance were calculated to display 
compliance to statistical assumptions (see appendix 2). A pair-wise comparison 
post-hoc test was performed with a Bonferroni adjustment for any data with 
significant F values. The alpha value of significance was set at p ≤ 0.05. All data is 
presented as mean ± standard error of the mean (SEM).  
4.3 Results 
4.3.1 Responses of lactate production and glucose uptake reveal an effect of 
Continuous and Intermittent stretch modalities  
Data analyses revealed significant differences in peak Lactate concentration 
between conditions (Control = 1.733 ± 0.18, Continuous = 6.63 ± 0.50, 
Intermittent = 7.50 ± 0.15 mmol.L, p < 0.000, Fig. 4-2 A). Post-hoc analysis 
revealed significant differences between Control and Continuous (p = 0.000) and 
also Control and Intermittent stretch (p = 0.000). There was however, no 
significant difference between stretch modalities (p = 0.175).  
Furthermore, significant differences in peak glucose concentration was observed 
between conditions (Control = 23.47 ± 0.26, Continuous = 20.13± 0.64, 
Intermittent = 19.07 ± 0.19 mmol.L, p = 0.001, Fig. 4-2 B). Post-hoc analysis 
revealed significant differences between Control and Continuous (p = 0.008) and 
also Control and Intermittent stretch (p = 0.000). There was no significant 
difference in peak glucose concentration between stretch modalities (p = 0.183).  
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Figure 4-2.  Conditioned media analysis. N = 3 replicate constructs per condition were subjected to Continuous and Intermittent 
mechanical stretch. All assays were performed in duplicate. A) Conditioned media lactate response to stretch. Significant increases in 
peak lactate production for Continuous and Intermittent stretch compared to Control (main effect, *p= 0.000).B) Media glucose response 
to stretch. Significant reduction in peak glucose concentration for Continuous and Intermittent stretch compared to Control (main effect, 
*p= 0.000).A significant difference existed following 1 complete interval of stretch (*p= 0.001). Data is presented as mean ± SEM. 
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4.3.2 A gross molecular output provides evidence for a transcriptional 
response to Continuous and Intermittent stretch  
Both of the stretch protocols induced mean increases (approaching significance) 
in RNA:DNA ratio (Fig. 4-3), suggesting an increase in the level of transcription 
compared to Control (Control = 0.23 ± 0.08, Continuous = 2.14 ± 0.34, 
Intermittent = 3.77 ± 1.74, p = 0.065). This data provides evidence that the 
mechanical stretch protocols are initiating acute molecular adaptations alongside 
biochemical substrate regulation. Results from the investigation of specific RNA 
transcripts are detailed below.  
4.3.3 MMP-9 mRNA expression following Continuous and Intermittent stretch 
As an acute marker of transcriptnioal acitivity MMP-9 mRNA was measured as 
this gene has previously been shown to be activtated following a single bout of 
continuous cyclical loading of SkM in vivo (Rullman, et al., 2007). No significant 
differences were observed for MMP-9 mRNA between conditions (p = 0.094). 
Intermittent stretch protocol increased MMP-9 mRNA above Control 
(Intermittent = 6.63 ± 3.49 fold, Fig. 4-4), whilst the CC protocol produced a 
minimal effect on stimulating MMP-9 transcription (Continuous= 1.97 ± 0.91 
fold, Fig. 4-4). Such data provides corroborating evidence for in vivo-like 
responses to MMP-9 in the Intermittent condition, similar to that seen with 
muscle contraction in the form of acute endurance exercise (Rullman, et al., 
2007).  
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Figure 4-3. Continuous and Intermittent stretch induce an acute transcriptional 
response. N = 3 replicate constructs per condition were subjected to Continuous 
and Intermittent mechanical stretch. All assays were performed in duplicate. 
Increases in the RNA:DNA ratio demonstrates an increased level of gene 
transcription above un-stretched control constructs (p = 0.065). Data is 
presented as mean ± SEM. 
 
Figure 4-4.  MMP-9 mRNA expression following Cyclic Stretch. Intermittent 
stretch induces a mean but non-significant increase in MMP-9 mRNA above 
Control. No significant differences were observed between conditions (main 
effect, p = 0.094). N = 3 replicate constructs per condition. Data is presented as 
mean ± SEM. 
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4.3.4 Higher Strain Intermittent and Lower Strain Continuous Cyclic 
Mechanical stretch results in increased mtDNA Copy Number 
The current investigation utilised a qPCR based method for quantifying 
mitochondrial content by analysing mtDNA copy number. Continuous stretch 
caused a mean increase in mtDNA copy number compared to Control despite no 
statistical effect (617.46 ± 231.36 vs 415.72± 176.36, p = 0.188, Fig. 4-5). 
However the Intermittent protocol gave rise to a significantly greater mtDNA 
copy number compared to Control (1107.15± 399.40 vs 415.72± 176.36, p = 0.04, 
Fig. 4-5), suggesting a rapid increase in mitochondrial DNA content following this 
stretch protocol.  
 
Figure 4-5. Continuous and Intermittent stretch and condequential mtDNA 
copy number. N = 3 replicate constructs per condition were subjected to 
Continuous and Intermittent mechanical stretch. No effect of Continuous stretch 
on mtDNA copy number above Control (p = 0.18). Intermittent stretch 
significantly increased mtDNA copy number above Control (*p = 0.04). Data is 
presented as mean ± SEM.  
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4.3.5 Increased mtDNA Copy Number are partially underpinned by the 
regulation of PGC-1α,‎NRF-1, NRF-2 and Cytochrome C  
In the attempt to model the mechanical stimulus associated with SkM 
contraction in vivo, it was necessary to quantify genes that have been associated 
with increasing the oxidative potential of SkM. The Intermittent stretch protocol 
significantly increased the expression of PGC-1α compared to Control (5.6 ± 3.54 
vs. 0.75 ± 0.2, p = 0.043, Fig. 4-6 A). However, the Continuous protocol did not 
induce any change in the expression of this gene (p = 0.9, Fig. 4-6 A). A significant 
difference was however observed between the Continuous and Intermittent in 
the expression of PGC-1α (p = #0.045). The increased expression of PGC-1α 
mRNA in the Intermittent condition, suggests the protocol is activating the 
mechanisms associated with inducing PGC-1α transcription.   
The mitochondrial transcription factor A (mTFA, Tfam), a gene closely associated 
with PGC-1α in the mechanism of mitochondrial biogenesis, was not significantly 
altered in either of the protocols (p = 0.323, Fig. 4-6 B), despite a trend towards a 
reduction in expression in the Continuous condition. However Cytochrome C, a 
gene and protein often used as a representative measure of mitochondrial 
content, saw significant regulation (main effect, p = 0.002) in Intermittent (3.81 ± 
0.20 fold, *p = 0.004) and trending towards a reduction in Continuous (p = 0.077) 
stretch, compared to Control (Fig. 4-6 C). There was also a signicant difference 
between stretch modalities (#p = 0.001).  
The co-ordinated expression of the nuclear respiratory factors NRF-1 and -2 is 
required for an increase in mtDNA content (Hood, 2001) and as such the 
regulation of these genes in the current experiment provides a mechanism for 
the increased mtDNA content. A significant increase (p = 0.005) in NRF-1 mRNA 
was observed following stretch, with post-hoc analysis revealing a significant 
effect for Continuous stretch (1.78 ± 0.12 fold, p = 0.021, Fig. 4-6 D) whilst a 
physiological trend was found for Intermittent stretch (8.34 ± 1.82 fold, p = 0.059, 
Fig. 4-6 D).  
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No significant statistical effect was found NRF-2 mRNA expression for Continuous 
(2.79 ± 1.25 fold) and Intermittent (2.77 ± 0.24 fold) conditions compared to 
Control (p = 0.356, Fig. 4-6 E). These data suggest that the proposed mechanism 
for NRF-1 expression required for mtDNA synthesis is being modulated within 
this model of mechanical stimulation. 
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Figure 4-6. Regulation of genes implicated in mtDNA synthesis and mitochondrial biogenesis. N = 3 replicate constructs per condition were 
subjected to Continuous and Intermittent mechanical stretch. Control constructs were tethered to the t-CFM without stretch. A) Significant 
increase in PGC-1 mRNA in the IC condition compared to Control (*p = 0.043) and Continuous (#p = 0.045) conditions. B) Tfam mRNA in 
Continuous compared to Control and Intermittent conditions (p = 0.323). C) Significant increase in Cytochrome C mRNA in the Intermittent 
condition compared to Control (*p = 0.004) and Continuous (#p = 0.001) conditions. D) Significant increase in NRF-1 mRNA in Continuous 
stretch above Control (*p = 0.021) and approaching significance in Intermittent stretch (p = 0.059). E) No effect in NRF-2 mRNA in Continuous 
and Intermittent conditions compared to Control (p = 0.356). Data is presented as mean ± SEM. 
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4.4 Discussion 
The aim of the current investigation was to test the acute metabolic and 
transcriptional responses to two diverse mechano-stimulation protocols. Data 
presented here demonstrates the development of two distinct mechanical 
stretch protocols, predictably producing responses both in terms of acute 
biochemical responses (lactate and glucose) and with respect to mtDNA copy 
number and the underpinning mRNA regulation, displayed in section 3.3. These 
data putatively show similar responses that are seen with in vivo exercise both 
acutely (biochemical and transcriptional) and chronically (mtDNA, Gibala, et al., 
2006, Gibala, et al., 2009, Burgomaster, et al., 2008, Gibala, et al., 2009, Perry, et 
al., 2010, Bartlett, et al., 2012).   
When analysing the lactate present in the conditioned media, it was found that 
both protocols induced significant increases following the stretch protocols. It 
has been suggested that the net increase in lactic acid production is a 
consequence of the mass of the working muscle and the intensity of the 
activation of the tissue (Billat, et al., 2003). In light of this hypothesis, the 
responses in lactate production may represent different cellular workloads 
within the engineered tissue, compared to Control.  
Previous data has shown a significant increase of 46% above control, in media 
lactate production following 4-6 hrs of in vitro mechanical stretch of monolayer 
cultures (Hatfaludy, et al., 1989). However this is the first investigation to show 
the acute increase in Lactate production following mechanical stretch in a 3D 
bio-mimetic model, with the magnitude similar to that seen in vivo (Faude et al., 
2009). It seems likely that the in vivo-like response is due to the nature of the 
model with respect to the alignment of the myotubes and the attachment and 
deformation of the cells in a 3D environment. The nature of the stimulation itself 
with regards to the frequency and duration may also contribute to the surprising 
commonality of data compared to SkM in response to contiuous and 
intermittent exercise in vivo (Zafeiridis, et al., 2010).  
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Both stretch protocols significantly reduced media glucose concentration (p < 
0.001), showing similarities to moderate intensity continuous and intermittent 
exercise in vivo whereby a decrease in blood Glucose concentration of 
approximately 1 mmol.L is evident compared to pre-exercise conditions (p < 0.05, 
(Mackenzie, et al., 2011). Further, evidence has suggested the beneficial effect of 
intermittent contraction in glycaemic control both acutely (Mackenzie, et al., 
2012) and hours post exercise (Iscoe and Riddell, 2011).  
Hatfaludy et al., (1989) also observed increases in [3H] deoxy-D-glucose uptake 
by 34% compared to pre stretch conditions, in muscle cultures subjected to 
stretch-relaxation protocols using a monolayer in vitro stretch system. In another 
monolayer stretch model, data has also shown a calcium-dependent and IGF-I 
independent mechanism for glucose uptake by SkM cells following in vitro 
stretch (Iwata, et al., 2007).  
These in vitro systems have provided fundamental evidence that mechanical load 
and stretch of SkM cells, results in up-take of glucose, independent of 
mechanisms that are regulated by systemically acting insulin. The precise 
mechanism whereby increases in calcium are achieved with SkM stretch are yet 
to be fully elucidated, however calcium increases may in part be regulated by 
active contraction. Data generated from the current investigation, provides 
evidence for the use of this system to examine the stretch induced-glucose 
uptake mechanisms in a more physiologically representative in vitro tissue.  
4.4.1 An Increase in MMP-9 mRNA Provides Further Evidence for the In Vivo 
Nature of the Response to the Mechno-Stimulation 
Data presented here showed a trend towards an increase in MMP-9 mRNA 
following (Fig. 4-5) Intemrittent stretch. With no statistical significance achieved, 
furutre experiments should seek to determine whether this trend could be 
reproduced. Previous in vivo data provides further support for the in vivo-like 
nature of the stimulation protocols in regulating MMP-9 mRNA.  
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Rullman et al., (2007) demonstrated that following 65 mins of continuous cycling 
exercise MMP-9 mRNA was elevated immediately post, reaching significance by 
120 mins post exercise (p < 0.05, Rullman, et al., 2007). Matrix 
metalloproteinases (MMP’s) play a significant role in extra cellular matrix (ECM) 
remodelling and have been shown to be activated during the migratory phase of 
activated satellite cells (myoblasts, (Lewis, et al., 2001, Zimowska, et al., 2008, 
Zimowska, et al., 2012), during SkM regeneration from damage). The activation 
and enhancement of the satellite cell pool has recently been shown to be 
dependent on the intensity rather than the duration of endurance exercise 
(Kurosaka, et al., 2011), with data presented here providing a potential 
mechanism for this response with an enhanced transcription of MMP-9 in the 
Intermittent condition.  
4.4.2 A Role for PGC-1α,‎NRF-1, NRF-2 and Cytochrome C in the Increase in 
mtDNA  
Results presented here show a significant increase in mtDNA copy number in the 
Intermittent condition (Fig. 4-6), illustrating a rapid increase in mtDNA content 
when controlling for nuclear DNA. This is the first investigation to show an 
increase in mtDNA copy number following mechanical stretch of bio-mimetic in 
vitro SkM.  
Conversely, Safdar et al., (2011) showed increases in transcripts associated with 
mitochondrial biogenesis and mtDNA replication, despite no overall increase in 
mtDNA copy number, following acute endurance-based exercise in vivo.  
The authors suggested that an increase in mtDNA copy number may result from 
multiple bouts of contractile activity that causes transient increases in the 
required transcripts (Safdar, et al., 2011). This view is supported by Perry et al 
(2010), who found a significant increase in mtDNA (p < 0.05) 24 hrs following 
three bouts of high intensity interval training (Perry, et al., 2010).   
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The increase in mtDNA copy number compared to Control following Intermittent 
stretch, may be a result of the accelerated nature of the mechanisms activated 
within the in vitro system. This rapid increase in mtDNA provides an ideal system 
to delineate the mechanisms controlling this vastly complex cellular process. 
Allowing for multiple sampling of the constructs throughout finite time periods, 
investigating the roles of intrinsic and extrinsic factors independently and 
utilising a clonal cell line are all advantages of the system described here above 
in vivo experiments.  
When seeking to understand the mechanisms whereby an increase in mtDNA 
occurs following mechano-stimulation, it is necessary to investigate the 
responses to genes associated with increasing the oxidative potential of the 
tissue. Here, it has been shown that Intermittent stretch can up-regulate PGC-1α 
mRNA (Fig. 4-7 A), a master regulator of mitochondrial biogenesis, which is one 
of the mechanisms required to increase oxidative metabolism of SkM 
(Fernandez-Marcos and Auwerx, 2011).  
Importantly, in the context of the data presented here, in vivo data has shown 
increases in PGC-1α following high intensity (greater strain or load) interval 
based SkM contraction (Gibala, et al., 2009, Little, et al., 2011). This therefore 
provides a context for the data presented here, suggesting an interval mode of 
exercise training can induce PGC-1α mRNA expression in vivo and in vitro. This 
data suggests the importance of the strain and load type upon SkM in activating 
PGC-1α mRNA, illustrating that primary mechanical load can induce such a 
response.  
A recent study has demonstrated the requirement of an intact adipocytokine 
system for the activation of PGC-1α mRNA following SkM contraction (Li, et al., 
2011), suggesting the necessity of a systemic environment. The novel finding 
presented here shows an increase in PGC-1α mRNA following Intermittent 
stretch in an isolated bio-mimetic model of SkM.  
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As such, this data provides evidence for the intrinsic regulation of PGC-1α 
transcriptional control in this system. An increase in NRF-1 mRNA reported here 
(Fig. 4-7 D) following Continuous mechanical strain provide further evidence for 
an activated mechanism towards increasing the oxidative potential of the 
construct. An increase in NRF-1 mRNA despite no increase in NRF-2 mRNA in the 
Continuous condition proposes a greater role for NRF-1 in the acute response to 
Continuous stretch in this system. The NRF’s are transcriptional regulators of 
many genes encoding subunits of the oxidative phosphorylation (OXPHOS) 
system along with mtDNA replication (Moraes, 2001), including the transcription 
of mtTFA (Scarpulla, 2011). Moreover, it has been shown that a dominant 
negative allele of NRF-1 prevents the ability of PGC-1α to induce mitochondrial 
proliferation, defining the role of NRF-1 in PGC-1α activated mitochondrial 
biogenesis (Scarpulla, 2008). Increases in both PGC-1α (5.6-fold, p = 0.04) and 
NRF-1 (1.78-fold, p = 0.021) mRNA’s found following in the current investigation 
(p < 0.05), provides evidence for the dependent role of the NRF’s in increasing 
the mtDNA content observed in this current investigation.  
PGC-1α is a transcriptional co-activator which has been associated with the 
indispensible expression of Tfam, a protein required for mtDNA transcription 
( Scarpulla, 2008, Scarpulla, 2011). Recently it has been reported how Tfam is in a 
complex with PGC-1α in the D-loop region of mtDNA, which is modulated by 
acute contractile activity (Safdar, et al., 2011).  
The data for Tfam expression is considierably varied (Fig. 4-7 B), with greater 
sample numbers required to make a judgement on the response of this gene to 
mechanical load. The variability in expression mRNA of Tfam found in this 
investigation may reflect complex temporal regulation and inherent differnces in 
up-stream cell signalling required for its transcription, a hypothesis which 
requires investigation.  
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The RNA primer generated from the L-strand promoter required for mtDNA 
replication is dependent on Tfam (Hood, 2001), therefore investigating the 
protein expression of this essential protein warrants experimentation in this 
model and may provide more insightful data. Recently, the notion of mRNA half-
life with respect to genes that regulate mitochondrial biogenesis has been 
investigated. Data proposed how the half-life of particular mRNA’s (including 
Tfam) was particularly unstable and in particular in contracted muscle cells (Lai, 
et al., 2010). Moreover, the half-life of Tfam has been shown to be shorter in 
slow twitch muscle fibres (D'souza, et al., 2012), which may have pertinence for 
the in vitro constructs used in the current investigation. Furthermore, the 
expression of Tfam protein is thought to be 1700-3000 times more than mtDNA, 
levels which are thought to wrap human mtDNA entirely (Takamatsu, et al., 
2002).  
This therefore suggests, the requirement for transcription seems limited. These 
hypotheses should be tested within the proposed model, to test whether the 
initial stimulus may have been sufficient to induce Tfam mRNA expression; 
however the degradation of the transcript contributed to a minimal effect being 
found. The time-course of Tfam mRNA half-life investigated previously also 
supports this notion (Lai, et al., 2010). This hypothesis could also be readily 
tested in the mechano-stimulation model proposed here.  
Intermittent stretch significantly increased the level of Cytochrome C mRNA 
(3.81-fold, p = 0.004, Fig. 4-7 C), a gene and protein required for oxidative 
phosphorylation (OXPHOS). Cytochrome C mRNA has been shown to be activated 
acutely following endurance based exercise in vivo (Wright, et al., 2007, Leick, et 
al., 2008, Safdar, et al., 2011) as a compensatory mechanism to induce 
homoeostatic recovery and enhance ATP production potential for future exercise 
bouts (Mahoney, et al., 2005).  
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It has been demonstrated in vitro (Wu, et al., 1999) and in vivo (Lin, et al., 2002) 
SkM that over-expression of PGC-1α protein results in increases in Cytochrome C 
mRNA and oxidative metabolism, providing evidence for the role of PGC-1α 
protein as transcriptional co-activator for this gene. An interesting finding of the 
current investigation is the reduction in Cytochrome C mRNA expression 
following Continuous stretch (Fig. 4-7 C). Such a finding again suggests a 
contrasting response to this form of stimulation compared to Intermittent 
stretch.  
4.4.3 A Metabolic Threshold Required for Increases in Oxidative Associated 
Molecular Responses   
Data presented here suggests a greater metabolic transcriptional response in the 
Intermittent (higher strain) than in the Continuous (lower strain) condition, as 
represented by increased mtDNA copy number (Fig. 4-6) and transcripts 
associated with such a response (Fig. 4-7). It is postulated therefore, that a 
mechano-metabolic transcriptional threshold may be required to initiate the 
mtDNA response observed. Future experiments should seek to establish whether 
the mean increase in lactate and reduction in glucose in the media observed 
between stretch modalities (Fig. 4-2), is indeed strain and workload dependent.  
This is supported by extant published data indicating an increase in PGC-1α 
mRNA following just 60 mins exposure of exogenous lactate to L6 myotubes 
(Hashimoto, et al., 2007). Furthermore, this hypothesis has recently has been 
tested successfully in vivo (Tobina, et al., 2011), whereby exercise above lactate 
threshold induced greater increases in PGC-1α mRNA expression compared to 
below lactate threshold. The production of lactate is thought to signal to activate 
redox sensitive and calmodulin kinase sensitive PGC-1α transcription (Fig. 4-8).  
Further investigations into metabolically activated proteins and transcription 
factors would be required to support such a hypothesis in this in vitro system.  
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Incrementally increasing the load placed upon the in vitro constructs, would also 
provide an ideal model to investigate this hypothesis in a controlled, biomimetic 
model such as that described here.  
 
Figure 4-7. Cellular overview of the acute biochemical and transcriptional 
responses to cyclical stretch presented within the chapter. GLUT (glucose 
transport protein), MCT (monocarboxylate transporter protein), AMPK (AMP 
activated protein kinase), p38 MAPK (p38 mitogen activated protein kinase), 
PGC-1α (Peroxisome proliferator-activated receptor gamma coactivator 1-alpha), 
ROS/RNS (reactive oxygen/nitrogen species), CaMK (calmodulin kinase), Tfam 
(mitochondrial transcription factor A), NRF-1/2 (nuclear respiratory factor 1/2), 
CytoC (cytochrome C oxidase), MMP-9 (matrix metalloproteinase -9).  
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4.4.4 Increases in metabolism and mitochondrial adaptation: relevance to 
SkM tissue engineering? 
The clear influence of mechanical signals during embryonic development of SkM 
is clear (Christ and Brand-Saberi, 2002), which has inspired the use of mechanical 
loasding to stimulate the development of tissue engineered SkM. Previously 
published data illustrates the improved contractile phenotype of tissue 
engineered constructs following stimulation (Moon du, et al., 2008, Boonen, et 
al., 2010, Corona, et al., 2012).  
There is however limited data surrounding the influence of mechanical loading 
on metabolic response ( Hatfaludy, et al., 1989, Iwata, et al., 2007) and 
mitochondrial adaptation, with respect to improving tissue engineered models. 
Data presented here supports the role of mechanical signals in increasing 
metabolism and stimulating a mitochondrial transcriptional response. With 
respect to developing a more bio-mimetic SkM model in vitro, stimulating 
metabolism and mitochondrial adaptation is a key finding with regards to the 
characterised response to contraction in vivo. As such the model presented here 
demonstrates a key finding with respect to developing in vivo-like tissue in vitro. 
The research goal for SkM tissue engineering is to successfully implant the 
constructs in vivo to repair damaged or diseased tissue ( Machingal, et al., 2011, 
Corona, et al., 2012). Increasing metabolism and stimulating mitochondrial 
biogenesis will improve cell survival, whilst also providing the machinery for ATP 
synthesis to support maturation. This provides evidence for the use of cyclic 
mechanical loading in the pre-conditioning of tissue engineered constructs prior 
to implantation.  
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4.5 Conclusions 
Data reported in this current invesitgation provides evidence for the 
characterisation of two models of in vitro mechanical stimulation. Continuous 
and Intermittent stretch result in in vivo-like responses to lactate production and 
glucose uptake (Fig. 4-3), whilst stretch in part leads to the transcription of genes 
associated with the acute metabolic response to in vivo exercise (Fig. 4-7). 
Moreover, it is demonstrated a rapid increase in mtDNA following a single bout 
of Intermittent stretch, which will be invaluable for ascertaining the molecular 
signals that mediate this response. Future investigations to aim to further 
characterise the transcriptional regulation of certain metabolic ‘candidate genes’ 
(PGC-1α, Tfam, NRF-1 and NRF-2) associated with adaptations to endurance 
exercise.  
The intracellular protein signalling, including post translational modifications 
should also be investigated within this model to investigate the acute mechanism 
which regulates mtDNA replication. Using such models to inform of the cellular 
and molecular adaptation to SkM mechano-stimulation will be invaluable in 
delineating the mechanisms by which increased SkM load can increase aerobic 
potential. This understanding with be vital in developing pre-clinical 
understanding of potential exercise and pharmacological therapies for a 
multitude of metabolic pathologies. Furthermore, this data will provide 
mechanistic understanding for the potential of mechanical stimulation in the 
pre-conditioning of SkM constructs prior to in vivo implantation for disease 
therapy in the future.  
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5 Acute Mechanical Overload in 3-Dimensional Bioengineered SkM Induces a 
Hypertrophic Transcriptional Response 
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5.1 Introduction 
SkM plays significant roles in movement and providing a large metabolic pool for 
substrate storage and utilisation. The previous chapter investigated the role of 
mechanical signals on stimulating metabolism and increasing mtDNA for 
increased aerobic potential, whilst the aim of the current chapter is to 
investigate the influence of mechanical signals on stimulating transcription of 
genes associated with the potential for increasing muscle mass. 
SkM mass plays a pivotal role in overall health and wellbeing. A decline in SkM 
mass and contractile proteins with disease (cachexia, Lenk, et al., 2010) and 
ageing (sarcopoenia, Pillard, et al., 2011) contributes to an increased 
susceptibility to metabolic diseases including; obesity, diabetes and associated 
cardiovascular disease (Degens and Alway, 2006, Narici and Maffulli, 2010). 
Moreover, a decrement in muscle mass and strength with age contributes to 
increased morbidity and mortality ( Carmeli, et al., 2002, Rantanen, et al., 2003).   
The mechanisms that govern the response of SkM hypertrophy have stemmed 
from the seminal work of Goldberg (1967) who demonstrated the rapid 
hypertrophic response in the target muscle after only 24hrs post tenotomy of a 
synergistic muscle (Goldberg, 1967) . This method of work overload-induced 
hypertrophy has received much attention (Armstrong, et al., 1979, Kandarian, et 
al., 1992, Esser and White, 1995, Linderman, et al., 1996) and has resulted in a 
far greater understanding of the molecular mechanisms that regulate this 
response. Increase in amino acid transport (Goldberg and Goodman, 1969, 
Henriksen, et al., 1993) and satellite cell proliferation (Schiaffino, et al., 1972, 
Rosenblatt and Parry, 1992, McCarthy and Esser, 2007, O'Connor and Pavlath, 
2007) have been shown in part to form the basis of hypertrophy.  
A global increase in protein synthesis (Goldspink, 1977) along with increases in 
protein content of the sub-fractions within SkM (Cuthbertson, et al., 2006), also 
play significant roles in the increase of SkM mass to overload or stretch. 
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SkM hypertrophy is characterised by an increase in total RNA content, whether 
following in vitro stretch or stimulation (Carson, et al., 2002) or in vivo exercise 
(Bickel, et al., 2005). The necessity for an increase in RNA to initiate a 
hypertrophic response following tenotomy has been demonstrated by the 
addition of a DNA-dependent RNA synthesis inhibitor, Actinomycin D, which 
ablated any compensatory hypertrophic response from occurring (Goldberg and 
Goodman, 1969). Specific gene transcript evidence has demonstrated roles for 
myogenic and hypertrophic genes; Insulin-like growth factor I (IGF-I, (Adams and 
Haddad, 1996, Awede, et al., 2002, Awede, et al., 1999) and matrix 
metalloproteinase 9 (MMP9, Lewis, et al., 2000, Dahiya, et al., 2011, Mehan, et 
al., 2011), along with the regulation of genes involved in atrophy including 
Myostatin, muscle RING finger protein 1(MuRF-1) and muscle atrophy factor box 
(MAFBx, McPherron, et al., 1997, McPherron, et al., 1997, Trendelenburg, et al., 
2009, Welle, 2009). Despite these relatively well characterised mechanisms 
involved in regulating SkM mass, the intrinsic regulation of these genes 
particularly in isolated in vitro models is less understood.   
Developing a model of overload induced hypertrophy in vitro, would overcome 
many of the experimental and ethical issues surrounding human and animal 
studies. Additionally, the development of an in vitro model of mechanical 
overload would reduce the necessity to use animal models for this research area.  
Previous published in vitro models have demonstrated a stretch-induced 
hypertrophic response, including the early work of Vandenburgh and Kaufmen 
(1979). Another model from the same laboratory developed a system for the 
computer programmable stretch regimens, extending the work to mimic loading 
modalities in vivo (Vandenburgh, 1988).  Existing published models have often 
employed a monolayer culture technique with uniaxial stimulation ( Hubatsch 
and Jasmin, 1997, Iwata, et al., 2007), a development on the previously 
published multi-axial strain.  
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Despite this advancement the in vitro models often lack bio-mimicity with 
regards to the cellular architecture, the dimension in which the cells are grown 
and the extra-cellular matrix composition. As such the development of 3D 
culture systems have tried to address these issues (Powell, et al., 2002, Cheema, 
et al., 2003, Auluck, et al., 2005, Cheema, et al., 2005, Mudera, et al., 2010,), 
including work from our laboratory.  
Recently, further advancements have been made with the development of a 
system mimicking in vivo SkM in terms of histology and genotype, allowing for 
the long term and hence enhanced maturation of the constructs (Smith, et al., 
2012). Furthermore, the characterisation of the purely myogenic cell seeded 
construct has been described earlier in Thesis (Chapter 3), providing an 
appropriate model to investigate the effect of mechanical signals on regulating 
SkM mass.  
The isolated nature of such a system also allows of the analysis of the intrinsic 
mechanisms activated in response to mechanical stimuli, controlling for the 
influence of systemic factors. Notwithstanding the potential role for systemic 
factors, an in vitro model as described (Smith, et al., 2012) allows for the 
investigation of single or multiple systemically regulated proteins in involved in 
hypertrophy. It is important however, to characterise the proposed model with 
respect to the regulation of many of the hypertrophic and atrophic genes 
described, before further advanced mechanistic studies can be undertaken. To 
this end, the following aims were proposed.  
5.2 Aims and Hypotheses 
1. To develop loading modalities that recapitulate existing models of 
overload induced hypertrophy. 
2. Use these models to investigate the regulation of genes involved in 
stimulating a hypertrophic response. 
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3. Investigate the regulation of genes that inhibit protein synthesis, or are 
involved in protein degradation at the lysosome. 
Taking the existing literature into consideration, it was hypothesised that 
mechanically loading the characterised SkM constructs described in Chapter 3, 
would result in a compensatory modulation of genes implicated in hypertrophy. 
Particularly, it was hypothesised that an increase in protein synthetic genes IGF-I 
and MMP-9 and a reduction in genes suppressing protein synthesis or involved in 
proteolysis, MuRF-1, MAFBx and Myostatin would result from mechanical 
overload.  
5.3 Methods 
5.3.1 Cell Culture  
For all experimentation cells were used below passage 8 and were grown to 80 % 
confluence before being trypsinised (Trypsin-EDTA, Sigma-Aldrich), prior to 
preparation for collagen constructs (see 2.4 for methods).  
5.3.2 Cell seeded 3D compliant collagen constructs 
Collagen constructs were prepared as previously described (4.2.1.1). The 
constructs were transferred to DM, following 4 days of culture in GM. A further 
10 days of culture allowed for the maturation of the constructs and the 
differentiation of myoblasts into multinucleated myotubes.  
5.3.3 Experimentation 
For experimentation, constructs were removed from the chambers and 
transferred to polyethylene moulds, floated in DM and mounted upon the 
Tensioning Culture Monitor (t-CFM, Cheema, et al., 2005)for mechanical stretch. 
N = 3 static controls (no mechanical stretch) were used to compare all data. 
Overload regimes were programmed as follows; Static Load (n = 4) 10 % strain 
for 60 mins, Ramp Load (n = 3) continuous increasing load to achieve 10 % strain 
at 60 mins (Fig. 5-1). Constructs were sampled immediately at 60 mins for RNA 
extraction. 
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Figure 5-1. Graphical representation of mechanical overload regimes. Static 
load was achieved by applying a 10 % strain immediately to the constructs once 
they were tethered to the t-CFM. Ramp load was programmed to continually 
apply increasing load in order that 10 % strain was achieved at exactly 60 mins.  
5.3.4 Lactate Analysis 
In order to analyse the metabolic activity of the constructs and to test whether 
the different regimes were initiating a differential workload, the production of 
lactate during the mechanical stretch protocols was assessed (see 2.9.1).  
5.3.5 Construct Sampling and Extraction Protocol 
Immediately following the end of the stretch protocol, the constructs were 
removed from the t-CFM and submerged in TRIzol (Invitrogen), prior to 
homogenisation and RNA extraction (see section 2.9.4.2).  
5.3.6 Primer Design and Synthesis 
Primers (Table 5-1) were designed and synthesised by Sigma-Aldrich. Primer 
sequences were analysed for GC nucleotide content as well as being analysed 
using a ‘Blast search’ (www.ncbi.nlm.nih.gov/tools/primer-blast/) to check for 
target sequence specificity.  Mean GC nucleotide content was 49.65 ± 3.94 % for 
all primers.  
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5.3.7 Quantitative Reverse Transcriptase Real-Time PCR (qRT-PCR) 
A one step reaction chemistry was used for the qRT-PCR for all experiments 
(Quantifast, Qiagen, Crawley, UK). The Qiagen (Crawley, UK) Qiagility Robot was 
used to perform all ‘master mix’ and sample preparations, using associated 
programmable software (see section 2.9.4). Samples were loaded into a 
Rotogene 3000Q (Qiagen, Crawley, UK) for the one step RNA-CT reaction.  
Samples were run in duplicate and the mean CT  (threshold cycle) values were 
used to calculate relative mRNA expression of the genes of interest (GOI). An 
experimental control (no overload) along with an endogenous control gene (RPII-
B), were used to calculate the mRNA expression of each GOI. The relative gene 
expression levels were calculated using the comparative CT (ΔΔCT) equation All 
individual samples were normalised to a single designated control sample, in 
order that the variation in control samples could be analysed.   
Table 5-1. qPCR Primer Sequences  
Target 
Gene 
Forward‎Sequence‎(5’‎to‎3’) Ref. Seq. Number 
RPII-B F:GGTCAGAAGGGAACTTGTGGTAT 
R:GCATCATTAAATGGAGTAGCGTC 
NM_153798.2 
IGF-I F: GCTTGCTCACCTTTACCAGC 
R: TTGGGCATGTCAGTGTGG 
NM_010512  
 
MMP-9 F: CTGGCAGAGGCATACTTG 
R: GCCGTAGAGACTGCTTCT 
NM_013599.2 
IGFBP-2 F: AGTGCCATCTCTTCTACAA NM_008342.3 
 R: GCTCAGTGTTGGTCTCTT  
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IGFBP-5 F: GAAGAGGTGGTGACAGAG NM_010518.2 
 
MuRF-1 
 
MAFBx 
R: TGACAACAAGATCGGGAA 
F: CCAAGGAGAATAGCCACCAG 
R: CGCTCTTCTTCTCGTCCAG 
F: GTCGCAGCCAAGAAGAGAA 
R: CGAGAAGTCCAGTCTGTTGAA 
 
NM_001039048.2 
 
NM_026346.3 
Myostatin F: TACTCCAGAATAGAAGCCATAA 
R: GTAGCGTGATAATCGTCATC 
NM_010834.2 
 
5.3.8 Statistical analyses 
All statistical analysis was performed using SPSS software version 17 (SPSS INC, 
Chicago, IL, USA) and Graphpad Prism 6 (California, USA). Significant differences 
between variables were analysed using one way repeated measures ANOVA’s. 
Normal distribution and homogeneity of variance were calculated to display 
compliance to statistical assumptions (see appendix 2). A pair-wise comparison 
post-hoc test was performed with a Bonferroni adjustment for any data with 
significant F values. The alpha value of significance was set at p ≤ 0.05. All data is 
presented as mean ± standard error of the mean (SEM).  
5.4 Results 
5.4.1 A superior increase in lactate production in RL suggests an increased 
cellular metabolic demand and workload compared to SL 
Confirming a continued increase in metabolic activity on the myotubes in the 
Ramp Load condition, peak Lactate was significantly greater compared to Control 
(p = 0.003) and Static Load conditions (p= 0.000, Ramp Load = 6.43 ± 0.08, 
Control = 1.73 ± 0.22, Static Load = 4.8 ± 0.32, Fig. 5-2).  
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The Static Load condition also induced a significantly greater peak lactate 
concentration compared to Control (p = 0.000). Together these data provide the 
evidence for an increased metabolic activity following the mechanical overload 
regimes employed here.   
 
Figure 5-2.  Conditioned media peak lactate analysis. N = 3+ constructs per 
condition analysed. Peak lactate concentration within conditioned media was 
immediately sampled at 60 mins of experimentation. Assays were performed in 
duplicate. A significant increase in peak lactate was observed for both Static Load 
and Ramp Load compared to Control (*p < 0.01). There was also a significant 
increase in peak lactate between Ramp Load and Static Load (**p < 0.001). Data 
is presented at mean ± SEM.  
5.4.2 Increases in IGF-I‎and‎MMP9‎mRNA’s‎acutely‎following‎overload 
Statistical analysis revealed significant modulation of IGF-I mRNA (p = 0.002), 
with Static Load significantly increasing IGF-I mRNA to 71.42 ± 16.42-fold 
compared to both Contorl (3.94 ± 3.88, p = 0.003) and Ramp Load (17.40 ± 7.77, 
p = 0.011, Fig. 5-3 A). There was no effect on IGF-I mRNA expression following 
Ramp Loading, compared to Control (Control = 3.94 ± 3.88 vs. Ramp Load = 17.40 
± 7.77, p = 0.603).  
 157 | P a g e  
 
To illustrate the extent of IGF-I mRNA regulation in these conditions, the raw 
average CT values for each sample for IGF-I and the housekeeping gene (RPII) 
have been displayed in Table 5-2. The clear reduction in CT values demonstrates 
a clear up-regulation of this transcript.  
A significant regulation in MMP-9 mRNA was also observed (p = 0.013) with 
increases found for both Static Load (p = 0.027) and Ramp Load (p = 0.005) 
compared to Control, whilst Ramp Load moderately increased MMP-9 mRNA 
compared to Static Load (p = 0.234, Static Load = 16.37 ± 6.69, Ramp Load = 
22.70 ± 2.70, Control = 4.06 ± 2.37, Fig. 5-3 B). Increases in both IGF-I and MMP-9 
mRNA for both SL and RL compared to Control, suggests the acute regulation of 
these genes following mechanical overload. The differential response in IGF-I and 
MMP-9 transcription to each stimulus, demonstrates a contrasting response 
dependent on the type of mechanical overload; SL has the ability to induce 
potential enhanced signalling through IGF-I, whilst RL demonstrates a greater 
ability to remodel the extra-cellular matrix through MMP-9.  
Table 3. The extent of IGF-I transcription in response to mechanical overload. 
Raw CT values for the housekeeping gene (RPII) and IGF-I demonstrates a clear 
increase in IGF-I mRNA.  
Sample RPII IGF-I 
Control 18.17 26.8 
Static Load 17.24 19.3 
Ramp Load 17.46 21.7 
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Figure 5-3. Increases in IGF-I and MMP-9 mRNA to Static Load and Ramp Load. 
N = 3+ constructs per condition were analysed. A) Increase in IGF-I mRNA 
following Static Load (*p = 0.003) and no significant modulation in Ramp Load (p 
= 0.603). IGF-I was also significantly increased in Static Load above Ramp Load 
(**p = 0.003). B). Significant increases in MMP-9 mRNA for Static Load (*p = 
0.027) and Ramp Load (**p = 0.005), compared to Control. Data is presented at 
mean ± SEM.  
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5.4.3 A role for IGFBP2 and IGFBP5 in the acute response to mechanical 
overload 
With enhanced transcription of IGF-I, it was logical to investigate any role IGF 
binding proteins may have in enhancing or impeding the action of IGF-I in 
response to mechanical overload and exercise ( Severgnini, et al., 1999, Bickel, et 
al., 2003, van den Beld, et al., 2003, Rehfeldt, et al., 2010).  
No statistical main effect was observed in IGFBP-2 mRNA expression, with a 
mean increase in the Static Load condition, with a non-significant reduction in 
Ramp Load, compared to Control (p = 0.057, Control = 1.03 ± 0.03, Static Load = 
1.51 ± 0.52, Ramp Load = 0.44 ± 0.03, Fig. 5-4 A). A reduction in IGFBP-5 mRNA 
expression occurred following both overload regimes (p = 0.018), with 
significance in the Ramp Load condition compared to Control, and approaching 
significance in Static Load (p = 0.027 and 0.059 respectively, Control = 1.01 ± 0.01, 
Static Load = 0.46 ± 0.23, Ramp Load = 0.34 ± 0.12, Fig. 5-4 B). No difference in 
IGFBP-5 mRNA was found between overload conditions (p = 1).  
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Figure 5-4.  Modulation‎of‎IGFBP’s‎in‎response‎to‎SL‎and‎RL.‎N = 3+ constructs 
per condition were analysed. A) IGFBP-2 mRNA following Static and Ramp 
Loading (p = 0.057). B) Significant modulation of IGFBP-5 mRNA (p = 0.018). 
Significant reductions in IGFBP-5 mRNA in Static Load (*p = 0.027) and 
approaching significance in Ramp Load (**p = 0.059) compared to Control. No 
differences were found between Static and Ramp Loading conditions. Data is 
presented at mean ± SEM.  
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5.4.4 No significant changes in either Myostatin mRNA or UPP associated 
transcripts following overload 
Myostatin is a potent negative regulator of protein synthesis, whilst MuRF-1 and 
MAFBx enhance protein degradation via the ubiquitin proteasome pathway 
(UPP). As such, a reduction in these genes may contribute to enhanced protein 
synthesis and reduced protein breakdown leading to net protein accretion. Both 
overload regimes contributed to variable but mean reductions in Myostatin 
mRNA compared to Control (both p = 0.572, Control = 0.45 ± 0.35, Static Load = 
0.15 ± 0.08, Ramp Load = 0.08 ± 0.06, Fig. 5-5 A). Further experimentation would 
be necessary to determine whether this effect was indeed true, with the 
variability in the Control samples leading to non-significant data. A Control 
expression value should be close to ‘1’ and as such the mean expression of 0.45 ± 
0.35, illustrates the varaiblity in this data set.  
Additionally, no significant changes were apparent in MuRF-1 mRNA (Control = 
1.24 ± 1.00, Static Load = 1.03 ± 0.22, Ramp Load = 1.87 ± 0.47) and MAFBx 
mRNA expression (Control = 1.07 ± 0.34, Static Load = 1.37 ± 0.39, Ramp Load = 
1.13 ± 0.23, p = 0.469 and p = 0.632 respectively, Fig. 5-5 B and C).
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Figure 5-5. Modulations in genes associated with protein synthesis inhibition and degradation. N = 3+ constructs per condition were 
analysed. A) No changes in MuRF-1 mRNA in either Static Load or Ramp Load compared to Control (p = 0.469). B) No changes in MAFBx 
mRNA in Static Load or Ramp Load compared to Control (p = 0.632). C). Variable, but mean reductions in Myostatin mRNA in both Static 
Load and Ramp Load conditions compared to Control (p = 0.572). Data is presented at mean ± SEM.
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5.5 Discussion 
The aim of the current investigation was to analyse the acute metabolic and 
transcriptional responses of two mechanical overload regimens, to provide 
evidence for whether these models could be used in examining the cellular and 
molecular regulation of SkM mass.   
5.5.1 Evaluating lactate production confirms the effect of mechanical 
overload on cellular metabolism  
In order to analyse whether the mechanical overload regimes were in fact 
eliciting a cellular metabolic response above control and to assess the extent to 
which the different regimens moderated this response, media conditioned by 
the construct during stretch was analysed for lactate (Fig. 5-2). Despite a reduced 
total gross workload in the Ramp Load condition, the enhanced metabolic 
response in this condition (demonstrated by increases in peak media Lactate 
compared to Static Load, p < 0.001) could be explained in terms of an intricate 
cellular response to the mechanical strain. It has previously been postulated that 
cells in 3D matrices respond to minimise the perceived strain placed upon the 
extra-cellular matrix during tension (Eastwood, et al., 1998). This observation is 
supported by the change in shape of the cells associated with cytoskeletal 
rearrangements in accordance with the strain placed upon the extra-cellular 
matrix (Eastwood, et al., 1996). This data may provide evidence for the enhanced 
metabolic response in RL, as the cells will be continually reorganising themselves 
with the continuous increased load.  
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5.5.2 Differential mechano-responsive expression of hypertrophic genes IGF-I 
and MMP-9 
With evidence to suggest a differential metabolic demand upon the cells in the 
Ramp Load condition compared to Static Load (Fig. 5-2), modulation in IGF-I 
mRNA was found to be independent of this metabolic demand. Static Load 
significantly increased IGF-I mRNA above Control T and Ramp Load (both p < 
0.05), demonstrating the augmented acute regulation of this gene in response to 
this specific mode of overload.  
Numerous in vivo models of mechanical overload have demonstrated increases 
in IGF-I, including models of synergistic ablation (Adams and Haddad, 1996, 
Adams, et al., 1999), mechanical overload (Awede, et al., 1999, McKoy, et al., 
1999) or in vitro stretch ( Goldspink, et al., 1995, McKoy, et al., 1999) induced 
hypertrophy.  
IGF-I is a growth factor that has been implicated in the hypertrophic response of 
SkM and works at the endocrine, paracrine and autocrine levels with variations 
in protein structure and function arising from the alternate splicing of the IGF-I 
gene (Goldspink, 2005). Despite the liver supplying a large proportion of 
circulating IGF-I, it has been demonstrated that liver deficient IGF-I mice display 
similar gains in SkM strength to resistance exercise compared to control wild 
type mice (Matheny, et al., 2009). Moreover, localised infusion of IGF-I induces 
SkM hypertrophy in rats (Adams and McCue, 1998).  
These findings provide support for the use and production of local IGF-I in the 
hypertrophic response in basal and exercise conditions in vivo. However, the use 
of in vitro experiments provides a means to investigate the role of locally 
produced IGF-I in response to overload or stretch. Stretch induced hypertrophy 
in vitro has been shown to be dependent upon the activation of PI3K/Akt and 
mTOR (Sasai, et al., 2010), signalling molecules that lie downstream of IGF-I.  
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Furthermore, mechanical stretch of bio-engineered developing SkM up-regulates 
IGF-Iea mRNA following an hr of ramp stretch (Cheema, et al., 2005). IGF-Iea 
(MGF) has been shown to influence the activation and proliferation of satellite 
cells (Ates, et al., 2007) and thus the regulation of this is more pertinent for 
developing or regenerating SkM tissue. Data presented here further supports 
this notion of the intrinsic regulation of IGF-I in the response to acute mechanical 
overload in a bio-mimetic model of SkM in vitro, in order to initiate the signalling 
mechanisms required for a compensatory hypertrophic response.  
The mechanical overload regimes used in the current investigation increased the 
expression of MMP-9 mRNA to a similar extent compared to CT (both, p < 0.05). 
An increase in MMP-9 has been demonstrated to play a pivotal role in 
hypertrophy, satellite cell activation and migration, and the maintenance of SkM 
mass.  
MMP’s are a large family of Zinc (Zn2+) containing endopeptidases causing 
proteolysis of selected extra cellular matrix (ECM) components (Carmeli, et al., 
2002). MMP’s are secreted in a pro-enzyme form which is not active until the 
propeptide is removed by proteolysis, with MMP-9 predominantly degrading 
collagen IV, the most abundant collagen in the basement membrane (Liu, et al., 
2010). Not only does this degradation of the ECM allow for the enhanced action 
of growth factors (such as IGF-I), MMP’s have been shown to enhance the bio-
availability of IGF-I through the proteolysis of IGF binding proteins (Coppock, et 
al., 2004). Overexpression of an active mutant of MMP-9 in mice leads to 
increases in phenotypic (fibre cross-sectional area and contractile proteins) and 
functional (isometric force) characteristics of SkM (Dahiya, et al., 2011).  
Upon the deletion of the MMP-9 gene fibre hypertrophy was reduced, 
underpinned by reductions in pAkt (Dahiya, et al., 2011), a signalling protein 
downstream of IGF-I. Collectively, these data provide the mechanistic evidence 
for the role of MMP-9 in the process of hypertrophy.  
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In this respect, the increases in the transcription of MMP-9 established in this 
investigation suggest an activated mechanism to induce the potential for 
hypertrophy.  
5.5.3 Modulation‎of‎the‎gene‎expression‎of‎IGFBP’s‎-2 and -5 illustrates a 
mechanism towards in the increased action of IGF-I 
In order to investigate a potential enhancement in IGF signalling following the 
mechanical overload regimes, the roles of IGFBP’s- 2 and -5 were investigated. 
Ramp Load reduced the expression of IGFBP-5 (p = 0.008), whilst Static Load 
moderately increased decreased IGFBP-5 (p = 0.027). IGFBP’s regulate the action 
of IGF-I, working to inhibit or potentiate its action (Clemmons, 1998).  
IGFBP’s control growth and development through governing the bio-availability 
of IGF-I and the affinity to the IGF-IR, inhibiting growth in excess quantities (Wolf, 
et al., 2005). Consequently, in a transgenic mouse model overexpressing IGFBP-2, 
myofibre size is reduced and the ability for proliferating nuclei is hindered 
(Rehfeldt, et al., 2010). Moreover, increased circulating serum concentrations of 
IGFBP-2 in vivo, correlates with increased disability and muscle strength (van den 
Beld, et al., 2003) thus demonstrating a role for this protein the consequential 
function of SkM. The response of IGFBP-2 mRNA resported here, warrants 
further investigation to determine whether increased sample sizes would 
contribute to significant effects in the differential response to Static and Ramp 
Loading (Fig. 5-4). 
The modulation of IGFBP-5 has also been shown in a model of overload induced 
hypertrophy, where IGFBP-5 mRNA reduced to a third of control levels (Awede, 
et al., 1999, Awede, et al., 1999). Interestingly, unloading of the overloaded hind 
limb resulted in atrophy coupled with an increase in IGFBP-5 mRNA (Awede, et 
al., 1999, Awede, et al., 1999). The regulation of IGFBP-5 mRNA is also evident 
following electrical stimulation of C2C12 myotubes, whereby modest reductions 
in expression compared to control are evident over a 3 day period (Bayol, et al., 
2005).  
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Data presented here provides evidence that the regulation of IGFBP-5 mRNA is 
regulated in a mechano-mediated manner, which may provide evidence for a 
greater response compared to Bayol et al., (2005) where the mechanical 
response would only be secondary to the electrically evoked contraction.  
Awede et al., (1999) also established a temporal relationship between decreasing 
IGFBP-5 mRNA and increasing IGF-I mRNA. Data surrounding the influence of 
IGFBP’s on IGF-I action and hypertrophy are compelling, with data presented 
here providing further support for the functions of IGFBP-5 in the response to 
mechanical overload of SkM. These data support the research questions and 
hypotheses outlined for this investigation, whereby a hypertrophic 
transcriptional signature is evident. Future work using a timecourse model of 
mRNA expression, should seek to determine whether interactions between 
IGFBP-5 mRNA and consequential protein production contribute to increased 
IGF-I mRNA following overload.  
5.5.4 Myostatin mRNA following mechanical overload  
When investigating the molecular regulation of SkM mass, it is important to 
consider the mechanisms involved in inhibiting protein synthesis or increasing 
proteolysis. To this end, the effect of the mechanical overload regimes upon 
myostatin and members of the ubiquitin proteasome pathway were investigated. 
Despite no significant effect of mechanical overload being present for any of 
these genes, a mean but variable reduction was evident for myostatin (Fig. 5-5). 
Myostatin is a member of the TGFβ family of growth factors (Elkina, et al., 2011) 
and was discovered to have a profound effect on SkM mass in myostatin 
knockout models and naturally occurring myostatin null animals (McPherron and 
Lee, 1997). The influence of myostatin in directly inhibiting protein synthesis, or 
increasing protein tissue breakdown through MuRF-1 and MAFBx signalling is still 
disputed (Welle, 2009).  
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However there is evidence to suggest that myostatin directly inhibits signalling 
through the Akt/TORC1/P70S6K pathway of protein synthesis in C2C12 myotubes, 
independent of the activation of MuRF-1 or MAFBx (Trendelenburg, et al., 2009). 
However an alternative view, points towards myostatin activating MuRF-1 and 
MAFBx via upstream protein FoxO-1 (McFarlane, et al., 2006), which works to 
directly to breakdown contractile and structural proteins via ubiquination. As 
such the expression pattern of MuRF-1 or MAFBx following overload may reflect 
a complex temporal expression pattern, which warrants further investigation.   
5.5.5 Stimulating the mechanisms for hypertrophy in vitro: application to 
SkM tissue engineering?  
Previous literature detailed below, has demonstrated the positive influence of 
mechanical signals in contributing to enhanced maturation and development of 
tissue engineered SkM ( Powell, et al., 2002, Cheema, et al., 2005, Moon du, et 
al., 2008, Corona, et al., 2012, 2005). However, there is evidence to suggest that 
cyclical mechanical stimulation may hinder maturation of C2C12’s seeded in 
tissue engineered constructs (Boonen, et al., 2010). Data presented here 
supports the role of mechanical stimulation in the enhanced hypertrophic 
transcriptional response. Increasing the potential for myotube growth 
contributes to enhanced development of the construct, with respect to 
engineering a more in vivo representative tissue. Furthermore the ability to 
generate force, if implanted in vitro would be greater following hypertrophy of 
the embedded myotubes. In addition, the use of ramp and static mechanical 
overload compared to cyclical load (Boonen, et al., 2010) appears to contribute 
to enhanced maturation potential.  
5.6 Conclusion 
The data from the current investigation supports the experimental hypothesis 
surrounding the expression of key hypetrophic genes. Particulalry, this study 
demonstrates the intrinsic role of IGF-I and the IGFBP-5 in increasing the 
potential for IGF-I signalling to enhance protein synthesis.  
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Coupled with the reduction in Myostatin mRNA, the overload regimes have 
induced a transcriptional response known to induce compensatory hypertrophy. 
In addition, this study has provided evidence for the use of an animal-free bio-
mimetic in vitro model to investigate the response of SkM to mechanical 
overload. Furthermore, the use of ramp and static loading of tissue engineered 
SkM will contribute to an enhanced maturation potential for use as pre-clinical 
or implantation models for disease.  
Future experiments will seek to understand the acute protein signalling 
mechanisms (which are difficult to investigate in vivo) that are activated upon 
mechanical loading, which contribute to the transcription of the genes 
investigated here. The investigation into the consequences of the altered 
transcription of the genes discussed here is also warranted. The proposed effect 
of modulated mRNA of the genes investigated here is represented in Fig. 5-6. 
Furthermore, the effect of mechanical loading upon phenotypic adaptation 
should be explored with respect to myotube hypertrophy and myonuclear 
addition. 
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Figure 5-6. Schematic representation of the acute transcriptional responses and key potential mechanisms regulating consequential 
hypertrophy. 
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6 Thesis Discussion  
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6.1 Summary of Thesis Aims   
The aim of this Thesis was to develop, characterise and utilise an in vitro model 
of SkM, to further understand the regulation of SkM adaptation to mechanical 
loading. The limitations of in vivo research has steered the development of in 
vitro models of mechanical loading, which often lack bio-mimicity with respect to 
the morphology of the cells, overlooking of the influence of a representative 
ECM and the vector nature of loading. Therefore, the experiments presented in 
this Thesis aimed to combat these issues to provide a model that could reflect in 
vivo physiology to a greater extent.  
6.2 Novelty of Findings  
Data presented within this Thesis provides novel evidence for the use of the 
proposed model to investigate SkM physiology.  
6.2.1 Chapter 3 
The development of a long term culture system, using small collagen constructs 
represents an advancement of previously published literature (see section 3.3, 
Cheema, et al., 2003, Cheema, et al., 2005). Moreover, the conserved behaviour 
of C2C12 myoblasts within 3 ml compared to 5 ml constructs ensures a reduced 
culture requirement and economic cost of reagents.  
Novel data was also presented to illustrate the extent of matrix remodelling 
(macroscopic contraction, see section 3.3.2) and myoblast differentiation within 
an isolated population of myogenically determined seeded cells (see section 
3.3.3). It had previously been postulated that a non-myogenic population of cells 
would be required for sufficient remodelling of the matrix to ensure myogenic 
cell-cell contact for fusion (Smith, et al., 2012). This data is significant with 
respect to investigating the intrinsic response of myoblasts within a 
representative niche (Sharples, et al., 2012). The uni-axial alignment and 
morphology of these fused cells conveys distinct similarity to in vivo SkM (Gillies 
and Lieber, 2011), an improvement of previously published monolayer culture 
systems.  
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Moreover, this model permits the study of other physiological and 
pathophysiological stimuli on SkM cells within a construct that is characteristic of 
in vivo tissue. These characterisation data supported the hypotheses that an 
utilising a high seeding density and recapitualing the in vivo SkM niche, would 
contribute to the development of a bio-mimetic SkM model.  
6.2.2 Chapter 4 
The precise effect of mechanical cues in stimulating SkM response to exercise in 
vivo is challenging to investigate, due to the influence of many other 
confounding factors including systemic circulation, neural influence and ethical 
limitations. Data presented in this Thesis advances previous in vitro studies with 
respect to the cell morphology, ECM and the modalities of stimulation 
investigated (Passey, et al., 2011).  
Studies investigating the effect of mechanical strain on metabolism are limited, 
despite the clear mechanical component of SkM contraction. The development 
of an in vitro model to investigate this was presented in this Thesis. The 
execution of cyclic stimulation protocols that replicate continuous low strain and 
intermittent higher strain mechanical loads revealed a mode-dependent 
metabolic and transcriptional effect (see section 4.3). Previous studies have 
investigated the effect of mechanical signals on mediating glucose uptake (Iwata, 
et al., 2007), however this is the first investigation to characterise the metabolic 
effect following of mechanical strain of SkM cells in bio-mimetic culture. 
Furthermore, the response of the metabolic parameters measured (lactate and 
glucose) discovered similarities to that of in vivo exercise (Billat, et al., 2003, 
Mackenzie, et al., 2011). Investigating the molecular response to cyclical 
stimulation, confirmed a rapid increase in mtDNA content a response 
underpinned in part by the regulation genes involved in mitochondrial biogenesis 
(Hood, 2001, Safdar, et al., 2011, see sections 4.3.4 and 4.3.5).  
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This original data is the first to illustrate a mechanical influence on mitochondrial 
dynamics in SkM and challenges previously published hypotheses as to the 
systemic circulating adipokines required (Li, et al., 2011). This rapid effect of 
mechano-stimulation on mtDNA provides a highly controlled and efficient model 
to study mitochondrial dynamics in SkM. Additionally, this model represents a 
key adaptation to endurance-based exercise providing evidence for a mechano-
metabolic influence on stimulating mtDNA synthesis. Together, the data 
presented in Chapter 4 supported the set hypotheses, demonstrating a 
metabolic and associated metabolic transcriptional response to cyclic mechanical 
strain.  
6.2.3 Chapter 5 
The molecular response of SkM to mechanical signals has been shown for over 
50 years (Goldberg, 1967), providing the earliest mechanistic data regulating 
hypertrophy. Numerous in vivo models have been employed to investigate 
mechanical overload and hypertrophy, including synergistic ablation and 
resistance exercise. 
There is also a body of research that have used in vitro models to characterise 
the molecular signals that co-ordinate compensatory hypertrophy (Vandenburgh, 
et al., 1989, Powell, et al., 2002, Hornberger, et al., 2005, Sasai, et al., 2010). 
Data presented in this Thesis establishes two models of mechanical overload, 
which show transcriptional modulation similar to that seen in previous models 
(increases in IGF-I, MMP-9 and decreases in IGFBP-5 mRNA, see section 5.4). 
Increases in the expression of genes associated with hypertrophy and a decrease 
in the expression of genes associated with atrophy supports the hypotheses 
generated and reflects a trend towards stimulating protein accretion in this 
model. The isolated nature and accurately defined stimulation of this system, 
allows for the investigation of the intrinsic muscle cell response to mechanical 
overload (Sharples, et al., 2012). The novelty of this data resides in the bio-
mimicity of the constructs used, the uni-axial tension applied and the 
consequential pattern of gene expression.   
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In conclusion, the data presented in this Thesis describes the development and 
utilisation of a novel SkM model to investigate the effect of mechanical loading 
on the biochemical and molecular response of muscle cells. The data 
accumulated here will form the basis of future investigations to analyse the 
response and adaptation of SkM to increased loading. The application of the 
models to pathologies and particular myopathies will permit the pre-clinical 
investigation of potential exercise, pharmacological and genetic therapies to 
combat the diseases.  
6.3 Limitations and Future Directions  
The following sections will aim to outline the current limitations to the 
experimental design and procedures conducted within this Thesis. As such, it is 
hoped that future expeirments will be able to overcome these issues.  
6.3.1 Experimental Design and Statistical Analysis 
When designing experiments it is important to consider the number of samples 
required (sample size), to be able to observe a satistical effect between control 
and treatment groups. With this in mind, prospective power calculations to 
determine sample size are often performed for in vivo invesirgations, to ensure 
enough participants or animals are included in the study. In vitro experiments are 
often limited in sample size, largely due to resrource and time constraints, 
however can display enough statistical power to see an effect. Due to the novelty 
of the data presented in this Thesis, it was difficult to perform classical 
prospective power calculations. In this regard the ‘Resource Equation’ method 
for determining sample size could be considered as an alternative approach 
method (Mead, 1988).  
An approximate sample size can be calculated by the number of degrees of 
freedom for the error term in the inferential statistical test (Festing, 2001). This is 
described by the formula; 
 
E = N – T – B  
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Where E, N, T and B are the error, total, treatment and block degrees of freedom 
in the inferential test.  
 
Equation 6.1 
The suggestion is that E should be between 10 and 20 (Festing, 2001). Therefore 
for an experiment with a single indepedent variable with two levels, with a total 
of 6 observations the following equation would be true;  
E = 5 – 1 = 4 
Thus the experimental design described would be deemed under powered for 
determining a statistical effect, because the error term is less than 10. In the case 
of the experiments described in this Thesis, unfortunately using the method 
described would reveal insufficient sample sizes. However, it is important to 
consider that if a statistical effect has been shown there must be enough 
statistical power to show this effect. Future experiments utilising the model 
described herein, should perform prospective power calculations in order to 
ensure the chance of an effect of treatment can be witnessed. This will make 
sure the controlled in vitro model will indeed prove to be system whereby basic 
mechanisms can be investigated in a refined pre-clinical setting.  
6.3.2 Advancement of the Model System 
The data presented in this Thesis demonstrates the ability to investigate the 
development of 3D tissue engineered SkM. Following development, it has been 
demonstrated that these constructs can be used to examine the intrinsic muscle 
cell responses following mechanical overload. Despite the ability to analyse these 
intrinsic mechanisms, the presence of a systemic circulatory system limits the 
extrapolation of findings to in vivo SkM. Indeed, the existence of a vascularised 
SkM model promotes maturation of myotubes within a tissue engineered SkM 
model with the ability for electrical excitability (Borschel et al., 2007).  
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With this in mind, future work should aim to increase the bio-mimicity of the 
model by investigating the effect of systemically acting proteins on the response 
to mechanical stretch. The systematic investigation of proposed effector proteins 
such as adipocytokines (Li et al., 2011), would form a highly controlled system to 
examine intrinsic-extrinsic protein interaction. The integration of a basic 
perfusion flow system would also allow the continuous delivery of nutrients and 
growth factors, contributing to a more in vivo-like microenvironment.  
Despite the objective of current Thesis to investigate the effect of mechanical 
stretch on SkM cells, it is important to consider the intrinsic and neural 
excitability that stimulates contraction in vivo prior to a mechanical response. 
Efforts have been made to incorporate motoneurons into SkM models, with 
encouraging signs of neuromuscular interaction (Das et al., 2010; Smith et al., 
2012b). The functionality of these interactions in terms of whether a full 
neuromuscular junction is present is difficult to test due to the amount of extra-
cellular collagen. The ability to test functional synapses relies on electro-
physiological techniques, which to date have shown promising results in 
monolayer co-culture systems (Umbach et al., 2012).   
The density of the collagen matrix within the model described here also reduces 
the resolution to be able to witness intrinsic excitation. The contraction of the 
collagen matrix has been attributed in part to originate from passive and active 
contraction of the myotubes (Smith et al., 2012a). The inability to observe any 
potential active contraction, particularly in response to stretch, has been 
ascribed to the innate stiffness of collagen (Khodabukus and Baar, 2009). The 
capacity to observe this phenomenon within this model would further increase 
its bio-mimicity. Studying cellular calcium dynamics during and following 
mechanical stretch would provide evidence as to whether an active contractile 
response was achieved, an occurrence that has been demonstrated in other cell 
types (Dalrymple et al., 2007, Iribe and Khol, 2008).  
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Furthermore, the staining of the myotubes present in the system with an 
antibody against myosin heavy chain or othe relevant proteins to provide 
indication as to the presence of contractile machinery, would offer data 
concerning the potential for active contraction of the developed myotubes. 
Additionally, the development of the model to increase the occurrence of 
neuromuscular interaction and reduce matrix volume and stiffness for 
electrophysiological analysis would provide an ideal model to study moto-
neuromuscular interaction following stretch.    
The transmission of mechanical force within SkM is controlled in part by the ECM 
and the myotendinous junctions (Larkin et al., 2012). The model presented here 
uses a matrix comprised of type I collagen, a major constituent of the ECM in vivo. 
However the transmission of mechanical force is facilitated by the A-frame 
structures which attach to the mechanical stimulation system. Future work 
should aim to attach the SkM model to a tissue engineered tendon, in order to 
further enhance the in vivo nature of the system.  These tissue hybrids have been 
successfully engineered and tested in vitro, providing evidence for the 
interaction of the two tissue types with positive expression of specific muscle-
tendon unit (MTU) protein paxillin (Larkin et al., 2006). Utilising an MTU system 
will enable the analysis of the response of SkM cells to mechanical signals in an 
environment similar to in vivo SkM tissue.  
Furthermore, the transmission of external force through a more in vivo-like MTU 
system would allow for the dinlineation of the precise mechanical sgnals which 
regulate mechano-activation of SkM cellular mechanisms. Indeed, furutre 
investigations should also aim to define the influences of stretch activated 
channels (SAC’s, Spangenburg and McBride, 2006, Butterfield and Best, 2009), 
integrins ( Boppart, et al., 2011, Lueders, et al., 2011) and the dystrophin-
dystroglycan complex (Parcell, et al., 2009) on the signal transduction following 
mechanical stimuli within the model presented here and fututure bio-mimetic 
systems.  
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The rationale for using the C2C12 cell line within the experiments presented here 
was based upon the requirement to investigate the intrinsic regulation of 
myogenic cells in response to mechanical stimulation. Although this provides a 
highly controlled environment for the study of myogenic cells, it is clear that non-
myogenic cells regulate myogenic cell fate and behaviour (Brady et al., 2008; 
Stern et al., 2009; Brzoska et al., 2011). Future experiments should aim to 
characterise the effect of these two different cell types on the response to 
mechanical stimulation. There is evidence in vivo for the activation of 
mesenchymal stem cells other than satellite cells following eccentric exercise 
(mainly pericytes, Valero et al., 2012). The use of primary cell culture 
methodologies to identify these non-myogenic cell types, combined with 
mechanical stimulation would enable the controlled investigation of the 
mechanism whereby these cells are activated. The ability to examine the 
differential proportions of these cell types in vitro, will also contribute to a 
greater understanding of cell-cell interaction, particularly in response to 
mechanical strain.    
The final methodological advancement that should be made for this model is the 
analysis of intra-cellular protein. The ability to successfully measure intra-cellular 
protein will be indispensible to understand the mechanisms that regulate 
responses to mechanical signals in SkM. The ‘gold standard’ method of protein 
quantification, Western Blotting, was used to investigate a potential intra-cellular 
mechanism (see appendix 1). However, limitiations surrounding protein isolation 
and purification prevented robust data from being generated. Future 
investigations should aim to use more sensitive methods of protein analysis, to 
overcome the limited cellular protein isolation possible in this system. An 
increasingly popular method of protein analysis is the cytometric bead array, 
which uses flow cytometric technology with antibody conjugated beads. This 
technology allows for the analysis of multiple proteins of interest, including post-
transnationally modified proteins, with a very small amount of protein (Morgan 
et al., 2004, Sharples et al., 2012).  
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Developing a method to investigate proteins involved in converting mechanical 
signals into biochemical signals (putative mechano-chemical proteins), will 
enable a greater understanding of the mechano-transduction pathways.  
The data presented in Chapter 4 shows a rapid increase in mtDNA content 
following cyclical mechanical stimulation. Future experiments should aim to 
address the underlying mechanism which is regulating this response. Efforts 
should be made to delineate whether the mechanism is mediated by mechanical 
or metabolic signals, by manipulating these two parameters. It seems likely that 
these two parameters are inextricably linked, however a cause and effect 
relationship as to the stimulating mechanism of mitochondrial biogenesis should 
be explored. The hypothesis of a metabolic threshold for mitochondrial 
biogenesis could be explored within this system using incremental strain, which 
may provide sustenance to the high intensity interval training principle 
surrounding increased mitochondrial biogenesis and aerobic metabolism.  
The process of mitochondrial biogenesis and mtDNA replication is controlled by a 
multitude of proteins and genes, with the transduction network forming a highly 
complex system. In order to ascertain a direct effector mechanism for the 
influence of mechanical signals on mtDNA replication, the use of protein and/or 
gene overexpression or inhibition would allow for the investigation of single 
proteins and genes.  
Data presented in Chapter 5 illustrates a hypertrophic transcriptional response to 
mechanical overload, exemplified increases in hypertrophic genes and a down 
regulation of genes involved in atrophy. Despite this evidence demonstrating an 
acute transcriptional response to mechanical overload, the acute protein 
signalling mechanisms associated with translation initiation at the ribosome. The 
advancement of the system that allows for long term culture without the 
development infection would enable the longer term stimulation of the 
constructs.  
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This would permit the study of multiple bouts of mechanical stimulation where 
particular focus could be placed upon adaptation; examining for myotube 
hypertrophy using histological techniques. The interplay between signalling 
mechanisms that regulate mitochondrial biogenesis and hypertrophy 
(particularly AMPK-mTOR) is complex in nature, with previous studies illustrating 
a mode specific activation of these two adaptive responses (Atherton et al., 
2005). This led to the proposal of an intra-cellular switch mechanism which co-
ordinates the divergent response. This hypothesis has recently been challenged 
with a highly controlled in vivo experiment (Vissing et al., 2011), however there is 
still limited molecular evidence as to the fibre type-fibre size (oxidative or 
hypertrophy) phenomenon (van Wessel et al., 2010).  
6.3.3 Future Applications of the Model 
The use of this model to investigate the cellular and molecular pre-dispositions 
to SkM injury is also a research theme that should be pursued with this model, 
particularly following the development of a model of mechanical overload 
presented in this Thesis. The application of this model to study the effect of 
mechanical stress on diseased cells will enable the ‘pre-clinical’ testing of 
potential exercise therapies. Furthermore, the model presented here will be able 
to identify the mechano-chemical signals that are impaired in diseased muscle 
cells. Particularly, the evidence for exercise as a therapy for muscular dystrophy 
is debated in the scientific community with much progress to be made regarding 
this matter (Yamada, et al., 2012). The use of pre-clinical models to ‘screen’ the 
response of dystrophic cells to mechanical stimulation will provide an invaluable 
to inform as to whether exercise may reduce the debilitation seen with this 
disease.  
Finally, the application of this model to study the effect of mechanical stress on 
diseased cells will enable the ‘pre-clinical’ testing of potential exercise therapies. 
Furthermore, the model presented here will be able to identify the mechano-
chemical signals that are impaired in diseased muscle cells.  
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Particularly, the evidence for exercise as a therapy for muscular dystrophy is 
debated in the scientific community with much progress to be made regarding 
this matter (Markert et al., 2012). The use of pre-clinical models to ‘screen’ the 
response of dystrophic cells to mechanical stimulation will provide an invaluable 
to inform as to whether exercise may reduce the debilitation seen with this 
disease.  
6.4 Conclusion 
This Thesis has presented novel data regarding the development and use of an in 
vitro SkM model to investigate the acute biochemical and molecular effect of 
mechanical stimulation. This model will be a valuable tool in delineating the 
mechanisms that regulate SkM cell response and adaptation to mechanical 
signals. Furthermore the use of this model as a pre-clinical tool will form a highly 
controlled environment to investigate various stimuli prior to in vivo testing. 
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8 Appendices 
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8.1 Appendendix 1 
 
Towards the optimisation of biochemical and Western Blot analyses for the 
investigation of acute cellular responses to cyclic mechanical stretch 
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8.1.1 Introduction 
The data from Chapter 3 revealed an increase in mtDNA content following 
cyclical stretch. The transcriptional mechanisms that underpin this response 
were proposed, with the particular focus on PGC-1α. The adaptation of SkM 
mitochondria to exercise is regulated by transient increases in both the 
transcription of key genes and post-translationally modified proteins (PGC-1α, 
Tfam, NRF-1 and -2). Identifying the precise way in which these mechanisms are 
transduced is an important and popular research theme within molecular 
exercise and SkM physiology.  
Increased mechanical load of SkM (through physical exercise) forms another 
major part of the signal that is required to activate many signalling pathways 
associated with physiological adaptation. To this end, models of mechanical 
stretch have been used to investigate in isolation, the role of mechanical signals 
in transducing signalling mechanism. As previously described (see 1.11), these 
models have been commonly employed to examine mechanisms underpinning 
hypertrophy. Conversely, minimal attention has been given to the influence of 
mechanical signals in regulating metabolic adaptation of SkM. This is surprising 
considering the interaction between many signalling mechanisms that regulate 
hypertrophy and metabolic adaptation, including the interplay between mTOR 
signalling and AMPK signalling (Coffey, et al., 2006).   
As such in vitro models have begun to be used to study mechano-transduction 
related to metabolic responses and adaptation. Stretching SkM cells in 
monolayer culture has been shown to increase glucose uptake (Iwata, et al., 
2007), through a Ca2+/CaMK dependent mechanism (Iwata, et al., 2007).  
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Despite not identifying the upstream activating mechanism within this system, 
this data provides clear evidence as to the influence of mechanical stretch in 
glucose uptake. Surprisingly, investigating the influence of mechanical stretch 
upon activating mitochondrial biogenesis has not been considered to date, 
despite evidence to suggest the activation of proteins that regulate this response 
to in vitro stretch (Atherton, et al., 2009, Iwata, et al., 2007).  
The model used by Iwata and colleagues is however basic in nature, taking the 
form of monolayer culture and multi-axial stretch. This system therefore negates 
the influence of cell-matrix interaction with regards to stretch and moreover 
does not reflect the vector movement of SkM in vivo.  This provides a rationale 
for investigating the effect of in vitro stretch on the metabolic parameters of SkM, 
using a model which more greatly recapitulates the in vivo environment.  
It Chapter 2 it was demonstrated that intermittent cyclic stretch increased 
mtDNA content and increased the transcriptional response of key genes involved 
in mitochondrial biogenesis. This data illustrated the influence of mechanical 
signals in mediating this rapid transcriptional response. In seeking to understand 
the acute metabolic and the upstream protein mechanisms potentially involved 
in this outcome, the current investigation aimed to optimise, characterise and 
utilise methods to this effect.   
Due to the novelty of the model presented in this thesis, it was essential to 
assess whether particular methods and assays were compatible and feasible for 
use and as such this chapter aims to present important progress towards this end.  
8.1.2 Aims  
1. To investigate and characterise the use of SDS-PAGE and Western 
Blotting to assess acute protein signalling mechanisms as a consequence 
of cyclic mechanical loading. 
2. To analyse the acute metabolic biochemical response to cyclic mechanical 
loading, investigating aerobic and anaerobic pathways of ATP production. 
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8.1.3  Methods 
For all cell culture procedures please refer to Materials and Methods 2.1. In 
order to investigate the acute protein signalling mechanisms associated with 
activating PGC-1, it was necessary to develop a Western Blotting protocol.  
8.1.3.1 Protein expression using Sodium Dodecyl sulphate Polyacrylamide Gel 
Electrophoresis (SDS-PAGE) and western blotting 
The analysis of intra-cellular protein signalling using Western Blotting has 
become a key feature of many in vitro-based SkM experiments in recent years. 
Standard monolayer culture techniques allow for the high extraction yield of 
protein in order to use in Western Blotting, however tissue engineered 
constructs pose methodological limitations, with respect to a high content of 
extra-cellular protein (matrix and serum proteins). This limitation has resulted in 
few studies (especially in SkM) investigating protein signalling. Western Blot data 
has been published using Fibrin-based matrices (Huang, et al., 2005, Khodabukus 
and Baar, 2009, Khodabukus and Baar, 2012), however the cells in model have 
the ability to remodel the matrix to a greater extent than in collagen based 
constructs. This increases the cellular: extra-cellular content enabling increased 
protein extraction. A recent investigation has been published providing a method 
for extraction of cellular protein from collagen gels (Chen, et al., 2011), from 
which the following method is based.  
8.1.3.2 Western Blotting Principle 
Western Blotting is based upon the electrophoretic separation of negatively 
charged proteins, the blotting of those proteins onto a membrane and the 
immuno-detection of a protein of interest. A standard method for Western 
Blotting is described below. 
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8.1.3.3 Procedure  
8.1.3.3.1 Protein Extraction 
Passage 5 C2C12’s were used and following experimentation, GM was removed 
from samples (either 2D monolayer cultures, or 3D collagen gels) and rinsed with 
PBS. 3D samples were removed from their glass chambers and placed in a 50ml 
tube. Samples were then subjected to 500µL of a lysis buffer containing 8M Urea 
and 1 % SDS in TBS (Chen, et al., 2011). In monolayer cultures, a pipette tip was 
used to scrape the bottom of the well to remove cells, before being transferred 
to a 50ml tube. All samples were then subjected to homogenisation using a stick 
homogeniser (Ika T10), with 30 second blasts until the tissue or cells were 
completely dissolved. Protein concentration was then determined using the 
Pierce 660nm protein assay.  
8.1.3.3.2 SDS-PAGE 
The Bio-Rad Mini Protean system was used for the separation of the proteins 
within the sample. Two gels were cast simultaneously. A 12 % resolving gel (6.7 
ml dH20, 8 ml 3 0% w/v acrylamide (Sigma-Aldrich, UK) 5 ml 1.5 M Tris HCl pH 8.8, 
200 µL 1% SDS, 100µL Ammonium Persulphate (APS) and 10µL TEMED) and 4% 
stacking gel (6.05 ml dH20, 1.3 ml 30 % w/v acrylamide (Sigma-Aldrich, UK) 2.5 ml 
1M Tris HCl pH 6.8, 100 µL 1 % SDS, 50 µL Ammonium Persulphate (APS) and 10 
µL TEMED) were cast into the glass plates. The plates were transferred to the 
running tank and running buffer (10x running buffer; 30.3 g Tris Base, 144 g 
Glycine, 10 g SDS and 1 L dH20) was added to cover 5 cm above the top of the 
gels.  
Samples were prepared with 25 µg of protein diluted 1:1 in sample buffer (4 ml 
dH20, 1 ml 1M TRIS HCl pH 6.8, 800 µL Glycerol, 1.6 ml 1 0% w/v SDS, 400 µL 2--
mercaptoethanol and 200 µL 0.05 % w/v bromophenol blue) in a 1.5 ml tube and 
boiled for 10 mins along with a molecular weight (MW) standard (BioRad, UK). 
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The MW standard and samples were loaded and the gels were run for 30-40 
mins at 80 V or until the bromophenol blue dye was at the ‘stack line’.  
At this point the voltage was increased to 120 V until the bromophenol blue was 
evident at the bottom of the gel. For analytical purposes, the gels were 
sometimes stained with Coomassie Brilliant Blue to view the separated proteins. 
Gels stained with Coomassie are longer suitable for electrophoretic transfer and 
therefore were dried and scanned, using a ChemiDoc XRS (BioRad, UK) scanner 
for imaging.   The migration front of each SDS-PAGE gel was recorded against the 
molecular weight markers to ensure that the particular proteins of interest 
corresponded to their respective molecular weight.  
8.1.3.3.3 Transfer and Western Blotting 
Gels were prepared for transfer by immersing in transfer buffer (3.02 g Tris Base, 
14.4 g Glycine, 200 ml Methanol and 800 ml dH20) and allowed to equilibrate for 
10 mins at 4˚C. Gels were then prepared in the transfer cassette with 
Nitrocellulose membranes (manufacturer) for transfer. The cassettes were 
loaded into the Bio-Rad™ mini Trans-Blot unit filled with transfer buffer, for 
transfer at 100 V for 60 min.  
8.1.3.3.4 Immunoblotting 
Following transfer the membranes were immediately washed in wash buffer 
(TBST, TBS plus TWEEN 20) for 5 min on a rocker, before being blocked (0.4 g BSA 
in 10 ml TBS) for 60 min at 4˚C. Membranes were then washed 3 x 5 mins in 
wash buffer before the addition of the Primary Antibody for 2 hr at RT.  
Following 3 x 5 min washes, the HRP conjugated Secondary Antibody was added 
for incubation at RT for 1 hr. Finally, the membranes were washed prior to 
detection.  
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8.1.3.3.5 Detection Using Enhanced Chemiluminescence (ECL)  
Membranes were prepared protein side up on sheet of acetate film, for the 
addition of the ECL reagents (1ml per membrane, mixed 1:1 peroxidase buffer 
and detection reagent, Thermo Scientific, UK). Following 5 min incubation at RT 
the membranes were transferred to the Bio-Rad Chemi Doc system for the 
detection of protein bands. Membranes were placed protein side up and 
positioned in the centre of the detection plate. A live acquire exposure 
programme was generated on the associated Quantity One software, to take 10 
images with 5 sec exposures over a 60 second sampling time.  
8.1.3.3.6 Quantification 
Band intensities were quantified using the Quantity One densitometric analysis 
functions. A rectangle was drawn around the largest visible band, with the 
rectangle surface area being repeated for all other bands, along with the 
labelling of a background area. Densitometric data was calculated based upon 
the volume intensity of each band minus the calculated background intensity. 
Data is presented as a relative abundance of the protein of interest, 
appropriately calibrated and normalised depending on the experiment.  
8.1.4 Succinate dehydrogenase (SDH) activity assay 
The activity of succinate dehydrogenase was measured following a previously 
published protocol. 
8.1.4.1 Principle 
Various methods have been used to analyse the activity of SDH within in vivo 
SkM biopsy samples, or within cultured cells. The most commonly utilised 
method for SDH activity analysis with in vivo samples is concerned with the 
staining of frozen cross sections. The quantification of the activity is based upon 
the staining intensity using a particular microscope filter. Limitations of this semi-
quantitative method are evident, with the necessity for all microscope imaging 
settings being consistent between samples.  
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Alternative methodologies utilising spectrophomtetric measurements are based 
upon the increased extinction of a reaction buffer (commonly nitroblue 
tetrazolium, NBT) at a particular wavelength. The principle behind this procedure 
involves the progressive reduction of NBT by NAD to an insoluble coloured 
compound (NBT-diformazan; NBT-dfz) which is used as a reaction indicator at 
500 nm (Powers, et al., 1993). This modified quantitative method has proven to 
be useful in analysing the SDH activity on muscle cells cultured in vitro (Yang, et 
al., 2002) and hence was chosen for use in this investigation.  
8.1.4.2 Procedure 
Protein was extracted from samples using a lysis buffer containing 8 M Urea and 
1% SDS. Quantification of the protein concentration of the lysates was 
performed using a Bio Rad DC protein assay, following the manufactures 
instructions. 250 µL of each lysate was then added to 24- well plate with the 
addition of the 100 µL of the reaction buffer containing 0.1 M sodium succinate, 
0.1 M sodium phosphate buffer, 0.01 M NBT and 0.1 M DMSO. Samples were 
then incubated at 37˚C for 30 min, with the final reaction reagent being 
measured on a nanovue spectrophotometer at 500 nm. The activity of SDH was 
displayed as OD/µg of extracted protein.  
8.1.5 Creatine Kinase Assay 
8.1.5.1 Principle 
The measurement of CK activity has been performed for many years on blood 
serum samples and has formed a key method in the diagnosis and analysis on 
myocardial infarctions and particular myopathies (Dreyfus, et al., 1960, Scebat, 
et al., 1961). The measurement of CK activity has also be used to mark the 
differentiation of myoblasts into multinucleated myotubes (Auluck, et al., 2005), 
with the particular kit used here (Catachem Inc., Connecticut, NE, USA) being 
previously used in differentiated muscle cell C2 and C2C12 lysates (Sharples, et 
al., 2011, Sharples, et al., 2010).  
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The biochemical reactions that the assay is formulated upon follow the 
phosphagen system for generating ATP as described in the literature review. The 
production of glucose-6-phosphate (G-6-P) from the hexokinase (HK) reaction is 
oxidised in the presence of nicotinaminde adenine dinucleotide (NAD) which 
forms 6-phosphogluconate (6-PG), a reaction that is catalysed by G-6-P 
dehydrogenase (G-6-PDH). The reduction of NAD to NADH during this oxidation 
reaction results in the increase in absorbance at the emission at 340 nm, which 
can be measured spectrophotometrically. The reduction of NAD to NADH is 
proportional to the activity of CK is this assay.   
                   CK 
PCr + ADP ==> Creatine + ATP  
                
                           HK  
ATP + Glucose ==> ADP + G-6-P  
 
                   G-6-PDH  
G-6-P + NAD ==> 6-PG + NADH ==> Increased absorbance at 340 nm  
Equation 2. The biochemical reactions of the CK assay. The reactions are 
displayed with the catalysing enzymes above the arrow .  
8.1.5.2 Prodecure 
The assay was set up on a 96 well UV plate (BD Biosciences, San Jose, CA, USA). 
The correct amount of aqueous reagent (reagent A) and reagent powder 
(reagent B) from the CK kit from Catachem, Inc. (Connecticut, NE, USA), needs to 
be correctly weighed and pipetted to ensure the efficiency of the reaction meets 
the manufacturers recommendations. This is of particular importance when 
using the formula to calculate CK activity which has been developed based upon 
certain amounts of reagent used.  Following the manufactures instructions, 200 
µL of the working enzymatic reagent is required for each sample.  
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4 µL of sample was pipetted into the 96 well plate, with each sample being ran in 
duplicate. Blank samples were also loaded containing 4 µL of lysis buffer 
containing 8 M Urea and 10 % SDS. 200 µL of the working CK reagent was added 
using a multichannel pipette as quick and efficiently as possible. The 96 well 
plate was inserted into Varioskan plate reader (Thermo-Fisher), where readings 
at 340 nm were taken every 30 secs for up to 10 mins. CK activity was calculated 
using the following equation based upon the difference in absorption at 340 nm 
at two different time-points. CK activity was measured from the same time-
points for each sample to ensure satisfactory comparison. Enzymatic activity for 
CK was normalised to total protein content following the manufacturers 
recommendations.  
ΔA.min-1 = (Time-point 2 – Time-point 1)/ (Measure time 1 – Measure time 2)   
CK activity (U.l-1) = (ΔA.min-1 x 0.204 x 1000)/ (6.22 x 0.004) 
Where: 
ΔA.min-1 = change in absorbance per minute at 340 nm  
0.204 = total reaction volume 
1000 = conversion to ml 
6.22 = constant of millimolar absorptivity of NADH at 340 nm 
0.004 = sample volume in ml 
Equation 3. Calculation of Creatine Kinase Activity 
8.1.6 Results 
In order to assess the protein extraction efficiency of cellular collagen constructs 
for use with Western Blotting analysis, monolayer cultures, a-cellular constructs 
and cellular constructs were lysed to analyse protein concentration (Table 1). The 
apparent lower concentration of protein evident in the monolayer cultures 
compared to collagen constructs reflects the extra-cellular protein content with 
collagen constructs, in the form of collagen and media serum proteins. Data also 
revealed an interesting phenomenon, in that there was no difference in the 
protein isolated from cellular constructs compared to a-cellular constructs (p = 
0.78), despite the addition of 12 x 106 cells.  
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This therefore demonstrates an inability of the cellular fraction of protein 
content to be efficiently isolated and purified from the extra-cellular content.  
Table 6.1 Protein Extraction Characterisation. Concentration of protein (mg.mL) 
isolated from 3 independent cultures of monolayer, a-cellular and cellular 
experiments. All samples were run in triplicate on the same microplate and 
protein concentration was determined against known BSA standards diluted in 
lysis buffer. Data is presented as individual sample concentrations, mean values 
and SE.  
 
 
 
 
 
Following the isolation of protein and the evident poor extraction of cellular 
protein in the cellular constructs, it was important to optimise and analyse the 
ability of the lysates to run on SDS-PAGE. Following the optimisation of the 
necessary voltage required to ensure even running of all the samples throughout 
the SDS-PAGE gel, samples from the monolayer, a-cellular and cellular lysates 
were loaded and ran on SDS-PAGE and stained with Coomassie Blue.  
The electrophoresis of isolated proteins was successful, with clear separation of 
protein identified in the monolayer samples (Fig. 6-1. A, lanes 1 and 2). The 
heavy and irregular banding on the gel (highlighted by continuous box) in lanes 3, 
4, 5 and 6 (a-cellular and cellular construct samples) is likely to be a combination 
of collagen protein and albumin contained within the media serum.   
 
n Monolayer A-Cellular Cellular 
1 0.93 2.53 1.92 
2 1.15 2.22 2.22 
3 0.93 1.75 2.16 
Mean 1.00 2.17 2.10 
SEM 0.17 0.31 0.20 
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There is evidence for the electrophoresis of cellular protein in the cellular 
construct samples (Fig. 6-1. A, lanes 5 and 6, identified by the dotted highlighted 
box), since there is no evidence of protein in the a-cellular samples at the same 
molecular weight. Notwithstanding the identification of minimal isolated cellular 
protein from the total protein concentrations between a-cellular and cellular 
constructs, evidence suggests the successful electrophoresis of cellular protein.  
Following the identification of positive electrophoresis in the cellular construct 
samples, it was important to assess the transfer of protein from the SDS-PAGE 
gel to a nitrocellulose membrane for immuno-blotting. Following electro-transfer, 
the membrane was stained for Ponceau S a reversible non-specific protein stain. 
Figure 6-1., B demonstrates the extent to which the protein can transfer to the 
membrane, with the monolayer samples (lanes 1 and 2) appearing to transfer to 
the greatest extent. The irregular region which is speculated to contain collagen 
and serum protein, also transfers to the membrane (lanes 3, 4, 5, and 6) with 
little evidence for abundant cellular protein present.  
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Figure 8-1 SDS-PAGE and Electro-transfer. A. SDS-PAGE gel stained with 
Coomassie Blue. MW = Molecular Weight marker. Lanes, 1 = monolayer culture 
sample 1, 2 = monolayer culture sample 2, 3 = a-cellular collagen construct 
sample 1, 4 = a-cellular collagen construct sample 2, 5 = cellular collagen 
construct sample 1, 6 = cellular collagen construct sample 2.  
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Following the transfer onto the nitrocellulose membrane it was important to 
evaluate whether immuno-blotting could be performed and in particular to 
assess the extent to which protein could be detected. The detection of β-Actin 
revealed a negative result for the a-cellular sample (Fig. 6-2., A, lane 1), with 
positive detection for cellular (lanes 2, 3 and 4) and monolayer (lanes 5, 6 and 7) 
samples confirming specificity of antibody detection at the correct molecular 
weight. In order to provide further evidence for the reduced cellular protein 
extraction from the cellular construct samples, the quantification of β-Actin was 
used. β-Actin is commonly used as a loading control protein, as it is a 
ubiquitously expressed cellular protein and has been demonstrated to reflect 
total cellular protein content. This analysis confirmed the significant reduced 
expression of β-Actin in construct samples compared to monolayer samples (p = 
0.0009), suggesting the reduced content of cellular protein loaded in this 
condition. Despite this difference, the important observation was the positive 
detection in cellular construct samples, a finding which has proven difficult to 
achieve to date.  
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Figure 8-2 Western‎Blot‎for‎detection‎of‎β-Actin. A) Representative Western 
Blot for β-Actin. Lane 1 = a-cellular construct sample, lanes 2, 3 and 4 = cellular 
construct samples, lanes 5, 6 and 7 = monolayer samples. B) Densitometric 
quantification of β-Actin expression in monolayer and cellular construct samples. 
Data is presented as a mean ± SEM of duplicate samples across three separate 
Western Blots.  Data is expressed as a % relative expression compared 
monolayer sample 1 replicate 1 in each run. *p = 0.0009.  
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In order to identify further if the cyclic stretch protocol was eliciting an acute 
biochemical stimulus as well as increasing the cellular metabolism rate above 
control, we aimed to characterise the activity of SDH as an indication of 
metabolic flux and Krebs’ cycle activity.  
Following a previous published method for analysing SDH activity in cell culture 
(Yang et al., 2002), analysis was performed on lysates MON1, MON2 and MON3 
and also CT1, CT2 and CT3. The normalised SDH activity revealed a significant 
increase (p = 0.0549) in C samples (0.00022019 ± 0.005003) compared to M 
samples (2.04461E-05 ± 0.001481, Fig. 6-3). Further, due to the activity being 
normalised to protein concentration, if the value was being normalised to only 
cellular protein within the cell construct samples the activity would be 
significantly greater. This data suggests in the basal state there is an increased 
metabolic flux associated with cells in a 3D environment compared to 
conventional monolayer culture. Moreover, this data demonstrates the use of 
this assay in identifying whether cyclic stretch of 3D constructs increases cellular 
aerobic metabolism.   
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Figure 8-3.  SDH activity between monolayer and cellular construct samples. 
Data is presented as mean ± SE of triplicate samples across two independent 
assays. Statistical analysis revealed a significant difference between conditions (p 
= .0549).  
Following the characterisation and of the analytical procedures discussed 
previously an intermittent stretch protocol was performed as described in the 
chapter methods section (4.555). To provide a mechanistic rationale for an 
increase in PGC-1α mRNA, the analysis of pP38 MAPK (Tyr180/182) was 
performed. The phosphorylation of this residue has been demonstrated to 
activate phosphorylate and activate PGC-1α protein, which translates to the 
nucleus to auto-regulate the PGC-1α gene.  
Figure 6-4 exhibits a representative Western Blot from CT and ST samples. This 
analysis unfortunately cannot provide the data required to inform upon the 
activation or suppression of pP38 MAPK (Tyr180/182) in the ST condition due to 
inconsistency in immuno-detection. The variation in band intensity and negative 
outcome in some samples seems likely to be due to the limited available cellular 
protein for antibody affinity.
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Figure 8-4.‎Representative‎Western‎Blots‎for‎pP38‎MAPK‎(Tyr‎180/182),‎Total‎P38‎MAPK,‎and‎β-Actin. ‘C’ represents the control 
samples and ‘S’ represents the stretch samples. These representative blots were taken from two independent Western Blots. 
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Analysing SDH activity following stretch demonstrated no effect of SDH activity in 
ST (0.000809 ± 0.01567) compared to CT (0.000717 ± 0.007926, p = 0.88), 
suggesting no enhanced increase in Krebs’ cycle activity. Despite a marginal 
increase, this data provides evidence that this mode of cyclic stretch in 
manipulating cellular metabolic activity, if further experiments were conducted 
and potentially for longer durations.  
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Figure 8-5. SDH Activity between Control and Intermittently Cyclic Stretched 
constructs. Data is represented as mean ± SEM for n = 4 CT samples and n = 3 ST 
samples. All sample assays were performed in duplicate and at the same time. 
Data is representative on two independent assays. Statistical analysis revealed a 
no significant difference between conditions (p = 0.88).  
To further support the notion that cyclic stretch stimulates an intracellular 
metabolic response along with the stretch directly manipulating the structural 
components of the cell, the analysis of Creatine Kinase was performed. 
Measuring CK activity in both the conditioned media and construct lysates 
confirmed a mean increase between ST and CT samples. CK activity increased 
from 6.01 ± 0.98 in CT to 10.66 ± 1.63 in the conditioned media (Fig. 6-6. A, p = 
0.516) indicative of an increased release of CK during the stretch programme.  
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This reflects the direct influence of the mechanical stretch upon the structural 
proteins of the muscle cells, providing evidence that the model employed here 
directly manipulates the cells with the matrix. Further, CK activity was found to 
be greater in the lysates of the ST condition (7.86 ± 0.97, Fig. 6-6. B) compared to 
CT (4.78 ± 0.93, p = 0.311). An increase in intracellular CK activity would provide 
additional support for the increase in metabolic activity from cyclic mechanical 
stretch.    
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Figure 8-6. Creatine Kinase Activity between Control and Intermittently Cyclic 
Stretched constructs. A) Conditioned media analysis. B) Construct lysates 
analysis. Data is represented as mean ± SEM for n = 4 CT samples and n = 3 ST 
samples. All sample assays were performed in duplicate and at the same time. 
Data is representative on two independent assays.  
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8.1.7 Discussion 
The aim of this chapter was to develop and utilise methods for the analysis of the 
acute biochemical and intra-cellular protein signalling responses to intermittent 
cyclic stretch. Through analysing these parameters, it was hypothesised that the 
mechanisms that underpinned the transcriptional response demonstrated in 
chapter 4 could be understood in greater detail.  
8.1.7.1 The isolation of protein from collagen constructs reveals the limited 
extraction of cellular protein 
The first important step in the analysis of intracellular metabolic reactions, along 
with protein signalling mechanisms is the high and consistent yield of protein 
following extraction. A study which has utilised a similar method to generate bio-
engineered tissue to investigate cytomechanical forces successfully proposed an 
intra-cellular mediated mechanism for the main outcome measure (Chen, et al., 
2011). The isolation of cellular protein to achieve positive and consistent 
Western Blot was clearly possible for this aforementioned experiment. However, 
it is important to consider the difference in cell type used between the current 
experiments and that performed by Chen et al., (2011). Fibroblasts (such as that 
used by Chen et al., 2011) have been demonstrated to have a distinct ability to 
attach, contract and remodel a collagen matrix (Brady, et al., 2008, Cheema, et 
al., 2003). In this respect it can be hypothesised that the ratio of cellular: matrix 
protein would be substantially greater in fibroblast seed collagen constructs 
compared to myogenic seeded constructs presented in this Thesis.  
Tissue engineered SkM constructs using alternative matrix protein composition 
have the ability to isolate cellular protein for the investigation of contractile and 
intra-cellular signalling proteins (Khodabukus and Baar, 2009, Khodabukus and 
Baar, 2012). The extent of matrix remodelling within these models may reflect 
the ability to extract cellular protein however it is important to consider that 
these models do not represent in vivo SkM structure within respect to ECM 
structure, therefore negating for the influence of cell-matrix interaction within 
their experimental conditions. 
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8.1.7.2 Reduced‎and‎inconsistent‎expression‎of‎β-Actin in cellular constructs 
compared to monolayer samples 
The detection of β-Actin was used to identify whether cellular protein could be 
successfully detected using Western Blotting. Quantification of the expression of 
β-Actin established a significant reduction in cellular constructs compared to 
monolayer samples. This further demonstrates the reduced cellular protein that 
can be effectively extracted from the cellular constructs.  There was also a large 
variability in the expression of β-Actin, suggesting an inconsistency in the amount 
of cellular protein that was loaded. Additionally, the ‘contaminating’ influence of 
excess serum proteins and collagen may also contribute to reduced antibody-
antigen interaction and thus may reflect the variations observed here (MacPhee, 
2010, Gallagher, et al., 2001).  Furthermore, considering the significant 
abundance of β-Actin within SkM samples (Lieber, et al., 2002), such 
inconsistency presents issues with regards to the comparability of samples from 
within a particular experimental condition. As Western Blotting is a semi-
quantitative method for the analysis of protein expression, the consistency of 
protein loading between samples is extremely important (Spurway and 
Wackerhage, 2006).   
8.1.7.3 Cellular constructs display increased SDH activity compared to 
monolayer samples 
The activity of SDH, an enzyme complex of the Krebs’ cycle has been investigated 
extensively within in vivo SkM. The activity of this enzyme has been 
demonstrated to reflect oxygen consumption (VO2), when oxygen is not a rate 
limiting factor (Wust, et al., 2012).  
Data presented here shows the increased activity of SDH in cellular constructs 
compared to monolayer samples, suggesting an increased aerobic metabolism of 
cells within a 3D environment. This finding is a logical one, with respect to the 
cells attachment and contraction of the matrix in a 3D environment requiring 
increased energy supply, compared to monolayer culture.  
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This data also provides further support of the use of 3D tissue engineered 
constructs compared to conventional monolayer culture to study muscle 
physiology, as the increased metabolic activity reflects the in vivo rate of SkM 
metabolism to a greater extent. 
8.1.7.4 Methodological limitations prevent a mechanism of PGC-1α‎
transcription from being presented 
In order to investigate the mechanism whereby intermittent cyclic stretch 
increases the expression of PGC-1α mRNA, the activation of P38 MAPK was 
investigated using Western Blotting. P38 MAPK has been demonstrated to 
phosphorylate PGC-1α protein (Atherton, et al., 2005) which auto-regulates its 
own transcription (Scarpulla, 2002). Western Blotting for pP38 MAPK (Tyr 
180/182) and total P38 MAPK exposed the inconsistent nature of using this 
method to investigate protein signalling within this model of SkM. Due to the 
apparent limited cellular protein that is extracted from cellular collagen 
constructs, the amount of protein of interest available for detection is low or 
present in varying amounts. This limitation has prevented the reliable and valid 
investigation into whether this key signalling mechanism is modulated following 
intermittent cyclic stretch. 
Alternative methods for reliable detection of proteins of interest may serve as 
more appropriate methods for this analysis. Immuno-precipitation (IP) has been 
demonstrated to be effective in enriching the content of low abundant proteins 
compared to immuno-blotting of whole cell lysates (Trieu, et al., 2009). 
Additionally, Enzyme-Linked Immunosorbent Assays (ELISA’s) also serve as a 
more precise method to detect proteins in low abundance (Alegria-Schaffer, et 
al., 2009). These methods may be more appropriate to investigate candidate 
signalling mechanisms within this model of SkM, where extracted cellular protein 
content is in low.  
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8.1.7.5 Increases in SDH and CK activity indicate a metabolic effect of 
intermittent cyclic stretch 
Investigating the activity of SDH following stretch established the potential for an 
increase if the sample size was increased and also if the protocol was for a longer 
period. An increase would suggest the stretch protocol has the potential to 
increase in the metabolic flux through the Krebs’ cycle and may therefore 
represent increased oxygen consumption. This is the first investigation to 
examine the effects of mechanical stretch upon the activity of SDH and provides 
evidence for the direct effect of mechanical perturbations of cell structure upon 
metabolic activity.  
This finding has many implications for the understanding of the enhanced or 
impaired mitochondrial function witnessed in athletic and pathological 
population’s respectively. It has been shown for many years that exercise can 
enhance aerobic capacity, which in part is due to increased mitochondrial 
function (Costill, et al., 1976, Foster, et al., 1978, Green, et al., 1980, Green and 
Narahara, 1980).  
More recently, the impaired aerobic capacity and mitochondrial function 
associated with pathological conditions has been investigated. Such 
investigations have demonstrated the reduced activity of SDH, contributing to 
impaired ATP synthesis (Wust, et al., 2012)(Nagatomo, et al., 2012). Data 
presented here contributes to the understanding of mechanical signals in 
stimulating SDH activity, which provides novel evidence as to the enhanced or 
impaired SkM function in athletic and diseased populations. The increase in CK 
activity presented here provides evidence for the influence of the mechanical 
signal upon stimulating CK activity. The activity of CK is fundamental for the 
anaerobic synthesis of ATP through the utilisation of mitochondrial phosphor-
Creatine (PCr, (Saks, 2008).  
 
 243 | P a g e  
 
The increase in CK activity measured in the lysates following intermittent stretch 
provides evidence for the requirement of ATP synthesis from anaerobic sources, 
required to meet the energy demand of the cells in response to stretch. 
Moreover, this data supports the lactate data from chapter 4 further providing 
evidence that the mechano-stimulation causes a metabolic response within the 
myotubes.  
The CK protein is bound to the M-Line of the sarcoplasmic reticulum of the 
myofibrils and the I-Band of the sarcomeres to provide ATP for actin-myosin 
interaction (Baird, et al., 2012). It is speculated to be released into the circulation 
following high specific force contractions and the loss of Ca2+ homoeostasis 
(Kendall and Eston, 2002). In this light, the detection of CK and CK activity within 
blood plasma has been used for many years as a marker of muscle damage, 
however the use of this marker has received much criticism due to the 
heterogeneity in response of individuals (Baird, et al., 2012). The increase in CK 
and CK activity in blood plasma has been postulated to reflect the tissue enzyme 
activity, with appearance in blood deemed to be a natural occurrence following 
regular SkM contraction (Thompson, et al., 2006). This evidence provides support 
that the increase in CK activity found within the conditioned media during the 
current investigation, may reflect an in vivo-like response to activation rather 
than muscle cell damage following mechano-stimulation.  
8.1.8 Conclusions 
Data presented in this chapter has demonstrated the isolation and 
characterisation of protein isolated from collagen SkM constructs. 
Methodological advancements were made with respect to the successful 
electrophoretic separation and electro-transfer of isolated proteins. Further, 
progress was made in the detection of intra-cellular proteins that regulate PGC-
1α mRNA expression. Future experiments will seek to increase the sensitivity of 
protein detection in order to provide more definitive evidence as to the 
expression of these proteins of interest.  
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Of particular attention was the investigation of SDH and CK activity following 
intermittent cyclic stretch. Data provided further support that the mechano-
stimulus is sufficient to induce a cellular metabolic response, supporting the 
lactate data presented in chapter 4.  Future experiments should aim to explore 
the effect of manipulating the mechanical variables in order to investigate the 
contribution of aerobic and anaerobic metabolism. Moreover, the increased 
activity of the SDH complex warrants further experimentation to provide a model 
to study SkM aerobic metabolism in vitro.    
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8.2 Appendix 2 
8.2.1 Statistical Analyses Summary  
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8.2.1.1 Statistical Analyses Chapter 3 
8.2.1.1.1 Table 1 Normal Distribution Analysis 
 Gel Width Peak Force RFD RPF PGC MMP-9 Tfam CytoC COXII Myog T/C PGC-1a T/C 
Normality test 1             
K2 0.9791 1.952 0.8877 1.396 N/A N/A N/A N/A N/A 6.345 3.142 
P value 0.6129 0.3767 0.6416 0.4977      0.0419 0.2079 
Passed normality test? Yes Yes Yes Yes      No Yes 
P value summary ns ns ns ns      * ns 
            
Normality test 2            
KS distance     0.1498 0.2399 0.3108 0.3711 0.239 0.1679 0.2665 
P value     0.2 0.2 0.0718 0.0098 0.2 0.2 0.0184 
Passed normality test?     Yes Yes Yes No Yes Yes No 
P value summary     ns ns ns ** ns ns * 
See list of abreviations Page xii and Chapter 3 for details. T/C denotes Timecourse.  
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8.2.1.1.2 CFM Data 
 
Dependent Variable (I) Condition (J) Condition 
Mean 
Difference (I-J) Sig. 
95% Confidence Interval 
Lower Bound Upper Bound 
Peak_Force 1.00 2.00 115.68667 1.000 -835.3615 1066.7348 
3.00 -322.27000 1.000 -1273.3181 628.7781 
4.00 -231.37333 1.000 -1182.4215 719.6748 
2.00 1.00 -115.68667 1.000 -1066.7348 835.3615 
3.00 -437.95667 .887 -1389.0048 513.0915 
4.00 -347.06000 1.000 -1298.1081 603.9881 
3.00 1.00 322.27000 1.000 -628.7781 1273.3181 
2.00 437.95667 .887 -513.0915 1389.0048 
4.00 90.89667 1.000 -860.1515 1041.9448 
4.00 1.00 231.37333 1.000 -719.6748 1182.4215 
2.00 347.06000 1.000 -603.9881 1298.1081 
3.00 -90.89667 1.000 -1041.9448 860.1515 
RFD 1.00 2.00 4.40667 .881 -5.1354 13.9487 
3.00 3.02333 1.000 -6.5187 12.5654 
4.00 -3.98333 1.000 -13.5254 5.5587 
2.00 1.00 -4.40667 .881 -13.9487 5.1354 
3.00 -1.38333 1.000 -10.9254 8.1587 
4.00 -8.39000 .094 -17.9321 1.1521 
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3.00 1.00 -3.02333 1.000 -12.5654 6.5187 
2.00 1.38333 1.000 -8.1587 10.9254 
4.00 -7.00667 .204 -16.5487 2.5354 
4.00 1.00 3.98333 1.000 -5.5587 13.5254 
2.00 8.39000 .094 -1.1521 17.9321 
3.00 7.00667 .204 -2.5354 16.5487 
Peak_Force_Relative 1.00 2.00 133.59056* .029 13.3631 253.8180 
3.00 116.60481 .058 -3.6226 236.8322 
4.00 152.18306* .014 31.9556 272.4105 
2.00 1.00 -133.59056
*
 .029 -253.8180 -13.3631 
3.00 -16.98574 1.000 -137.2132 103.2417 
4.00 18.59250 1.000 -101.6349 138.8199 
3.00 1.00 -116.60481 .058 -236.8322 3.6226 
2.00 16.98574 1.000 -103.2417 137.2132 
4.00 35.57824 1.000 -84.6492 155.8057 
4.00 1.00 -152.18306* .014 -272.4105 -31.9556 
2.00 -18.59250 1.000 -138.8199 101.6349 
3.00 -35.57824 1.000 -155.8057 84.6492 
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8.2.1.1.3 Gel Width Timecourse 
 
ANOVA 
Gel_Width 
 Sum of Squares df Mean Square F Sig. 
Between Groups 30.320 4 7.580 17.436 .000 
Within Groups 4.347 10 .435   
Total 34.667 14    
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(I) Day (J) Day 
Mean Difference 
(I-J) Sig. 
95% Confidence Interval 
Lower Bound Upper Bound 
1.00 3.00 1.56733* .016 .3678 2.7668 
5.00 2.70167* .001 1.5022 3.9012 
7.00 3.31767* .000 2.1182 4.5172 
14.00 4.05700* .000 2.8575 5.2565 
3.00 1.00 -1.56733* .016 -2.7668 -.3678 
5.00 1.13433 .061 -.0652 2.3338 
7.00 1.75033* .009 .5508 2.9498 
14.00 2.48967* .001 1.2902 3.6892 
5.00 1.00 -2.70167* .001 -3.9012 -1.5022 
3.00 -1.13433 .061 -2.3338 .0652 
7.00 .61600 .279 -.5835 1.8155 
14.00 1.35533* .031 .1558 2.5548 
7.00 1.00 -3.31767* .000 -4.5172 -2.1182 
3.00 -1.75033* .009 -2.9498 -.5508 
5.00 -.61600 .279 -1.8155 .5835 
14.00 .73933 .200 -.4602 1.9388 
14.00 1.00 -4.05700* .000 -5.2565 -2.8575 
3.00 -2.48967* .001 -3.6892 -1.2902 
5.00 -1.35533* .031 -2.5548 -.1558 
7.00 -.73933 .200 -1.9388 .4602 
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8.2.1.1.4 Myogenin Timecourse Data 
 
 
ANOVA 
Myogenin 
 Sum of Squares df Mean Square F Sig. 
Between Groups 5761421.871 3 1920473.957 3.021 .072 
Within Groups 7627643.443 12 635636.954   
Total 13389065.314 15    
 
8.2.1.1.5 PGC-1 Timecourse Data 
ANOVA 
Expression 
 Sum of Squares df Mean Square F Sig. 
Between Groups .899 3 .300 3.186 .132 
Within Groups 1.129 12 .094   
Total 2.028 15    
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8.2.1.1.6 Bowing CT Data 
8.2.1.1.6.1 Regression- Myogenin CT 
Variables Entered/Removed
b
 
Model Variables Entered 
Variables 
Removed Method 
1 Gel_Width
a
 . Enter 
a. All requested variables entered. 
b. Dependent Variable: Myogenin 
 
 
Model Summaryb 
Model R R Square Adjusted R Square 
Std. Error of the 
Estimate 
1 .631a .40 .312 1.87413 
a. Predictors: (Constant), Gel_Width 
b. Dependent Variable: Myogenin 
 
ANOVAb 
Model Sum of Squares df Mean Square F Sig. 
1 Regression 16.268 1 16.268 4.632 .068a 
Residual 24.586 7 3.512   
Total 40.854 8    
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Model Summaryb 
Model R R Square Adjusted R Square 
Std. Error of the 
Estimate 
1 .631a .40 .312 1.87413 
a. Predictors: (Constant), Gel_Width 
b. Dependent Variable: Myogenin 
 
Coefficientsa 
Model 
Unstandardized Coefficients 
Standardized 
Coefficients 
t Sig. 
Collinearity Statistics 
B Std. Error Beta Tolerance VIF 
1 (Constant) 14.603 2.398  6.090 .000   
Gel_Width 3.998 1.858 .631 2.152 .068 1.000 1.000 
a. Dependent Variable: Myogenin 
 
Collinearity Diagnosticsa 
Model Dimension Eigenvalue Condition Index 
Variance Proportions 
(Constant) Gel_Width 
1 1 1.965 1.000 .02 .02 
2 .035 7.544 .98 .98 
a. Dependent Variable: Myogenin 
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Residuals Statisticsa 
 Minimum Maximum Mean Std. Deviation N 
Predicted Value 17.8852 21.5191 19.5856 1.42600 9 
Residual -2.49925 2.20094 .00000 1.75309 9 
Std. Predicted Value -1.192 1.356 .000 1.000 9 
Std. Residual -1.334 1.174 .000 .935 9 
a. Dependent Variable: Myogenin 
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8.2.1.1.6.1.1 Charts 
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8.2.1.1.6.2 Regression- RNA Concentration 
Variables Entered/Removedb 
Model Variables Entered 
Variables 
Removed Method 
1 Gel_Width
a
 . Enter 
a. All requested variables entered. 
b. Dependent Variable: RNA 
 
 
Model Summaryb 
Model R R Square Adjusted R Square 
Std. Error of the 
Estimate 
1 .883a .779 .751 83.18747 
a. Predictors: (Constant), Gel_Width 
b. Dependent Variable: RNA 
 
ANOVAb 
Model Sum of Squares df Mean Square F Sig. 
1 Regression 194953.539 1 194953.539 28.172 .000a 
Residual 55361.246 8 6920.156   
Total 250314.785 9    
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Model Summaryb 
Model R R Square Adjusted R Square 
Std. Error of the 
Estimate 
1 .883a .779 .751 83.18747 
a. Predictors: (Constant), Gel_Width 
b. Dependent Variable: RNA 
 
 
Coefficientsa 
Model 
Unstandardized Coefficients 
Standardized 
Coefficients 
t Sig. 
Collinearity Statistics 
B Std. Error Beta Tolerance VIF 
1 (Constant) 756.831 106.413  7.112 .000   
Gel_Width -435.144 81.983 -.883 -5.308 .001 1.000 1.000 
a. Dependent Variable: RNA 
 
Collinearity Diagnosticsa 
Model Dimension Eigenvalue Condition Index 
Variance Proportions 
(Constant) Gel_Width 
1 1 1.969 1.000 .02 .02 
2 .031 7.965 .98 .98 
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Coefficientsa 
Model 
Unstandardized Coefficients 
Standardized 
Coefficients 
t Sig. 
Collinearity Statistics 
B Std. Error Beta Tolerance VIF 
1 (Constant) 756.831 106.413  7.112 .000   
Gel_Width -435.144 81.983 -.883 -5.308 .001 1.000 1.000 
a. Dependent Variable: RNA 
 
Residuals Statisticsa 
 Minimum Maximum Mean Std. Deviation N 
Predicted Value 4.0313 399.5775 209.5500 147.17848 10 
Residual -151.53473 110.02058 .00000 78.42990 10 
Std. Predicted Value -1.396 1.291 .000 1.000 10 
Std. Residual -1.822 1.323 .000 .943 10 
a. Dependent Variable: RNA 
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8.2.1.1.6.2.1 Charts 
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8.2.1.1.6.3 Regression- RPII CT 
 
Variables Entered/Removedb 
Model Variables Entered 
Variables 
Removed Method 
1 Gel_Widtha . Enter 
a. All requested variables entered. 
b. Dependent Variable: RPII 
 
 
Model Summaryb 
Model R R Square Adjusted R Square 
Std. Error of the 
Estimate 
1 .972a .945 .937 1.26267 
a. Predictors: (Constant), Gel_Width 
b. Dependent Variable: RPII 
 
ANOVAb 
Model Sum of Squares df Mean Square F Sig. 
1 Regression 190.835 1 190.835 119.696 .000a 
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Residual 11.160 7 1.594   
Total 201.995 8    
a. Predictors: (Constant), Gel_Width 
b. Dependent Variable: RPII 
 
Coefficients
a
 
Model 
Unstandardized Coefficients 
Standardized 
Coefficients 
t Sig. 
Collinearity Statistics 
B Std. Error Beta Tolerance VIF 
1 (Constant) 3.593 1.616  2.224 .062   
Gel_Width 13.692 1.251 .972 10.941 .000 1.000 1.000 
a. Dependent Variable: RPII 
 
Collinearity Diagnostics
a
 
Model Dimension Eigenvalue Condition Index 
Variance Proportions 
(Constant) Gel_Width 
1 1 1.965 1.000 .02 .02 
2 .035 7.544 .98 .98 
a. Dependent Variable: RPII 
 
Residuals Statistics
a
 
 Minimum Maximum Mean Std. Deviation N 
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Predicted Value 14.8342 27.2801 20.6578 4.88409 9 
Residual -1.85696 1.93748 .00000 1.18112 9 
Std. Predicted Value -1.192 1.356 .000 1.000 9 
Std. Residual -1.471 1.534 .000 .935 9 
a. Dependent Variable: RPII 
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8.2.1.1.6.4 Regression- IGF-I CT 
 
Variables Entered/Removed
b
 
Model Variables Entered 
Variables 
Removed Method 
1 Gel_Width
a
 . Enter 
a. All requested variables entered. 
b. Dependent Variable: IGF 
 
Model Summaryb 
Model R R Square Adjusted R Square 
Std. Error of the 
Estimate 
1 .678a .459 .382 2.53363 
a. Predictors: (Constant), Gel_Width 
b. Dependent Variable: IGF 
 
 
ANOVA
b
 
Model Sum of Squares df Mean Square F Sig. 
1 Regression 38.127 1 38.127 5.939 .045a 
Residual 44.935 7 6.419   
Total 83.062 8    
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ANOVAb 
Model Sum of Squares df Mean Square F Sig. 
1 Regression 38.127 1 38.127 5.939 .045
a
 
Residual 44.935 7 6.419   
Total 83.062 8    
a. Predictors: (Constant), Gel_Width 
b. Dependent Variable: IGF 
 
Coefficientsa 
Model 
Unstandardized Coefficients 
Standardized 
Coefficients 
t Sig. 
Collinearity Statistics 
B Std. Error Beta Tolerance VIF 
1 (Constant) 14.762 3.242  4.554 .003   
Gel_Width 6.120 2.511 .678 2.437 .045 1.000 1.000 
a. Dependent Variable: IGF 
 
Collinearity Diagnosticsa 
Model Dimension Eigenvalue Condition Index 
Variance Proportions 
(Constant) Gel_Width 
1 1 1.965 1.000 .02 .02 
2 .035 7.544 .98 .98 
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ANOVAb 
Model Sum of Squares df Mean Square F Sig. 
1 Regression 38.127 1 38.127 5.939 .045
a
 
Residual 44.935 7 6.419   
Total 83.062 8    
a. Dependent Variable: IGF 
 
 
Residuals Statisticsa 
 Minimum Maximum Mean Std. Deviation N 
Predicted Value 19.7870 25.3500 22.3900 2.18309 9 
Residual -4.78164 2.21996 .00000 2.36999 9 
Std. Predicted Value -1.192 1.356 .000 1.000 9 
Std. Residual -1.887 .876 .000 .935 9 
a. Dependent Variable: IGF 
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8.2.1.1.6.4.1 Charts 
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8.2.1.1.6.5 Regression- PGC-1 CT 
Variables Entered/Removedb 
Model Variables Entered 
Variables 
Removed Method 
1 Gel_Width
a
 . Enter 
a. All requested variables entered. 
b. Dependent Variable: PGC 
 
 
Model Summaryb 
Model R R Square Adjusted R Square 
Std. Error of the 
Estimate 
1 .833a .694 .651 1.23082 
a. Predictors: (Constant), Gel_Width 
b. Dependent Variable: PGC 
 
 
ANOVAb 
Model Sum of Squares df Mean Square F Sig. 
1 Regression 24.103 1 24.103 15.911 .005a 
Residual 10.604 7 1.515   
Total 34.708 8    
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ANOVAb 
Model Sum of Squares df Mean Square F Sig. 
1 Regression 24.103 1 24.103 15.911 .005
a
 
Residual 10.604 7 1.515   
Total 34.708 8    
a. Predictors: (Constant), Gel_Width 
b. Dependent Variable: PGC 
 
Coefficientsa 
Model 
Unstandardized Coefficients 
Standardized 
Coefficients 
t Sig. 
Collinearity Statistics 
B Std. Error Beta Tolerance VIF 
1 (Constant) 16.732 1.575  10.625 .000   
Gel_Width 4.866 1.220 .833 3.989 .005 1.000 1.000 
a. Dependent Variable: PGC 
 
Collinearity Diagnosticsa 
Model Dimension Eigenvalue Condition Index 
Variance Proportions 
(Constant) Gel_Width 
1 1 1.965 1.000 .02 .02 
2 .035 7.544 .98 .98 
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ANOVAb 
Model Sum of Squares df Mean Square F Sig. 
1 Regression 24.103 1 24.103 15.911 .005
a
 
Residual 10.604 7 1.515   
Total 34.708 8    
a. Dependent Variable: PGC 
 
Residuals Statistics
a
 
 Minimum Maximum Mean Std. Deviation N 
Predicted Value 20.7270 25.1502 22.7967 1.73577 9 
Residual -1.72091 1.88981 .00000 1.15132 9 
Std. Predicted Value -1.192 1.356 .000 1.000 9 
Std. Residual -1.398 1.535 .000 .935 9 
a. Dependent Variable: PGC 
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8.2.1.1.7 Cyclic Stretch Gene Expression Analysis 
 
 
t-test for Equality of Means 
t df Sig. (2-tailed) 
Mean 
Difference 
Std. Error 
Difference 
95% Confidence Interval of the 
Difference 
Lower Upper 
PGC Equal variances assumed .439 4 .683 .13522 .30783 -.71947 .98990 
Equal variances not 
assumed 
.439 2.000 .703 .13522 .30783 -1.18929 1.45972 
MMP9 Equal variances assumed -.656 4 .548 -.57177 .87178 -2.99222 1.84867 
Equal variances not 
assumed 
-.656 2.000 .579 -.57177 .87178 -4.32273 3.17919 
TFAM Equal variances assumed 130.154 4 .000 .98637 .00758 .96533 1.00741 
Equal variances not 
assumed 
130.154 2.000 .000 .98637 .00758 .95376 1.01897 
CYTOC Equal variances assumed -1.081 4 .341 -3.71198 3.43378 -13.24568 5.82171 
Equal variances not 
assumed 
-1.081 2.000 .393 -3.71198 3.43378 -18.48633 11.06236 
COX Equal variances assumed -.871 4 .433 -.40281 .46263 -1.68728 .88166 
Equal variances not 
assumed 
-.871 2.000 .476 -.40281 .46263 -2.39335 1.58773 
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8.2.1.2 Statistical Analysis Chapter 4 
8.2.1.2.1 Normal Distribution Analysis 
 Lactate Glucose mtDNA  PGC-1a Tfam CytoC MMP-9 NRF-1 NRF-2 
Number of values 9 9 9 9 9 9 9 9 9 
          
Minimum 1.4 18.7 140.5 0.4475 0.3276 0.08304 0.8981 0.8766 1 
25% Percentile 1.9 19.25 395.2 0.5482 0.3898 0.3117 1.061 1.051 1.32 
Median 6.4 19.6 626.8 1 1 1 3.399 1.376 2.428 
75% Percentile 7.5 23.25 927.2 2.898 4.209 3.695 8.432 1.702 2.953 
Maximum 7.8 23.9 1748 11.22 10.05 4.036 10.63 1.972 4.627 
          
Normality Test 1          
K2 3.323 3.364 6.513 18.52 7.341 4.958 2.041 0.8722 1.699 
P value 0.1898 0.186 0.0385 < 0.0001 0.0255 0.0838 0.3603 0.6466 0.4275 
Passed normality test? Yes Yes No No No Yes Yes Yes Yes 
P value summary ns ns * **** * ns ns ns ns 
          
Normality Test 2          
W 0.7841 0.835 0.8987 0.6255 0.7732 0.8218 0.8452 0.9497 0.9378 
P value 0.0134 0.0508 0.2443 0.0002 0.0101 0.0361 0.0659 0.6872 0.5593 
Passed normality test? No Yes Yes No No No Yes Yes Yes 
P value summary * ns ns *** * * ns ns ns 
          
Normality Test 3          
KS distance 0.255 0.2877 0.1945 0.3641 0.2644 0.2409 0.214 0.1851 0.1483 
P value 0.0943 0.0305 0.2 0.1 0.0695 0.1457 0.2 0.2 0.2 
Passed normality test? Yes No Yes Yes Yes Yes Yes Yes Yes 
P value summary ns * ns ** ns ns ns ns ns 
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8.2.1.2.2 Peak Glucose and Lactate 
 
Dependent Variable (I) Condition (J) Condition 
Mean 
Difference (I-J) Sig. 
95% Confidence Interval 
Lower Bound Upper Bound 
Lactate 1.00 2.00 -4.900 0.000 -6.392 -3.408 
3.00 -5.767 0.000 -7.258 -4.275 
2.00 1.00 4.900 0.000 -6.392 -3.408 
3.00 -0.8667 0.175 -2.358 0.6251 
3.00 1.00 5.767 0.000 -7.258 -4.275 
2.00 0.8667 0.175 -2.358 0.6251 
Glucose 1.00 2.00 3.333 0.008 1.423 5.244 
3.00 4.400 0.000 2.489 6.311 
2.00 1.00 -3.333 0.008 1.423 5.244 
3.00 1.067 0.183 -0.8440 2.977 
3.00 1.00 -4.400 0.000 2.489 6.311 
2.00 -1.067 0.183 -0.8440 2.977 
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8.2.1.2.3 Nucleic Acid Ratios 
 
Dependent Variable (I) Condition (J) Condition 
Mean 
Difference (I-J) Sig. 
95% Confidence Interval 
Lower Bound Upper Bound 
RNA_DNA .00 1.00 -.26112 .868 -.9999 .4776 
2.00 -.23154 1.000 -.9703 .5072 
1.00 .00 .26112 .868 -.4776 .9999 
2.00 .02958 1.000 -.7092 .7683 
2.00 .00 .23154 1.000 -.5072 .9703 
1.00 -.02958 1.000 -.7683 .7092 
 
8.2.1.2.4 mtDNA Analysis 
 
(I) Condition (J) Condition 
Mean 
Difference (I-J) Sig. 
95% Confidence Interval 
Lower Bound Upper Bound 
1.00 2.00 -201.73926 .563 -1007.7739 604.2954 
3.00 -691.43438 .041 -1497.4690 114.6002 
2.00 1.00 201.73926 .563 -604.2954 1007.7739 
3.00 -489.69512 .188 -1295.7297 316.3395 
3.00 1.00 691.43438 .041 -114.6002 1497.4690 
2.00 489.69512 .188 -316.3395 1295.7297 
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8.2.1.2.5 Gene Expression 
 
Dependent Variable (I) Condition (J) Condition 
Mean 
Difference (I-J) Sig. 
95% Confidence Interval 
Lower Bound Upper Bound 
NRF_1 .00 1.00 -.53833* .021 -.9620 -.1147 
2.00 .40167 .059 -.0220 .8253 
1.00 .00 .53833
*
 .021 .1147 .9620 
2.00 .94000
*
 .002 .5164 1.3636 
2.00 .00 -.40167 .059 -.8253 .0220 
1.00 -.94000* .002 -1.3636 -.5164 
NRF_2 .00 1.00 -1.22067 .220 -3.4046 .9633 
2.00 -1.20733 .225 -3.3913 .9766 
1.00 .00 1.22067 .220 -.9633 3.4046 
2.00 .01333 .989 -2.1706 2.1973 
2.00 .00 1.20733 .225 -.9766 3.3913 
1.00 -.01333 .989 -2.1973 2.1706 
MMP_9 .00 1.00 2.63667 .878 -37.5359 42.8093 
2.00 -36.76667 .066 -76.9393 3.4059 
1.00 .00 -2.63667 .878 -42.8093 37.5359 
2.00 -39.40333 .053 -79.5759 .7693 
2.00 .00 36.76667 .066 -3.4059 76.9393 
1.00 39.40333 .053 -.7693 79.5759 
PGC .00 1.00 -.17133 .945 -6.0050 5.6623 
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2.00 -4.87767 .043 -10.7113 .9560 
1.00 .00 .17133 .945 -5.6623 6.0050 
2.00 -4.70633 .045 -10.5400 1.1273 
2.00 .00 4.87767 .087 -.9560 10.7113 
1.00 4.70633 .045 -1.1273 10.5400 
Tfam .00 1.00 3.49567 .216 -2.6965 9.6878 
2.00 -.25233 .924 -6.4445 5.9398 
1.00 .00 -3.49567 .216 -9.6878 2.6965 
2.00 -3.74800 .189 -9.9402 2.4442 
2.00 .00 .25233 .924 -5.9398 6.4445 
1.00 3.74800 .189 -2.4442 9.9402 
CytoC .00 1.00 1.15267 .077 -.1693 2.4746 
2.00 -2.42033* .004 -3.7423 -1.0984 
1.00 .00 -1.15267 .077 -2.4746 .1693 
2.00 -3.57300
*
 .001 -4.8949 -2.2511 
2.00 .00 2.42033
*
 .004 1.0984 3.7423 
1.00 3.57300
*
 .001 2.2511 4.8949 
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8.2.1.3 Statistical Analysis Chapter 5 
8.2.1.3.1 Normal Distribution Analysis 
 Peak Lactate IGF-I MMP-9 Myostatin MuRF-1 MAFBx 
Number of values 9 11 11 12 12 12 
       
Minimum 1.4 0.5434 1 0.007264 0.2207 0.676 
25% Percentile 1.9 10.27 4.07 0.02799 0.6704 0.8448 
Median 4.9 29.14 10.78 0.1455 1.219 1.003 
75% Percentile 6.4 52.89 23.59 0.2857 1.526 1.697 
Maximum 6.5 93.05 29.96 7.674 3.306 1.925 
       
Normality Test 1       
K2 2.658 1.871 1.364 32.53 5.138 3.676 
P value 0.2647 0.3923 0.5056 < 0.0001 0.0766 0.1591 
Passed normality test? Yes Yes Yes No Yes Yes 
P value summary ns ns ns **** ns ns 
       
Normality Test 2       
W 0.858 0.8639 0.9414 0.4123 0.8916 0.871 
P value 0.0912 0.0647 0.5368 < 0.0001 0.1234 0.0672 
Passed normality test? Yes Yes Yes No Yes Yes 
P value summary ns ns ns **** ns ns 
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Normality Test 3       
KS distance 0.2006 0.2071 0.1588 0.3294 0.2219 0.2528 
P value 0.2 0.2 0.2 0.1 0.1056 0.0329 
Passed normality test? Yes Yes Yes Yes Yes No 
P value summary ns ns ns ns ns * 
 
8.2.1.3.2 Conditioned Media Lactate Analysis 
 
(I) Condition (J) Condition 
Mean 
Difference (I-J) Sig. 
95% Confidence Interval 
Lower Bound Upper Bound 
.00 1.00 4.70000* .000 3.8279 5.5721 
2.00 1.63333* .003 .7613 2.5054 
1.00 .00 -4.70000* .000 -5.5721 -3.8279 
2.00 -3.06667* .000 -3.9387 -2.1946 
2.00 .00 -1.63333
*
 .003 -2.5054 -.7613 
1.00 3.06667* .000 2.1946 3.9387 
 
 
8.2.1.3.3 Gene Expression Analysis 
Dependent Variable (I) Condition (J) Condition 
Mean 
Difference (I-J) Sig. 
95% Confidence Interval 
Lower Bound Upper Bound 
IGF 1.00 2.00 -7.15800 .603 -37.6321 23.3161 
3.00 -61.18646* .001 -89.4000 -32.9730 
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2.00 1.00 7.15800 .603 -23.3161 37.6321 
3.00 -54.02846* .003 -84.5025 -23.5544 
3.00 1.00 61.18646
*
 .001 32.9730 89.4000 
2.00 54.02846
*
 .003 23.5544 84.5025 
MMP9 1.00 RL -18.63386* .005 -29.9644 -7.3033 
SL -12.31072
*
 .027 -22.8007 -1.8207 
2.00 1.00 18.63386
*
 .005 7.3033 29.9644 
3.00 6.32314 .234 -5.0074 17.6537 
3.00 1.00 12.31072* .027 1.8207 22.8007 
2.00 -6.32314 .234 -17.6537 5.0074 
Myostatin 1.00 2.00 .26107 .883 -3.6429 4.1650 
3.00 -1.31829 .407 -4.7472 2.1106 
2.00 1.00 -.26107 .883 -4.1650 3.6429 
3.00 -1.57936 .364 -5.3123 2.1535 
3.00 1.00 1.31829 .407 -2.1106 4.7472 
2.00 1.57936 .364 -2.1535 5.3123 
MuRF1 1.00 2.00 -.61637 .391 -2.1635 .9307 
3.00 .21517 .728 -1.1437 1.5740 
2.00 1.00 .61637 .391 -.9307 2.1635 
3.00 .83154 .235 -.6478 2.3108 
3.00 1.00 -.21517 .728 -1.5740 1.1437 
2.00 -.83154 .235 -2.3108 .6478 
MAFBx 1.00 2.00 -.06754 .860 -.9117 .7767 
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3.00 -.30525 .376 -1.0467 .4362 
2.00 1.00 .06754 .860 -.7767 .9117 
3.00 -.23772 .522 -1.0449 .5695 
3.00 1.00 .30525 .376 -.4362 1.0467 
2.00 .23772 .522 -.5695 1.0449 
IGF_BP5 1.00 2.00 .68000
*
 .008 .2513 1.1087 
3.00 .55400* .020 .1253 .9827 
2.00 1.00 -.68000
*
 .008 -1.1087 -.2513 
3.00 -.12600 .499 -.5547 .3027 
3.00 1.00 -.55400* .020 -.9827 -.1253 
2.00 .12600 .499 -.3027 .5547 
 IGF_BP2 1.00 2.00 .58333 .144 -.2653 1.4320 
3.00 -.48900 .208 -1.3376 .3596 
2.00 1.00 -.58333 .144 -1.4320 .2653 
3.00 -1.07233
*
 .021 -1.9210 -.2237 
3.00 1.00 .48900 .208 -.3596 1.3376 
2.00 1.07233
*
 .021 .2237 1.9210 
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8.3 Appendix 3 
8.3.1 Ethical Clearance Confirmation 
 
 
 
 
 
